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ABSTRACT
The obligatory role of pituitary luteinizing hormone (LH) and
follicle-stimulating hormone (FSH) in the control of testicular function
is well established. However there is increasing experimental evidence,
largely in the rat, that quantitatively normal spermatogenesis not only
requires an adequate local supply of testosterone but also the complex
interactions between the various cellular components within the
seminiferous tubules and interstitial compartments of the testis. The
critical role of paracrine mechanisms in the testis may be reflected by
the defective spermatogenesis in idiopathic male infertility where
systemic levels of LH, FSH and testosterone are normal or elevated.
Thus to further our understanding of the hormonal control of
spermatogenesis and to define possible aetiological mechanisms in the
infertile man, the study of paracrine mechanisms in the human testis is
of paramount importance.
The approach to study paracrine mechanisms in the human testis was
to establish in vitro techniques whereby individual components of the
testis were isolated and specific functional markers defined so that
their subsequent interaction could be further studied in vitro. At the
same time, the delineation of these 'local' parameters were related to
the overall functional states of the testis as defined by circulating
levels of LH, FSH, testosterone and the histological assessment of
spermatogenesis.
Testes were obtained at orchidectomy for prostatic carcinoma.
Methods were established to examine the effect of intratesticular levels
of testosterone and systemic levels of LH, FSH and testosterone on
quantitative measures of spermatogenesis. For this purpose a simple
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technique which involved enumeration of spermatid nuclei in fixed
testicular homogenates to determine daily sperm production was adopted.
Daily sperm production in this group of ageing testes was generally
lower than has been observed previously for younger men. Although
intratesticular levels of testosterone varied widely there was no
indication of an intratesticular deficiency of testosterone as a
critical factor in subnormal spermatogenesis in the ageing testis.
Inhibin, a peptide marker of Sertoli cell function was measured in
human testicular extracts by bio- and radioimmunoassay. The
relationship observed between FSH and both inhibin bioactivity and
immunoactivity imply that the role of inhibin in the testis may be
somewhat different to the classical concept of FSH feedback.
A technique for the routine isolation of human Leydig cells was
established. Human Leydig cells purified by Percoll density
centrifugation were highly responsive to hCG, although sensitivity and
receptor number were significantly lower compared to the rat. This
system was used to test for the effects of putative paracrine factors on
human Leydig cell function.
In conclusion, a number of in vitro techniques have been
established and validated which provide a basis for future investigation
of seminiferous tubule and Leydig cell function in the human testis.
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CHAPTER 1
Review of the Literature
1
1.1 HISTORICAL ASPECTS
Since Neolithic times the importance of the male gonads in libido
and potency has been recognized. Castration as a punishment for sexual
offences was described as early as 2000 BC. Aristotle (400 BC) studied
/'
the effects of pre- and postpubertal castration in roosters and in man.
Despite his observations and accurate illustrations of testicular
anatomy, Aristotle maintained that the testes were not necessary for
fertility. The Romans believed the testes to be witnesses of a man's
virility, and hence our word "testis" comes from the Latin "testis"
meaning witness or spectator.
With the development of the simple microscope, de Graaf (1668)
described the testis as being composed of tubules. He also established
that the production of the fertilizing portion of the semen originates
in the testes. In 1677 Leeuwenhoek demonstrated the existence of
"animacules" or spermatozoa, which he thought were young developing
animals, in seminal fluid. By 1840 Koelliker concluded that the
spermatozoa are not young developing animals, but are the product of
cell development within the seminiferous tubules.
The "branched cells" of the testis which now bear his name were
described by Sertoli in 1865. He opposed previous suggestions that the
spermatozoa arose from his "branched cells" and described how the cells,
which we now call round spermatids, metamorphose into spermatozoa.
Sertoli also identified two types of spermatogonia and described three
developmental stages of the spermatocytes.
From his studies on the transplantation of testes from roosters to
ectopic sites in capons, Berthold (1849) concluded that a substance from
the testis must be transmitted through the bloodstream to affect other
tissues. This was the first description of the endocrine function of
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any gland. Although he did not attribute any endocrine function to the
cells named after him, Leydig (1850) first described the interstitial
cells of the testis. An endocrine role for the Leydig cells was
established in 1903 when Bouin and Ancell reported that in man and
animals with cryptorchidism, in whom there is no spermatogenesis but the
interstitial cells are intact, androgen-dependent functions, such as the
development of secondary sexual characteristics, are maintained.
Attempts to isolate the male hormones began in 1927 when McGee
prepared an extract from bull testes, which, when administered to
capons, was capable of restoring their masculinity. In 1935 the male
hormone, testosterone, was isolated from the testis by David and
co-workers and Ruzicka & Wettstein.
Around this time the importance of the pituitary involvement in
gonadal function was realized. Following the observations of Cushing
(1910) and Aschner (1912), who removed the pituitary in dogs and showed
that hypopituitarism led to genital hypoplasia, the idea that the
functions of the gonads might be regulated by a factor from the anterior
pituitary had been suggested. The two pituitary hormones which in the
ovary stimulate follicular growth (follicle-stimulating hormone - FSH)
and cause luteinization (luteinizing hormone - LH) were extracted from
the anterior pituitary (Fevold et al. 1931) and the relation of FSH to
spermatogenesis and LH to Leydig cell function was demonstrated by Greep
and co-workers (Greep et al. 1936; Greep & Fevold, 1937). The precise
role of FSH became less clear when it was shown that testosterone in the
absence of the pituitary is capable of maintaining spermatogenesis
(Walsh et al. 1934). The precise role of FSH in regulating
spermatogenesis remains a contentious issue to this day.
The past 30-40 years have seen great advances in our understanding
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of testicular structure and function. Detailed morphological studies in
the 1950's and 1960's revealed the structure and organization of
spermatogenesis in a number of species. Clermont (1963) and Heller &
Clermont (1964) described the cycle of the human seminiferous epithelium
and its organization into cell associations.
During the 1970's the emphasis was on the hormonal regulation of
spermatogenesis. The development of a number of techniques which
enabled the detection of sex steroids and pituitary hormones, and the
identification of target cells within the testis for these hormones,
subsequently led to the elucidation of molecular mechanisms for hormone
action.
In the 1980's a number of factors produced locally within the
testis, which are thought to mediate the interaction between the various
cellular elements in response to gonadotrophin stimulation, have been
identified. Most of the information on these intratesticular or
paracrine factors is derived from studies in the rat. The importance of
paracrine control of the human testis and possible dysfunction of these
mechanisms in idiopathic male infertility are only just being realized,




Spermatogenesis is the process by which the male gametes, the
spermatozoa, are formed. This takes place within the seminiferous
tubules where there is a close morphological relationship between the
developing germ cells and the Sertoli cells (see 1.3.1). Cell processes
from adjacent Sertoli cells extend laterally to envelop the developing
germ cells (Fig. 1.1). Within this arrangement, the germ cells proceed
through the developmental stages of spermatogenesis.
The spermatogonia are the stem cells from which all spermatozoa are
derived, the spermatogonia themselves being descended from the
primordial germ cells which reach and multiply in the genital cords in
the developing testis. In the fully differentiated testis the
spermatogonia are situated along the basement membrane of the
seminiferous tubule. In man three basic types of spermatogonia can be
distinguished - dark type A, pale type A and type B (Clermont, 1963).
Dark type A spermatogonia divide to maintain the basic store of
spermatogonia and also give rise to some pale type A cells which divide
and differentiate into type B spermatogonia. Type B spermatogonia
divide to produce the primary spermatocytes. The spermatocytes then go
through a long prophase which shows characteristic configurations of the
chromosomes (leptotene, zygotene, pachytene). This prophase is then
followed by the subsequent steps of the first reduction division that
yields the secondary spermatocytes containing the haploid number of
chromosomes. Each secondary spermatocyte then undergoes the second
reduction division to produce two round spermatids. These spermatids
then go through a series of nuclear and cytoplasmic modifications to
produce mature spermatozoa.
The seminiferous epithelium therefore is composed of four or five
5
FIGURE 1.1
Diagramatic representation of the developing germ cells enveloped in
the Sertoli cell cytoplasm.
From: Histology, M. Dym, p.979, Weiss, L. and Greep, R.O.







distinct generations of germ cells at different stages of development.
Cytological studies have shown that at any point in the seminiferous
tubule these generations of cells are not randomly arranged but form
cellular associations of fixed composition, such that spermatids at a
given stage of development are always associated with the same types of
spermatogonia and spermatocytes. The activities of several generations
of germ cells pass through a cycle, the length of which and the number
of stages involved vary in different species (Clermont, 1972). In man,
each cycle occupies about sixteen days (Heller & Clermont, 1964) and
comprises six different cell associations or stages (Clermont, 1963;
Fig. 1.2). In the rat, the cycle comprises fourteen different stages (I
- XIV) lasting approximately twelve days (Le Blond & Clermont, 1952).
These stages of the cycle of the seminiferous epithelium reflect the
constant rate of germ cell development, the cyclic commitment of the
cells to differentiation and the gradual displacement of successive
generations of maturing cells towards the tubular lumen.
The functional requirements of each individual stage have been
studied in the rat, aided by the spatial arrangement of each successive
stage of the spermatogenic cycle along the length of the seminiferous
tubule. This spatial arrangement is known as the wave of the
seminiferous epithelium, and in most mammals, including the rat, each
stage is distributed in sequence along the length of the seminiferous
tubule (Perey et al. 1961). This has permitted the development of
transillumination-assisted seminiferous tubule dissection in which pools
of seminiferous tubules at one specific stage of the cycle can be
isolated and their functional requirements investigated (Parvinen, 1982;
Parvinen & Ruokonen, 1982). Such studies have not been possible in the
human as different stages occupy helically running strip-shaped areas
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FIGURE 1.2
Diagramatic illustration of the cellular composition of six stages
(I - VI) of the cycle of the seminiferous epithelium in man. The
stages correspond to cell associations which succeed one another in
time in any given area of the seminiferous tubule according to the
sequence I - VI. Following stage VI, stage I reappears and the
sequence starts over again. The space allotted to each stage of the
cycle is proportional to its relative duration. The arrows correspond
to the most advanced labelled cells at various time intervals
(indicated on the arrows ) after an intratesticular injection of
^H-thymidine.
Ad, Ap, B - dark type A, pale type A,type B spermatogonia;
PI, L, Z, P - preleptotene, leptotene, zygotene, pachytene primary
spermatocytes; II - secondary spermatocytes; S - spermatids; SZ -
spermatozoa.
From: Y. Clermont (1970), In: The Human Testis, E. Rosemberg & C.A.






of the seminiferous epithelium (Schulze & Rehder, 1984). One area of
the seminiferous tubule is occupied by up to three stages (Kerr & de
Kretser, 1981), and as such, individual stages cannot be isolated.
Nevertheless there ..is much evidence to suggest that the functional
/
requirements of germinal cells in the human testis are analogous to
those in the rat (Sharpe, 1986).
While the morphological and kinetic aspects of spermatogenesis have
been studied extensively, we are now beginning to appreciate that the
control of spermatogenesis involves local interaction between the
various cell types within the testis. The problem that concerns us now
is the identification of the factors involved in this process.
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1.3 THE SERTOLI CELL
Since it was first described the Sertoli cell has been associated
with the process of spermatogenesis, but its importance is only now
being realized. ^
Primitive Sertoli cells, which differentiate from the
mesenchymatous medullary gonadal blastema, form cell cords which embody
the germ cells (Witschi, 1970; Jost et al. 1974). Mitosis of the
Sertoli cell occurs only in the immature testis (Clermont & Perey, 1957;
Steinberger & Steinberger, 1971), apparently independent of hormonal
control. After puberty Sertoli cell number remains constant, and this
fact has been employed in the use of the Sertoli cell as a constant
reference in the quantitation of spermatogenesis (Rowley & Heller,
1971). An age-related decline in Sertoli cell number has however
recently been observed (Johnson et al. 1984).
1.3.1 Blood-testis barrier
By virtue of its position in the seminiferous epithelium, the
Sertoli cell is intimately involved in the process of spermatogenesis.
The Sertoli cell maintains the integrity of the seminiferous epithelium
by specialized contacts with adjacent germ cells (see Russell, 1980 for
review). These specialized junctions also facilitate the movement of
maturing germ cells from the basal aspects of the seminiferous
epithelium to the tubular lumen (Russell, 1980).
In addition to the specialized Sertoli-germ cell contacts, adjacent
Sertoli cells are connected by tight junctions in the basal aspect of
the seminiferous epithelium. These tight junctions are the site of the
blood-testis barrier which separates the seminiferous epithelium into
basal and adluminal compartments (Fawcett, 1975) (Fig. 1.3). The basal
compartment contains spermatogonia and early spermatocytes which share a
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FIGURE 1.3
Illustration of Sertoli cell tight junctions which are the main
component of the blood-testis barrier. These structures divide the
seminiferous epithelium into a basal compartment which is occupied by
the spermatogonia and preleptotene spermatocytes, and an adluminal
compartment containing the postmeiotic germ cells.
From: D.W.Fawcett (1975), Handbook of Physiology, Section 7 Vol V.
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position with the Sertoli cell on the basal lamina and are interposed
between adjoining Sertoli cells in such a way that the Sertoli cells
arch over these cells and meet above them. Internal to the tight
junctions late spermatocytes and spermatids are situated in the
adluminal compartment.
The first evidence for the existence of the blood-testis barrier
came from the realization that seminiferous tubule fluid and rete testis
fluid were very different in composition from blood plasma and
testicular interstitial fluid (Setchell et al. 1969). The variation in
the rate of entry of various radiolabelled markers into the seminiferous
tubule from the blood added to the evidence for the existence of a
barrier. Electron microscopic studies with horseradish peroxidase and
lanthanum, both electron-dense intracellular markers, showed that
cell-cell junctions within the seminiferous epithelium constituted a
barrier to the passage of substances into the tubular fluid (Fawcett et
al. 1970; Dym & Fawcett, 1970).
Tight junctions between Sertoli cells first appear at puberty with
the development of the primary spermatocytes (Vitale et al. 1973). This
event coincides with the completion of Sertoli cell proliferation and
the secretion of seminiferous tubule fluid from these cells into the
newly formed tubular lumen. Seminiferous tubule fluid contains high
concentrations of potassium and bicarbonate and low levels of sodium and
chloride, compared to blood plasma or interstitial fluid (Setchell &
Waites, 1975). One of the main functions of the blood-testis barrier is
to maintain the ionic composition of the seminiferous tubule fluid which
creates a specific intratubular environment suitable for meiosis and
maturation of the postmeiotic germ cells (Setchell, 1980).
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Entry of substances into the seminiferous tubules depends mainly on
their lipid solubility; in general entry is high where lipid solubility
is high (Setchell & Waites, 1975). Testosterone enters seminiferous
tubule fluid much more rapidly than its lipid solubility would suggest
(Cooper & Waites, 1975; Setchell et al. 1978b). A specific saturable
carrier mechanism involving facilitated diffusion is thought to be
utilized in the transport of testosterone into the seminiferous tubules
(Setchell et al. 1978b).
FSH gains access to the basal compartment of the seminiferous
tubules by penetrating between the myoid cells at sites where cell-cell
junctions are relatively open (Dym & Fawcett, 1970). FSH is unable to
cross the blood-testis barrier and enter the adluminal compartment of
the seminiferous epithelium (Setchell et al. 1976). Therefore not
surprisingly all FSH-receptors are situated in the basal compartment of
the seminiferous epithelium (Orth & Christensen, 1979).
In addition, haploid germ cells, which express surface autoantigens
after meiosis, within the adluminal compartment of the seminiferous
epithelium are protected by the blood-testis barrier which ensures that
they are not recognized by the immune system (Millette & Bellve, 1977;
O'Rand & Romrell, 1977).
The integrity of the blood-testis barrier is maintained even when
the spermatocytes enter meiotic prophase and move from the basal into
the adluminal compartment. During this migration new tight junctions at
the base of the spermatocytes are formed while the old adluminal
junctions are still intact (Russell, 1977b).
From what we know about the blood-testis barrier it seems likely
that its functional integrity is essential for normal spermatogenesis.
Further study is required to see if specific abnormalities in the
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structure and function of the blood-testis barrier are associated with
abnormal spermatogenesis and impaired fertility.
1.3.2 Synthesis and secretion of proteins from the Sertoli cell
The tight junctional complexes which form the blood-testis barrier
prevent the free access of compounds in blood plasma to the germ cells in
the adluminal compartment. The Sertoli cell by the secretion of a number
of serum- and testis-specific proteins, is responsible for regulating
the environment in which the germ cells in the adluminal compartment
divide and differentiate.
A number of Sertoli cell products have been identified and used to
monitor the hormonal and cellular control of the Sertoli cells and the
seminiferous epithelium in vitro. Attempts have also been made to
measure specific Sertoli cell products in blood or semen to provide a
means of assessing testicular function and dysfunction in vivo,
(i) Androgen binding protein
Androgen binding protein (ABP), the first Sertoli cell protein to be
identified in the rat, is thought to maintain high concentrations of
androgen within the seminiferous tubule and lumen of the caput epididymis
and thus be important in spermatogenesis and sperm transport (Hansson &
Tveter, 1971; Ritzen et al. 1971; French & Ritzen, 1973; Hagenas et
al. 1975).
The purification and subsequent development of a radioimmunoassay
for ABP showed that small amounts of this specific protein are secreted
into the systemic circulation in rats (Gunsalus et al. 1978, 1980). This
observation gave rise to the idea that by measuring ABP levels in blood,
Sertoli cell function could be monitored, and as such the structure and
function of ABP has been observed in a number of species.
Studies attempting to demonstrate the presence of ABP in the human
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testis have been hampered by the presence of testosterone-oestrogen
binding globulin (TeBG) from serum (Bardin et al. 1981). A number of
studies have suggested the presence of a distinct human ABP which can be
distinguished from TeBG by charge and binding kinetics (Hsu & Troen,
1978). Furthermore, human Sertoli cells cultured in vitro have been
shown to secrete ABP which has physicochemical characteristics similar
to rat ABP, but as yet, correlation of human ABP with other aspects of
human testicular function is lacking.
(ii) Inhibin
Inhibin is a gonadal glycoprotein which feeds back to the anterior
pituitary to regulate the secretion of FSH, and in the male is produced
by the Sertoli cell (Steinberger & Steinberger, 1976). The existence of
a testicular factor which in some way regulates the pituitary gland was
suggested as early as 1923 when Mottram & Cramer observed morphological
changes in the anterior pituitary gland of a male rat whose seminiferous
epithelium was severely disrupted by radiation. Then in 1932 McCullagh,
who showed that injection of a water soluble extract from bovine testes
could inhibit the morphological changes in the pituitary cells following
irradiation, named this hypothetical testicular factor inhibin. Since
these early studies, suppressive effects of steroid-free testicular
preparations from a number of species on the pituitary production and
secretion of FSH have been described in a number of in vivo and in vitro
systems.
Conflicting reports existed concerning the properties of inhibin and
its purification until in 1985 the full sequence of two 32 kDa forms of
porcine follicular fluid inhibin were published (Mason et al. 1985).
The availablity of purified inhibin has enabled the development of
radioimmunoassay techniques for its measurement, which has confirmed the
16
hormonal nature of this peptide in the female (Tsonis et al. 1987b). The
development of more sensitive assay techniques for the detection of
inhibin in the systemic circulation in the male could prove a useful tool
in the diagnosis of infertility in men with disorders of the seminiferous
epithelium. Furthermore, because of its ability to suppress the
secretion of FSH, which theoretically could lead to a reduction in germ
cell production, inhibin has often been regarded as a potential regulator
of fertility in men. This avenue of potential male contraception must
however await confirmation of the actual role of FSH in germ cell
development in man.
(iii) Transferrin
Transferrin from the liver is found in the serum of all vertebrates,
and until recently it was thought that the Sertoli cell served as an
intermediate in the transport of iron from serum transferrin, across the
blood-testis barrier to the germ cells in the adluminal compartment of
the seminiferous epithelium. However testicular transferrin is secreted
by the Sertoli cell (Skinner & Griswold, 1980), and it is now believed
that the transport of iron to the developing germ cells is mediated by
the shuttling of the iron between the two distinct forms of transferrin
(Djakiew et al. 1986).
Diferric transferrin binds to its receptor on the basal plasma
membrane of the Sertoli cell, after which is is internalized by receptor
mediated endocytosis into the endocytic organelles (Morales & Clermont,
1986). Here, in an acidic atmosphere, iron is dissociated from serum
transferrin and released into the Sertoli cell cytoplasm. Subsequently
the transferrin molecule, still bound to its receptor, recycles to the
cell surface as apotransferrin, and the iron, now bound to testicular
transferrin is secreted from the apical pole of the Sertoli cells to the
17
developing germ cells and/or the lumen of the seminiferous tubule
(Djakiew et al. 1986).
Secretion of transferrin by the rat Sertoli cell varies according
to the stage of the spermatogenic cycle, secretion being highest in
stages IX to XIV (Wright et al. 1983). Human Sertoli cells stimulated
by FSH also secrete transferrin in culture (Lipshultz et al. 1982;
Holmes et al. 1984). Cellular interaction between the Sertoli cells and
the peritubular cells also appears to be involved in the control of
transferrin secretion in both the rat and man (see 1.6.3).
The majority of the transferrin in human seminal plasma is thought
to be of testicular origin and the use of seminal plasma transferrin as
a marker of Sertoli cell function has been suggested (Holmes et al.
1982). Liu and co-workers (1986) confirmed that seminal plasma
transferrin reflects Sertoli cell function, but that this is of limited
clinical value as the range of transferrin in seminal plasma from normal
men is wide and overlaps with values from men with genital tract
obstruction or seminiferous tubule failure.
(iv) Plasminogen activator
Sertoli cells in culture secrete the protease plasminogen activator
under the regulation of FSH (Lacroix et al. 1977; Lacroix & Fritz,
1982). Plasminogen, the substrate of plasminogen activator is
synthesized in the liver. Diffusion of circulating plasminogen into the
adluminal compartment of the seminiferous tubules has not been
demonstrated, suggesting the possible local synthesis of plasminogen.
Plasminogen can be detected in culture medium from rat seminiferous
tubules, however its cellular source remains unknown (Saksela & Vihko,
1986).
The secretion of plasminogen activator by the Sertoli cells is
highly stage-specific, with maximal secretion during stages VII and VIII
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in the rat (Lacroix et al. 1981; Vihko et al. 1984; Vihko et al.
1985). At these stages in the spermatogenic cycle, preleptotene primary
spermatocytes enter the adluminal compartment of the seminiferous
epithelium prior to meiosis and concomitantly spermatids are released
into the tubular lumen (Le Blond & Clermont, 1952). In the absence of
these specific germ cells, the stage VII-VIII secretion of plasminogen
activator is abolished indicating the role of plasminogen activator in
the restructuring of the seminiferous epithelium during germ cell
movement (Vihko et al. 1984).
(v) Gamma glutamyl transpeptidase
Gamma glutamyl transpeptidase (GGT) catalyses the transpeptidation
reaction which appears to be involved in the transport of certain amino
acids across the blood-testis barrier (Bustamante et al. 1982). Human
Sertoli cells contain GGT activity similar to that of the rat (Lipshultz
et al. 1982). In contrast to the rat, human Sertoli cell GGT is
responsive to FSH. This response is hormone specific and dose-dependent
(Lipshultz et al. 1982). In both the rat and the human GGT activity was
thought to be correlated solely with the Sertoli cell and thus appeared
to be an important marker of Sertoli cell function (Hodgen & Sherins,
1973; Krueger et al. 1974; Lipshultz et al. 1982; Tindall et al.
1983). More recently, studies in the rat have demonstrated that GGT
activity is localized predominantly in the arterial and arteriolar
endothelium (Niemi & Setchell, 1986). The specific activity of GGT
increases coincident with puberty and has been linked to the cessation
of Sertoli cell mitosis prior to the onset of spermatogenesis (Hodgen &
Sherins, 1973; Lu & Steinberger, 1977). This pubertal increase in GGT
activity could be associated with the increased volume of the vascular
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endothelium which takes place around this time (Niemi & Setchell, 1986).
GGT activity in testis homogenates and in homogenized cultured Sertoli
cells (Lu & Steinberger, 1977) could be explained by the effects of
contaminating endothelial cells (Niemi & Setchell, 1986). This new
information casts doubt on the possibility of the use of GGT as a
biological marker of Sertoli cell function.
(vi) Lactate and pyruvate production by the Sertoli cell
Glucose is essential for the maintenance of spermatogenesis in vivo
(Mancini et al. 1960). Induction of acute hypoglycaemia results in germ
cell degeneration (Zysk et al. 1975). The capacity of isolated germ
cells to utilize glucose as an energy source however appears to be poor,
as isolated pachytene spermatocytes and round spermatids do not survive
in the presence of glucose alone (Jutte et al. 1981). The failure of
the germ cells to utilize glucose directly appears to be due to a block
in glycolysis at the level of glyceraldehyde-3-phosphate dehydrogenase
(Cervenka et al. 1986). The maintenance of metabolic activity of germ
cells, as indicated by oxygen consumption and protein synthesis, is
dependent on exogenous lactate (Jutte et al. 1981). Lactate production
by the Sertoli cell in co-culture with pachytene spermatocytes is able
to maintain the metabolic activity and integrity of the germ cells, but
only in the presence of glucose (Jutte et al. 1982).
The specific isoenzyme of lactate dehydrogenase (LDH-C4) is present
in pachytene spermatocytes and round spermatids (Meistrich et al. 1977).
Lactate from the Sertoli cells can be utilized by means of LDH-C4, which
has been shown to preferentially catalyze the oxidation of lactate to
pyruvate (Blanco et al. 1976) . Lactate oxidation to pyruvate via the
tricarboxylic acid cycle supplies the germ cells with energy in the form
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of ATP.
LDH-C4 activity from the testis is present in seminal plasma
(Clausen & 0vlison, 1965). The extracellular presence of cell specific
intracellular enzymes is an indication of cell and/or membrane y
destruction. LDH-C4 activity in human seminal plasma has been shown to
originate from germ cells which have degenerated before release into the
semen, with increased LDH-C4/sperm ratio indicating dysfunction of the
seminiferous epithelium (Eliasson & Virji, 1985). LDH-C4 in relation to
sperm number is therefore an important marker, indicating the functional
status of the seminiferous epithelium.
1.3.3 Sertoli cell growth factors
A number of Sertoli cell-derived growth factors appear to be
involved in the paracrine regulation of the testis. Not surprisingly,
spermatogenesis, the most proliferative cell process in the body, might
be expected to be regulated by mitogenic factors of Sertoli cell origin.
Increasing awareness that growth factors are regulators of cell
metabolism and growth has prompted study of specific growth factor
contribution to the spermatogenic process.
(i) Sertoli cell regulators of mitosis and meiosis
Seminiferous growth factor (SGF) is a polypeptide thought to be of
Sertoli cell origin which is present in all mammals, including man
(Feig et al. 1983). The action of SGF is to induce DNA synthesis and
cell proliferation of prepubertal Sertoli cells, regulate the mitotic
division of the spermatogonia in the basal compartment of the
seminiferous epithelium and to induce the meiotic reduction divisions of
the spermatocytes in the adluminal compartment of the seminiferous
epithelium (Bellve & Feig, 1984).
In addition to SGF, meiosis in the male is regulated by two Sertoli
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cell products - meiosis-preventing substance (MPS) and meiosis-inducing
substance (MIS). In the human MPS activity is found in the foetus and
the prepubertal male, whereas little or no MPS activity is found in the
adult testis (Grinsted & Byskov, 1981). Prior to puberty the germ cells
appear to be prevented from entering meiosis by MPS (Byskov, 1978;
Grinsted et al. 1979). MIS activity is found both in foetal and adult
testes.
In the rat maximum MIS secretion is observed at the onset of
meiosis in stages VII and VIII. It is also secreted in high amounts
during the meiotic reduction divisions of stages XII and I (Parvinen,
1982). In contrast to the human, MPS is secreted at a constant rate in
the testes of adult rats. The role of MPS in the adult rat seems to be
the prevention of the spermatogonia from entering meiosis until maximum
MIS secretion at the appropriate stage of the cycle.
(ii) Somatomedin-C/insulin-like growth factor
In both clinical (Kulin et al. 1981) and experimental (Swerdloff &
Odell, 1977; Zipf et al. 1978) situations, growth hormone (GH)
increases LH-stimulated testosterone production by the Leydig cells in a
dose-dependent manner. Many of the physiological actions of GH are
thought to be mediated by the somatomedins, a family of small
polypeptide growth factors with insulin-like activity (Herrington et al.
1983). Somatomedin-C/insulin-like growth factor 1 (Sm-C/IGF 1) is the
most directly GH dependent of these peptides and originates in a number
of tissues, including ovarian granulosa cells (Adashi et al. 1985) and
testicular Sertoli cells (Ritzen, 1983).
Sm-C/IGF 1 accumulates in the medium of cultured Sertoli cells from
immature rats (Tres et al. 1986) and immature pigs (Benahmed et al.
1987). Recently immunoreactive Sm-C/IGF 1 has been reported to be
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present in rat peritubular myoid cell-conditioned medium (Skinner &
Fritz, 1986). In addition, both rat Sertoli and peritubular cells
display Sm-C/IGF 1 immunoreactivity as determined by immunofluorescence
and RIA (Tres et al. 1986). However the 1% peritubular cell
contamination of rat Sertoli cell cultures is not sufficient to account
for the amount of Sm-C/IGF 1-like activity detected in Sertoli cell
culture medium (Smith et al. 1987).
Immunocytochemical studies have demonstrated that Sertoli cells
show binding affinity for Sm-C/IGF 1 (Tres et al. 1986), and the
mitogenic effects of IGF 1 on immature Sertoli cells in culture have
been shown previously (Borland et al. 1984). In hypophysectomized adult
rats however very little binding of Sm-C/IGF 1 to Sertoli cells is
observed (Kasson & Hsueh, 1987). Sm-C/IGF 1 may therefore have
autocrine effects on Sertoli cell proliferation in the prepubertal
animal.
Binding of Sm-C/IGF 1 to pachytene spermatocytes has been observed
in immunofluorescent studies of Sertoli-germ cell co-cultures (Tres et
al. 1986). The significance of Sm-C/IGF 1 activity in Sertoli and germ
cell function is unknown, but it has been suggested that late meiotic
prophase spermatocytes may be stimulated by Sm-C/IGF 1 to progress into
meiotic division (Tres et al. 1986).
The presence of receptors for Sm-C/IGF 1 on Leydig cells
(Handelsman et al. 1985) adds this polypeptide to the increasing list of
potential Sertoli cell regulators of Leydig cell function (see 1.6.1).
The addition of Sm-C/IGF 1 to cultured porcine Leydig cells results in
increased LH/hCG binding in addition to increased hCG stimulated
testosterone production (Benahmed et al. 1987; Kasson & Hsueh, 1987).
Sm-C/IGF 1 while having no effect on its own, augments the steroidogenic
23
action of LH/hCG. Although the mechanism by which Sm-C/IGF 1 exerts its
effects on Leydig cell function remains unclear, this does not appear
to be due to a Sm-C/IGF 1 related increase in Leydig cell growth
(Benahmed et al. 1987).
The results suggest that Sm-C/IGF 1 derived from the Sertoli cell,
possibly under the control of GH, augments the actions of LH on Leydig
cell androgen biosynthesis, Sertoli cell function and ultimately
spermatogenesis.
(iii) Testicular interleukin-1
Interleukin-1 (IL-1), which represents a family of polypeptides,
was initially described as a macrophage-derived growth factor
(Dinarello, 1985). Infections, immunological reactions, injury, toxins
and inflammatory processes trigger IL-1 production. IL-1 is a potent
mitogen not only of lymphocytes but also of a number of other cell types
including fibroblasts, glial cells, osteoblasts, chondrocytes, synovial
cells, mesangial kidney cells and epithelial cells (Dinarello, 1985).
Significant amounts of IL-1 have been found in homogenates and cytosol
preparations of rat testis (Khan et al. 1987). Testicular macrophages,
which are predominantly confined to the interstitium (El-Demiry et al.
1986), appear not to be the major source of testicular IL-1, as
interstitial cell homogenates show negligible activity in a murine
thymocyte bioassay for IL-1 (Khan et al. 1987). Seminiferous tubules
from cryptorchid rats, devoid of germ cells, retain IL-1 activity,
pointing to the Sertoli cell as its most likely source. Whether IL-1
produced from these cells is related to the macrophage IL-1 family
remains to be clarified.
IL-1 activity has also recently been demonstrated in the human
testis (Arver & Sb'der, 1986). Relapse of childhood acute lymphoblastic
24
leukaemia often starts in the testis (Nesbit et al. 1980), and it has
been suggested that the presence of IL-1 in the testis may provide a
favourable environment for the rapid proliferation of lymphocytes in
this disease (Khan et al. 1987). Purification of human testicular IL-1
is now underway to investigate whether this mitogenic factor is involved
in the prolific germ cell activity during spermatogenesis (0. Soder,
personal communication).
1.3.4 Sertoli cell androgen receptors
Androgens are known to be essential for quantitatively normal
spermatogenesis to proceed (Steinberger, 1971). Although it is
conceivable that androgens could act directly on the germ cells,
conflicting evidence exists as to the presence of androgen receptors on
these cells (Sanborn et al. 1975; Grootegoed et al. 1977; Wright &
Frankel, 1980). The indirect action of androgens on spermatogenesis by
influencing Sertoli cell function is well accepted. High affinity
receptors specific for testosterone have been demonstrated in the
Sertoli cell. The presence of cytoplasmic androgen receptors (Tindall
et al. 1977) and the translocation of the hormone-receptor complex to
nuclear binding sites (Mulder et al. 1976; Sanborn et al. 1977),
chromatin acceptor sites for androgen receptor complexes (Tsai et al.
1977) and promotion of Sertoli cell secretory activity in the presence
of testosterone (Louis & Fritz, 1979) indicate the Sertoli cell as an
androgen target cell in the rat. Androgen receptors are however also
present on peritubular cells (Verhoeven, 1980), and androgen effects on
these cells are thought to modulate the function of the Sertoli cell
(see 1.6.3).
Androgen receptors have been demonstrated in the seminiferous
tubules of the human testis (Winters & Troen, 1984). To date there is
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no report of localization of the androgen receptor to specific
testicular cell types in man.
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1.4 INTERSTITIAL TISSUE
The interstitial tissue, which gives support to the seminiferous
tubules, is composed of loose connective tissue interspersed with Leydig
cells, macrophages, fibroblasts, vascular and lymphatic vessels and
unmyelinated nerve fibres (Fawcett et al. 1973). Copious amounts of
interstitial fluid, formed from serum by capillary filtration,
circulates in the interstitium (Setchell & Sharpe, 1981). This fluid is
a means of communication between the avascular seminiferous tubules and
the vascularized interstitial tissue.
The Leydig cell is the most common interstitial cell type. These
cells occur singly or in clumps of varying sizes and are often
associated with rich plexuses of vascular and lymphatic capillaries
(Fawcett et al. 1973).
Macrophages are present in the testicular interstitium of a number
of species including man (Kerr & de Kretser, 1981) and the rat
(Christensen & Gillim, 1969). Testicular macrophages are observed in
close association with the Leydig cells. In the rat, processes which
extend from the Leydig cells have been shown to interdigitate and make
contact with macrophage surface membranes (Miller et al. 1983).
Although these specialized contacts are thought to be associated with
the transport of waste materials and Leydig cell metabolites, it has
been suggested that testicular macrophages are involved in the endocrine
function of the testis (see 1.6.4).
Testicular fibroblasts of the human testis are thought to be Leydig
cell precursors (Chemes et al. 1985). Following hCG stimulation these
cells have been shown to differentiate into mature Leydig cells capable
of secreting testosterone (Chemes et al. 1985).
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1.4.1 The Leydlg cell
In mammals there are two generations of Leydig cells. Foetal
Leydig cells are of mesenchymal origin and are stimulated to develop by
placental hCG (Clements et al. 1976). These cells possess receptors for
LH, and under the influence of foetal pituitary LH they secrete
testosterone (Huhtaniemi et al. 1977) for masculinization of the foetus
(Roosen-Runge & Anderson, 1959). During early postnatal life foetal
Leydig cells undergo involution. Although the ultimate fate of these
cells is unknown, they are thought either to degenerate or to
de-differentiate and become fibroblast-like mesenchymal cells which at
puberty respond to LH and differentiate into the adult generation of
Leydig cells (Chemes et al. 1985). This adult Leydig cell population
although derived mainly from interstitial mesenchymal cells are also, to
a lesser extent, derived from mitosis of fully differentiated Leydig
cells (Mancini et al. 1963). Adult Leydig cells are rich in smooth
endoplasmic reticulum, Golgi apparatus and mitochondria, the organelles
involved in the synthesis of androgens and other Leydig cell products
(Ewing & Zirkin, 1983).
The onset of puberty is associated with altered frequency and
amplitude of LHRH secretion from the hypothalamus resulting in the
increased secretion of LH from the pituitary. Proliferation and
differentiation of adult Leydig cells has until recently been attributed
to the prepubertal increase in LH levels (Christensen & Peacock, 1980).
In the rat however conflicting evidence exists concerning the
prepubertal rise in LH with some reports of increased plasma LH (de Jong
& Sharpe, 1977) and others of no increase (Ketelslegers et al. 1978).
There is however a much closer relationship between rising FSH levels
and the differentiation of the adult generation of Leydig cells in the
rat (Swerdloff et al. 1972). Furthermore FSH, acting via the Sertoli
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cell, promotes rapid growth of Leydig cells in immature,
hypophysectomized rats (Kerr & Sharpe, 1985a,b) (see 1.5.6).
The synthesis and secretion of androgens by the Leydig cell
proceeds under the control of the trophic hormones from the anterior
pituitary (see 1.5). In addition these cells receive other hormonal and
paracrine input. Specific receptors for LHRH (Bourne et al. 1980;
Sharpe & Fraser, 1980; Clayton & Catt, 1981; Huhtaniemi et al. 1985),
prolactin (Huhtaniemi et al. 1981), insulin-like growth factor
(Handelsman et al. 1985), vasopressin (Meiden & Hsueh, 1985), epidermal
growth factor (Ascoli, 1981; Welsh & Hsueh, 1982) and catecholamines
(Anakawe et al. 1985) have been localized on rat Leydig cell membranes.
The physiological role of these potential regulators of Leydig cell
function remains to be clarified.
1.4.2 Heterogeneity of adult Leydig cells
A number of studies have demonstrated the heterogeneous nature of
the adult Leydig cell population. In the normal human testis, mature
Leydig cells which are rich in smooth endoplasmic reticulum, Golgi
apparatus and mitochondria are often observed adjacent to smaller cells
with poorly defined smooth endoplasmic reticulum and numerous lipid
droplets (Kerr & de Kretser, 1981).
The idea that there may be two distinct populations of adult rat
Leydig cells came initially from a study by Janszen and co-workers
(1976) who found two types of Leydig cells following isolation by
density centrifugation. Both cell types produced testosterone basally
and showed increased cAMP activity in response to LH. LH-stimulated
testosterone production however was observed in the "denser" cells only
(Janszen et al. 1976). Similar results have been obtained in a number
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of studies (Payne et al. 1980a; Cooke et al. 1981; Kerr et al. 1985a).
The lack of responsiveness of the "less dense" Leydig cells is not due
to the number or affinity of LH-receptors between the two populations
(Payne et al. 1980a). Furthermore pretreatment in vivo with LH
increases testosterone production of the "less dense" cells in vitro to
levels comparable to the more responsive "dense" cells (Payne et al.
1980b) .
Cooke and colleagues (1981) suggested that the heterogeneity of the
adult Leydig cell population in the rat may be indicative of a cycle of
Leydig cell function. An attempt to correlate this proposed Leydig cell
cycle to the spermatogenic cycle was made by Bergh (1982, 1983). He
observed that Leydig cells adjacent to the most androgen dependent
stages of the spermatogenic cycle (stages VII-VIII) are larger than
other Leydig cells in the same testis. Moreover, this effect is
abolished in the abdominal testis of unilaterally cryptorchid rats
(Bergh & Damber, 1984). It appears therefore that the seminiferous
tubules may secrete a factor(s) in a cyclical manner which locally
influences Leydig cell morphology and possibly function, and may in part
explain the heterogeneous nature of the Leydig cell population.
1.4.3 Testicular androgens
The Leydig cell is a highly differentiated cell whose primary
function is the synthesis and secretion of androgens. The main
secretory product of the Leydig cell is testosterone which is
synthesized via biosynthetic pathways common to other steroid secreting
tissues. Cholesterol is synthesized de novo in the Leydig cell smooth
endoplasmic reticulum, while the mitochondria exhibit the side-chain
cleavage enzymes which convert cholesterol to pregnenolone (van der
Vusse et al. 1973). The enzymes involved in the conversion of
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pregnenolone to testosterone are localized in the Leydig cell smooth
endoplasmic reticulum (Murota et al. 1966). Dehydroepiandrosterone,
androstenedione and dihydrotestosterone are also secreted by the Leydig
cell (Hammond et al. 1977). Secreted by the testis in small amounts,
dihydrotestosterone is derived mainly by reduction of testosterone by 5 ©C"
reductase at target sites in reproductive tissues.
1.4.4 Biological actions of androgens
The possibility that androgens might play a crucial role in human
spermatogenesis was overlooked for a long time despite evidence for a
profound effect of androgens on spermatogenesis in lower species. The
reluctance to consider a role for androgens in human spermatogenesis
resulted from studies in oligospermic and euspermic men in whom the
peripheral administration of testosterone leads to an arrest of
spermatogenesis and azoospermia (Heller et al. 1950). Peripheral
administration of androgens at low doses is now known to suppress the
release of pituitary LH via negative feedback mechanisms (Santen, 1981),
and while still being able to support secondary sex characteristics and
libido, reduces intratesticular testosterone to levels insufficient to
support spermatogenesis (Steinberger, 1971).
1.4.5 Testicular androgen receptors
Testicular androgen activity is mediated via androgen receptors
which have been localized in Sertoli cells (Mulder et al. 1976; Sanborn
et al. 1977; Tindall et al. 1977). The action of androgens on
spermatogenesis is thought to be mediated via Sertoli cell function (see
1.3.4) .
Androgen receptors have also been detected in Percoll-purified
Leydig cells from adult rats (Gulizia et al. 1983) and immature pigs
(Isomaa et al. 1987) and also in an established Leydig cell tumour line
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(Nakhla et al. 1984). The function of these receptors, which are
specific for androgens, is unknown but it has been suggested that
testicular androgens regulate their own production via an ultrashort
negative feedback mechanism (Purvis & Hansson, 1978; Adashi & Hsueh,/
1981).
1.4.6 Extratesticular androgen action
Circulating testosterone in the foetus is responsible for the
development and maintenance of the Wolffian ducts and their derivatives,
the epididymides, vasa deferentia, seminal vesicles and ejaculatory
ducts (Jost et al. 1973). Differentiation of the male external
genitalia and also the prostate are dependent on dihydrotestosterone,
the 5cX.-reduced form of testosterone (Wilson et al. 1983).
In addition to the reproductive tissues, testosterone acts on a
large number of body tissues including muscle, kidney, liver, adipose
tissue, red blood cells, skin, hair, bone and also the immune and
central nervous systems (for review, see Mooradian et al. 1987).
Testosterone exerts its effects on these tissues through the androgen
receptor both unchanged (e.g. testis, muscle, immune system) and via 5oC-
reductase (e.g. prostate, bone, skin, hair) and also in tissues with
high aromatase activity as an oestrogen via the oestrogen receptor (e.g.
adipose tissue, central nervous system).
1.4.7 Other Leydig cell products
(i) Oestradiol
In immature rats the Sertoli cell is the predominant source of
oestradiol (Rommerts et al. 1978). These cells lose their aromatase
activity during maturation after which they are unable to secrete
oestradiol in response to FSH (Rommerts et al. 1982). LH-stimulation of
isolated Leydig cells from adult rats increases their aromatase activity
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(Valladares & Payne, 1979) suggesting that in the mature animal the
Leydig cell is the main source of oestradiol. The human testis also
secretes oestradiol, again the interstitial tissue being the site of
aromatization (Payne et al. 1976).
In vivo administration of oestradiol to animals, including man,
results in a decrease in circulating plasma levels of testosterone and
inhibition of the testosterone response to LH stimulation (Jones et al.
1978; Saez et al. 1978). It has been argued that this anti-testicular
effect of oestradiol is due to suppression of pituitary LH secretion (de
Jong et al. 1975; Chowdhury et al. 1980). However the demonstration of
decreased plasma testosterone without any change in the level of LH in
oestrogen treated rats (Chowdhury et al. 1974; Sholiton et al. 1975)
and also of high affinity cytoplasmic oestrogen receptors on Leydig
cells (Brinkman et al. 1972) suggests that oestradiol might act directly
on the Leydig cell to suppress testosterone production. Oestradiol
exerts its inhibitory effect by blocking 17p^.-hydroxylase and 17,20
desmolase (Wang et al. 1980). The fact that desensitization of the
Leydig cells following large doses of LH/hCG (see 1.5.3) is due partly
to inhibition of these enzymes suggests that oestradiol may be a
mediator in this process (Catt et al. 1980), but whether this effect is
mediated via the oestrogen receptor or via functional modification of
the steroidogenic enzymes is not clear. Evidence to suggest that
oestrogenic effects are not mediated by the oestrogen receptor came from
Damber and co-workers (1983) who were unable to inhibit this oestrogenic
effect by tamoxifen, a potent anti-androgen which blocks the oestradiol
receptor. In contrast Cigorraga and colleagues (1980) showed that
tamoxifen is capable of inhibiting the decrease in responsiveness of the
Leydig cells to LH following a large dose of LH (hCG). So, any role of
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the Leydig cell oestrogen receptor in the gonadotrophin induced changes
in testicular steroidogenesis remains to be clarified.
(ii) Oxytocin and vasopressin
Oxytocin of Leydig cell origin has been detected in the rat testis
(Guldenaar & Pickering, 1985). It induces the contraction of the
peritubular myoid cells which propel the mature spermatozoa towards the
rete testis (Nicholson et al. 1986). Oxytocin has also been reported to
inhibit testosterone production by long-term (3 day) cultures of
testicular cells from hypophysectomized rats (Adashi et al. 1984). The
significance of these results is questionable since the inhibition of
testosterone production may be due to the effect of oxytocin on the
myoid cells present in the testicular cultures (Nicholson et al. 1986).
In short-term (24 h) culture of purified rat Leydig cells, no effect of
oxytocin on testosterone production is observed (Sharpe & Cooper, 1987).
Similarly intratesticular injection of oxytocin has no effect on
interstitial fluid testosterone content (Sharpe & Cooper, 1987). It
seems unlikely, therefore, that oxytocin is an autocrine regulator of
testosterone production in the rat testis.
Vasopressin is also present in the rat testis although its source
is unknown (Kasson et al. 1985; Kasson & Hsueh, 1986). Vasopressin has
been reported to be a potent inhibitor of hCG-stimulated testosterone
production by testicular cell cultures (Meidan et al. 1985). Data from
long-term (2-3 day) cultures of purified Leydig cells show that in the
presence of supraphysiological levels of hCG, vasopressin inhibits
testosterone production (Sharpe & Cooper, 1987). During short-term (5
h) culture vasopressin stimulates basal testosterone production and has
no effect on hCG-stimulated testosterone production (Sharpe & Cooper,
1987). The lack of an in vivo effect of vasopressin raises doubts as to
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the significance of this peptide in the paracrine control of Leydig cell
function (Sharpe & Cooper, 1987).
(iii) Pro-opiomelanocortin-derived peptides
Pro-opiomelanocortin (POMC)-derived peptides have been detected in
the male reproductive tract of a number of species with p-endorphin,
C<. -melanocyte-stimulating hormone and adrenocorticotrophic-like factors
present specifically in Leydig cell cytoplasm (Tsong et al. 1982a). A
growing number of studies suggest that POMC-derived products may have
some local intratesticular effects (1.6.1 (viii)).
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1.5 ENDOCRINE CONTROL OF THE TESTIS
The hormonal control of spermatogenesis involves the interaction of
gonadal steroid hormones and the pituitary gonadotrophic hormones LH and
FSH on specific cells of the testis. The involvement of the pituitary
gonadotrophins in the normal functioning of the gonads was realized more
than 50 years ago, but it is only in the last 15 years, with advances in
the isolation and detection of both LH and FSH, that their basic
mechanisms of actions have been elucidated.
1.5.1 Luteinizing hormone and the Leydig cell
The first demonstration of LH action on the Leydig cell was in 1936
when it was shown to maintain normal Leydig cell morphology in
hypophysectomized rats (Greep et al. 1936). It was not until over 30
years later that binding of LH was shown to be restricted to the
testicular interstitial cells of the rat (Mancini et al. 1967; de
Kretser et al. 1971). Subsequent studies have demonstrated receptors
for LH on the cell surface of Leydig cells in human foetal testes
(Huhtaniemi et al. 1977) and adult human testes (Hsu et al. 1978).
LH is thought to exert its action on the activity of the enzymes
involved in the synthesis of testosterone (Hall, 1970; Ewing & Brown,
1977). The endpoint of LH action appears to be the regulation of
mitochondrial cholesterol side chain cleavage involving the cytochrome
P450 system (Menon et al. 1967; van der Vusse et al. 1975).
Furthermore, LH is thought to be involved in the conversion of
cholesterol ester to free cholesterol (Moyle et al. 1973) and in the
transport of the free cholesterol to the mitochondria (Hall et al.
1979).
1.5.2 Mechanism of action
The mechanism of LH action on the Leydig cell has been studied
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extensively. Stimulation of androgen synthesis by LH is brought about
mainly by changes in the production of cAMP, the subsequent activation
of protein kinase and phosphorylation of specific proteins leading to
the increase in steroidogenic enzyme activity (Purvis et al. 1981;
Dufau et al. 1984) .
Changes in endogenous levels of cAMP in the testis do not however
completely support the idea that cAMP mediates the effects of LH on
steroidogenesis (Cooke et al. 1977). Recent data indicate that a number
of transducing systems including cAMP, protein kinase-C and fluxes of
intracellular concentrations of calcium are required for the stimulatory
action of LH on androgen production (Hall et al. 1981; Lin, 1985;
Themmen et al. 1985).
LHRH has also been shown to stimulate androgen production without
apparent changes in cAMP production (Sullivan & Cooke, 1984). The
mechanism of action of LHRH on Leydig cell steroidogenesis is not clear
but LHRH has been shown to increase intracellular calcium and to
stimulate incorporation of labelled phosphate into phosphatidyl inositol
(Molcho et al. 1984).
1.5.3 Regulation of LH receptors
The ability of peptide hormones to regulate the concentrations of
their specific receptor sites in endocrine target cells has been
demonstrated in numerous tissues. Initially receptors for insulin and
growth hormone were shown to be inversely proportional to the
concentrations of the homologous hormone in the peripheral circulation
(Roth et al. 1975).
LH (hCG) negatively regulates the number of its own receptors on
the Leydig cell plasma membrane. LH receptor number is decreased by
exogenous gonadotrophins (Hsueh et al. 1977; Sharpe, 1976) and also by
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elevation of endogenous LH levels following treatment with LHRH-A (Catt
et al. 1979). A single supraphysiological dose of LH (hCG) results in a
rapid (within 3-6 h) increase in receptor number (Hsueh et al. 1977;
Sharpe, 1980; Huhtaniemi et al. 1981). Following the, as yet
unexplained, initial transient up-regulation, high doses of LH induce a
prominent reduction or down-regulation in LH receptor numbers, and an
impaired responsiveness of the Leydig cell to subsequent hormonal
stimulation (desensitization) (Nozu et al. 1981 a,b, 1982).
Desensitization is the result of uncoupling of the receptor from
adenylate cyclase and the internalization of the hormone-receptor
complex. In the endosomal vesicles the hormone is dissociated from the
receptor and degraded while the receptor is returned to the cell surface
(Habberfield et al. 1986). This internalization and recycling process
appears to be important in maintaining the ability of the Leydig cell to
bind LH.
1.5.4 Leydig cell response to LH
Administration of LH (hCG) to men results in a biphasic response in
which there is a modest (20-60%) acute increase in plasma testosterone
levels within 6 h, followed by a 2- to 3-fold rise 2-3 days later (Saez
& Forest, 1979; Smals et al. 1979; Padron et al. 1980; Martikainen
et al. 1980; Nankin et al. 1980). A similar biphasic response is
observed in the rat (Hsueh et al. 1976; Sharpe, 1976).
The mechanism of this biphasic steroid response is not completely
understood although desensitization and down regulation of the LH
receptor is thought to be involved (Padron et al. 1980). The secondary
rise in testosterone production, the magnitude of which is determined by
the dose of LH (hCG) administered, has been attributed to trophic
effects of LH (hCG) on cytoplasmic organelles and possibly Leydig cell
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number. Although data on the effects of a single injection of LH (hCG)
is limited, chronic administration of hCG in man has been shown to
result in an increase in Leydig cell smooth endoplasmic reticulum,
mitochondria and Golgi apparatus, reflecting an increase in the capacity
of these cells to secrete testosterone (de Kretser, 1967). Similarly in
the rat, chronic stimulation with LH (hCG) increases cell size and
number (Christensen & Peacock, 1980; Nussdorfer et al. 1980).
1.5.5 Follicle-stimulating hormone
The seminiferous epithelium is the principal site of action of FSH
in the testis (Means & Vaitukaitis, 1972). Autoradiographic studies
have shown binding of FSH primarily to the basal aspect of the Sertoli
cell and also to the spermatogonial membrane (Orth & Christensen, 1977,
1978) . Binding of FSH to receptors located on the plasma membrane of
the Sertoli cell stimulates adenylate cyclase (Fakunding et al. 1975),
activates cAMP-dependent protein kinase (Fakunding & Means, 1977) and
stimulates RNA and protein synthesis (Means et al. 1976). In the rat,
ABP has been used extensively as a marker for FSH action on the Sertoli
cell (Ritzen et al. 1981).
The responsiveness of the Sertoli cells to FSH with respect to
accumulation of cAMP declines significantly during sexual maturation
(Steinberger et al. 1977). This diminished responsiveness of the
Sertoli cells to FSH with age is not due to impaired hormone binding, as
the binding of FSH actually increases during this period (Steinberger et
al. 1977). The loss of cellular response to FSH is due to decreased
production of cAMP secondary to increased phosphodiesterase activity.
This lack of response can be reversed by the phosphodiesterase inhibitor
l-methyl-3-isobutyl-xanthine (MIX) (Fakunding et al. 1975; Means et al.
1976). The FSH-dependent functions of the Sertoli cell in the immature
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animal are regulated by testosterone in the mature animal (Hansson et
al. 1976).
The precise role of FSH became less clear when it was shown that in
adult animals testosterone alone, when administered in high doses, is
capable of maintaining or restoring complete spermatogenesis in the
absence of FSH (Boccabella 1963; Buhl et al. 1982; Marshall et al.
1983). In mature hypophysectomized rats, in the presence of normal
levels of testosterone, failure to restore or maintain normal germ cell
number implies the need for other factors for quantitatively normal
spermatogenesis (Chowdhury, 1979; Stevens & Steinberger, 1983).
Similarly in hypogonadotrophic men, and men made hypogonadotrophic by
the administration of exogenous testosterone, both FSH and LH are
required for quantitatively normal spermatogenesis, although either FSH
or LH alone is sufficient to stimulate spermatogenesis in the presence
of testosterone (Bremner et al. 1984). These findings suggest that in
addition to testosterone, FSH is also required for quantitatively normal
spermatogenesis.
Although the adult seminiferous tubules have been shown to respond
to FSH only minimally (Ritzen et al. 1981) the actions of FSH appear to
be dictated locally by stage-dependent changes in the response to FSH
(Parvinen et al. 1980). Significant variation occurs in both the
binding of FSH and in the FSH-stimulated cAMP production depending on
the stage of the cycle of the seminiferous epithelium. The number of
FSH receptors and the amount of cAMP produced in response to FSH is
highest at stage I, and lowest during stages VII-VIII (Parvinen et al.
1980).
1.5.6 FSH and the Leydig cell
In the testis, although receptors for FSH are found only on the
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Sertoli cells and the spermatogonia (Means et al. 1976; Orth &
Christensen, 1977), in vivo studies have suggested that FSH also
regulates Leydig cell steroidogenesis. This information derives from
studies in which administration of FSH to immature hypophysectomized
rats results in increased Leydig cell LH receptor number (Odell et al.
1973; van Beurden et al. 1976; Chen et al. 1977) and increased
capacity of the Leydig cell to bind LH and secrete testosterone (Odell &
Swerdloff, 1975; Chen et al. 1976, 1977; Selin & Moger, 1977).
Morphometric studies by Kerr and Sharpe (1985a, 1985b) have shown that
these effects are due to FSH-induced differentiation of the adult
population of Leydig cells.
1.5.7 Mode of action
The regulatory effect of FSH on Leydig cell steroidogenesis is not
exerted directly on the Leydig cell but is mediated through the Sertoli
cell. In Sertoli-Leydig cell co-cultures FSH enhances Leydig cell hCG
binding, hCG-stimulated testosterone production and the development of
organelles involved in steroidogenesis (Benahmed et al. 1986). Leydig
cells cultured in conditioned medium from FSH-stimulated Sertoli cells
in culture as compared to conditioned medium from non-stimulated Sertoli
cells show an increase in their steroidogenic capacity (Benahmed et al.
1986). Since in vivo the Sertoli and Leydig cells are in different
compartments of the testis and unable to communicate through cell
contact, these results suggest that FSH regulates Leydig cell function
by means of FSH-stimulated Sertoli cell factors (see 1.6.1).
1.5.8 Control of FSH secretion
In many physiological and pathological conditions the levels of the
gonadotrophins LH and FSH change independently. In men suffering from
germinal cell failure, without damage of the Leydig cells, the levels of
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plasma FSH are often elevated whereas plasma LH levels are frequently
normal (Franchimont et al. 1975). Since the synthesis of both LH and
FSH is controlled by hypothalamic LHRH, there must be some factor which
can regulate the release of FSH at the pituitary level.
Regulation of FSH secretion via a negative feedback mechanism by a
water-soluble substance from the testis was postulated by McCullagh
(1932). This substance he called inhibin. It has since been confirmed
that water-soluble testicular extracts suppress FSH secretion without
altering LH release in male animals (Baker et al. 1976; Keogh et al.
1976; Eddie et al. 1978).
1.5.9 Source of inhibin
Direct evidence that inhibin is produced by the Sertoli cell in the
male came from in vitro studies in which medium from cultured rat
Sertoli cells was shown to selectively suppress FSH secretion in
cultures of pituitary cells (Steinberger & Steinberger, 1976; Bicsak et
al. 1987).
Inhibin is present in abundance in seminal plasma in a number of
species, including man (Franchimont et al. 1979). Seminal plasma
inhibin is of prostatic origin (Becsak et al. 1984) and reports as to
whether it is capable of suppressing FSH release from pituitary cells in
culture are conflicting (Ramasharma et al. 1984; Sheth et al. 1984; de
Jong & Robertson, 1985; Liu et al. 1985). The action of prostatic
inhibin is at present unknown.
The presence of inhibin in rete testis fluid (Setchell & Jacks,
1974; Baker et al. 1976) may indicate a means by which this peptide
gains entry to the peripheral circulation in order to mediate its
effects on the anterior pituitary (Baker et al. 1976). Little is
currently known about the mechanism(s) or route(s) by which inhibin is
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secreted from the testis into the peripheral circulation although in
sheep, the high concentration of inhibin in the ovarian vein (Tsonis et
al. 1986) suggests that a vascular route may be important.
1.5.10 Mode of action
Since the structure of inhibin was defined less than 2 years ago
(Mason et al. 1985), no report has yet appeared on the localization of
receptors for inhibin. So although the anterior pituitary is generally
accepted to be the site of inhibin action, direct action of inhibin on
the hypothalamus has also been reported (Lumpkin et al. 1981).
Using a 32 kDa inhibin from porcine follicular fluid, Fukuda and
co-workers (1987) have confirmed that inhibin acts to suppress FSH, but
not LH or any other pituitary hormone. Suppression of basal FSH release
is thought to be a consequence of reduced intracellular stores of FSH
(Scott & Burger, 1981b; Fukuda et al. 1987). Cycloheximide, a potent
inhibitor of protein synthesis, is capable of mimicking the actions of
inhibin, suggesting that the difference in response of both LH and FSH
to inhibin is due to differences between these hormones in
susceptibility to biosynthetic inhibition (Fukuda et al. 1987).
LHRH-stimulated release of both FSH and LH is suppressed by inhibin, and
cycloheximide, indicating that inhibin acts on the gonadotrophs by
inhibiting protein biosynthesis (Fukuda et al. 1987).
1.5.11 Testicular steroids and FSH secretion
Testicular steroids are known to be involved in the regulation of
LH secretion (Santen, 1981), but their role in the secretion of FSH is
not clearly defined. Testosterone in pharmacological doses has been
shown to suppress FSH (Baker et al. 1976) whereas other androgens such
as dihydrotestosterone and \lc/^ -hydroxyprogesterone have no effect
(Stewart-Bentley et al. 1974). Similarly oestrogens have been shown to
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suppress FSH (Baker et al. 1976) but are required in doses which are
large enough to produce gynecomastia in castrate men (Walsh et al.
1973). In rats both oestrone and oestradiol have been shown to suppress
FSH (Swerdloff et al. 1973).
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1.6 PARACRINE CONTROL OF THE TESTIS
The importance of the gonadotrophic hormones LH and FSH in the
development and maintenance of testicular function cannot be
over-emphasized. The gonadotrophins provide the basic stimuli on which
normal testicular function depends. However, it is difficult to imagine
that the maintenance of a highly complex structure such as the testis
could be achieved by the gonadotrophins alone. Indeed the way in which
the testis responds to these stimuli appears to be mediated by gonadal
factors. The testis is composed of various somatic and germinal cells
which interact in response to gonadotrophic stimulation by producing
paracrine factors. These factors mediate the actions of the
gonadotrophins according to local testicular requirements and, as such,
co-ordinate the functions of the various testicular cell types.
1.6.1 Sertoli cell-Leydig cell interactions
The Sertoli and Leydig cells were for a long time considered to be
completely independent cell types. Evidence of a close interdependence
of the two cell types is now accumulating.
The concept that the Leydig cells, by providing high local
concentrations of testosterone, regulate testicular function via the
Sertoli cells is well-established (Steinberger, 1971; Ritzen et al.
1981; Sanborn et al. 1984). The maintenance of quantitatively normal
spermatogenesis is completely dependent on adequate supplies of
testosterone (Desjardins et al. 1973; Nieschlag et al. 1973), while the
absolute amount of this hormone required remains unknown.
Results from several studies indicate the cyclical variation in the
requirements of the Sertoli cell for testosterone (Dym et al. 1977;
Russell & Clermont, 1977; Russell et al. 1981). In all cases
gonadotrophic deprivation leads to the disappearance of post-meiotic
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germ cells in stages VII and VIII in the rat. Recent studies involving
the administration of the Leydig cell toxin ethane dimethanesulphonate
(EDS) to adult rats have demonstrated disruption of post-meiotic germ
cells in stages VII and VIII as a result of short-term testosterone
deprivation (Kerr et al. 1985b, 1986; Bartlett et al. 1986). In view
of this stage-specific dependence of spermatogenesis on testosterone, it
is difficult to perceive how the testosterone supply could be regulated
sufficiently by the episodic release of pituitary LH to meet the demands
of individual stages of germ cell development. There now exists
considerable evidence to suggest that tubular factors, in response to
gonadotrophic stimulation, influence Leydig cell testosterone
production.
(i) Evidence for paracrine regulators of Leydig cell function
Evidence for communication between the interstitial and tubular
compartments of the testis came initially from a number of studies which
demonstrated that tubular damage, as a result of anti-androgens (Aoki &
Fawcett, 1978), cryptorchidism (Kerr et al. 1979a) vitamin A deficiency,
hydroxyurea treatment, foetal irradiation (Rich et al. 1979) or efferent
duct ligation (Risbridger et al. 1981), secondarily effects Leydig cell
function. Aoki & Fawcett (1978) observed the involution of seminiferous
tubules around intratesticular implants of the anti-androgen cyproterone
acetate, accompanied by hypertrophy and hyperplasia of Leydig cells in
the neighbouring interstitial tissue. These changes were not
accompanied by significant elevation of gonadotrophin levels and did not
occur in tubules distant to the implants or in the contralateral testis,




A growing number of studies have suggested that FSH, in addition to
its stimulatory influence on the Sertoli cell, may also exert effects on
Leydig cell steroidogenic function. FSH pre-treatment of
hypophysectomized rats results in an increase in LH-stimulated
testosterone secretion by the Leydig cells both in vivo (Odell &
Swerdloff, 1975; Selin & Moger, 1977) and in vitro (Chen et al. 1976;
van Beurden et al. 1976; Chen et al. 1977). In addition, FSH appears
to stimulate LH receptor number (Chen et al. 1977). As binding of FSH
to Sertoli cells (Orth & Christensen, 1977) but not to Leydig cells (de
Kretser et al. 1971; Means & Vaitukaitis, 1972) is well-established,
these observations suggest that the regulatory effect of FSH on Leydig
cell steroidogenesis may result from an interaction between the Sertoli
and Leydig cells via the production of a mediator by the Sertoli cell.
(iii) Oestradiol
Oestradiol was suggested as a possible local feedback messenger
between the Sertoli and Leydig cells (Aoki & Fawcett, 1978). However,
Sertoli cells are now known to lose their aromatase activity during
maturation (Rommerts et al. 1982), after which they are unable to
secrete oestradiol, effectively ruling out the possibility of oestradiol
as a potential messenger between the tubular and interstitial cells.
(iv) Testicular-LHRH
The possibility that the regulatory effect between the seminiferous
tubules and the Leydig cells is mediated, at least in part, by
testicular-LHRH has been suggested as a result of a number of
observations.
An LHRH-like peptide of testicular origin has been reported in the
rat (Dutlow & Millar, 1981; Sharpe et al. 1981, 1982a; Bhasin et al.
1983; Nagendranath et al. 1983; Hedger et al. 1985). Reports of
47
LHRH-like activity in spent media from Sertoli cell cultures indicates
the Sertoli cell as the site of its production (de Jong et al. 1979;
Sharpe et al. 1981, 1982a; Nagendranath et al. 1983).
LHRH was found to have no direct effects on the Sertoli cell
y
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(Gore-Langton et al. 1981) in keeping with the finding that specific
LHRH binding sites are present in Leydig but not Sertoli cells (Bourne
et al. 1980; Sharpe & Fraser, 1980; Clayton & Catt, 1981; Huhtaniemi
et al. 1985). These results suggest that the Sertoli cells produce an
LHRH-like peptide in response to FSH which acts on the Leydig cells to
locally regulate their function.
(v) Physiological role of testicular-LHRH
Most of the information available on the physiological effects of
testicular-LHRH has been obtained from the use of agonistic analogues of
hypothalamic LHRH. The suitability of these agonists, in the absence of
purified testicular-LHRH, has been proved by the demonstration that
LHRH-agonists prevent the gonadal actions of native LHRH in a
dose-dependent manner (Hsueh et al. 1981).
Initial studies with long-term (3 or more days) exposure to
LHRH-agonists reported a potent direct inhibitory effect on
steroidogenesis both in vivo and in vitro (Bambino et al. 1980; Hsueh
et al. 1981; Hsueh & Jones, 1981). Short-term incubations (of up to 24
hours) with LHRH agonist stimulates Leydig cell testosterone production.
This stimulatory effect has been demonstrated in vivo, in both normal
(Sharpe & Rommerts, 1983; Sharpe et al. 1983) and hypophysectomized rats
(Sharpe et al. 1982; Sharpe & Harmar, 1983), and in vitro (Hunter et
al. 1982; Sharpe & Cooper, 1982a, 1982b).
(vi) Mode of Action
The physiological role for testicular-LHRH seems to be as a
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stimulatory regulator of intratesticular levels of testosterone.
The method of action of testicular-LHRH is thought to be mediated by its
effects on testicular blood flow and capillary permeability (Sharpe,
1984a). The action of LHRH is to stimulate testicular blood flow (Damber
et al. 1984) and to reduce capillary permeability (Sharpe, 1984a).
Receptor binding sites for testicular-LHRH are present only on the Leydig
cells therefore LHRH stimulates the Leydig cells which in turn are
thought to secrete a vasoactive factor(s), possibly ^-endorphin which
acts upon the testicular capillaries (Sharpe 1984a). By controlling
capilliary permeability, testicular LHRH is in effect controlling the
volume of interstitial fluid and ultimately the intratesticular level of
testosterone. In addition, by controlling interstitial fluid volume,
testicular-LHRH is directly involved in the passage of other hormones, in
particular LH, into the intratesticular environment (Sharpe, 1984a).
So although testicular-LHRH clearly modulates testosterone
production by the rat Leydig cells, whether it has a localized effect on
the Leydig cells adjacent to particular androgen-dependent states (VII
and VIII) of the cycle of the seminiferous epithelium has not been
demonstrated. Immunohistochemistry has shown that tubular content of
LHRH varies in different cross sections (Paull et al. 1981). These
authors did not however relate LHRH content with the stage of the
spermatogenic cycle. A recently reported Sertoli cell LHRH-peptidase
may be involved in the modulation of testicular-LHRH secretion in
response to local environmental requirements at different stages of the
cycle (Hedger et al. 1986). Secretion of this peptidase into the
interstitial fluid may be a means by which the Sertoli cell can confine
testicular-LHRH to a site of action by preventing the accumulation of
this peptide and its subsequent diffusion through the interstitial fluid.
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(vii) Sertoli cell/Interstitial fluid stimulatory factor(s)
Substantial evidence exists for the presence of a Sertoli cell
factor, which is not testicular-LHRH, but which has local stimulatory
effects within the testis (Grotjan & Heindel, 1982; Benahmed et al.
1984; Parvinen et al. 1984; Sharpe & Cooper, 1984; Janecki et al.
1985; Verhoeven & Cailleau, 1985). Seminiferous tubules at stages VII
to VIII incubated with rat Leydig cells enhance testosterone production
by the Leydig cells, while LHRH-antagonist is not capable of diminishing
the seminiferous tubule effect (Parvinen et al. 1984).
Verhoeven & Cailleau (1985) reported a stimulatory factor from
immature Sertoli cell culture media which was not inhibited by
LHRH-antagonist. Maximally effective levels of this factor plus
LHRH-agonist had additional effects, suggesting that they act via
different receptor systems. The ability of both FSH and dibutyryl cAMP
to stimulate the levels of this factor in spent media from immature
Sertoli cell cultures undoubtedly points to the Sertoli cell as the
source (Verhoeven & Cailleau, 1985).
Although the physiological significance of these in vitro effects
are questionable, their potential importance is substantiated by the
comparable action of a factor produced in vivo. Testicular interstitial
fluid (IF) collected from normal adult rats is capable of enhancing
Leydig cell testosterone production by 6-fold or more in response to
maximally stimulating levels of hCG (Sharpe & Cooper, 1984; Sharpe,
1985).
This effect is not due to IF gonadotrophins as IF-factor activity
is also present in IF from hypophysectomized rats (Sharpe & Cooper,
1984). In addition, antiserum to LH fails to diminish the stimulatory
effect of the IF-factor (Sharpe & Cooper, 1984). The most important
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determinant of the magnitude of the stimulatory effect of IF-factor is
the ambient level of intratesticular testosterone (Sharpe & Cooper,
1984; Sharpe, 1985). Testicular damage which reduces intratesticular
testosterone, for example cryptorchidism, results in increased
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stimulatory effects of the IF-factor (Sharpe & Cooper, 1984; Sharpe et
al. 1986b). Testicular damage is often accompanied by changes in IF
volume which may give erroneous estimates of IF-factor activity. IF
volume is decreased in cryptorchid rats, however IF-factor activity
remains elevated even after IF volume has returned to normal levels
(Sharpe et al. 1986b). FSH is also elevated as a result of testicular
damage, but this does not explain the increased level of IF-factor
activity as in rats made unilaterally cryptorchid increased activity of
the IF-factor is seen in the abdominal testis only and not in the
contralateral scrotal testis (Sharpe et al. 1986b).
The Leydig cell toxin EDS provides a means by which the effect of
intratesticular testosterone on IF-factor activity can be investigated
(Sharpe et al. 1986a). Short-term deprivation of testosterone following
Leydig cell destruction leads to an increase in the activity of the
IF-factor. However at 3-7 weeks post EDS treatment when intratesticular
levels of testosterone are back to normal, IF-factor activity is still
elevated. This has been attributed by Sharpe et al. (1986) to
disruption of spermatogenesis which still persists to some extent even
after normal testosterone levels are restored (Bartlett et al. 1986).
In EDS-treated rats intratesticular levels of testosterone are back to
normal at around 3 weeks post-EDS, however Leydig cell number is still
greatly reduced (Kerr et al. 1985b). During this period of reduced
Leydig cell number the increased activity of the IF-factor may well be
the mechanism by which intratesticular testosterone levels are returned
to normal thus permitting restoration of spermatogenesis (Sharpe et al.
1986a).
Any communication between the Sertoli and Leydig cells must take
place via the testicular interstitial fluid, and as such, both the
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interstitial fluid-factor and the Sertoli cell derived factor may be
identical, or possibly members of a family of related peptides.
(viii) Testicular opiates
In addition to testosterone, other Leydig cell products are thought
to have local effects on the seminiferous epithelium. Immunoreactive
^3-endorphin, a peptide which is derived from the processing of a
precursor molecule pro-opiomelanocortin (POMC) (Krieger et al. 1980),
has been reported in human semen (Sharp & Pekary, 1981) and in rat
testis extracts (Sharp et al. 1980; Tsong et al. 1982a).
Immunoreactive ^-endorphin has been identified in the Leydig cells, but
not in the Sertoli or germ cells, of a number of species (Tsong et al.
1982b). In hypophysectomized rats, in which plasma levels of
^-endorphin are undetectable, this POMC-derived peptide is still
detectable in the Leydig cells (Tsong et al. 1982a). In addition, POMC
mRNA has been demonstrated in rat Leydig cells (Chen et al. 1984;
Pintar et al. 1984). Opioid receptors have been identified in mature
and immature rat Sertoli cells (Fabbri et al. 1985). These results
raise the possibility that POMC is synthesized in the Leydig cells and
that POMC-derived products may have some local intratesticular effects.
Several POMC-derived peptides, in addition to ^-endorphin, such as
^-endorphin, ^-endorphin, adrenocorticotrophin (ACTH) and<^ melanocyte
stimulating hormone (<?CMSH) have been found in the testis (Margioris et
al. 1983). MSH is synthesized by the Leydig cells and has been shown
to directly stimulate cAMP production by the Sertoli cells and to
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modulate the response of these cells to FSH (Boitani et al. 1986). This
action of C^MSH on the Sertoli cell may represent a paracrine
regulatory mechanism within the testis.
^-endorphin-like immunoreactivity and ACTH are present in rat
interstitial fluid, in concentrations which far exceed those of plasma,
confirming local synthesis of these peptides (Valenca & Negro-Vilar,
1986). Synthesis of ^-endorphin is modulated according to the local
hormonal milieu. In hypophysectomized rats, administration of hCG
results in an increased secretion of JB-endorphin-like immunoreactivity
into the interstitial fluid whereas LHRH-A appears to have inhibitory
effects on the interstitial fluid levels of jB-endorphin-like
immunoreactivity (Valenca & Negro-Vilar, 1986). However in the
short-term, administration of LHRH-A to intact animals results in
elevated interstitial levels of ^B-endorphin-like immunoreactivity
concomitant with decreased interstitial fluid volume (Valenca &
Negro-Vilar, 1986). These authors suggest that in response to LH,
testicular opiates may regulate interstitial fluid production, and in
doing so, effectively alter intratesticular hormone concentrations.
Evidence of a paracrine effect of JB-endorphin has been observed in
immature rats. Administration of a jB-endorphin antagonsit, naloxone,
results in increased Sertoli cell division, testicular hypertrophy and
increased ABP production, suggesting that ^5-endorphin might inhibit
Sertoli cell function in immature rats (Gerendai et al. 1983). Adult
Sertoli cell function, however, as indicated by ABP production is not
affected by intratesticular treatment with opioid antagonists (Gerendai
et al. 1984). In normal rats, naloxone administration results in
decreased serum testosterone levels suggesting that endogenous
testicular opiates may regulate testosterone production. It is not
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clear whether these opiates regulate Leydig cell testosterone production
directly, by an autocrine mechanism, or indirectly through another cell
type, by a paracrine mechanism.
Thus there is evidence to suggest that POMC-derived peptides are
present in the male reproductive tract, with ^-endorphin and ACTH-like
factors present specifically in Leydig cell cytoplasm. These peptides
have been shown to exert local inhibitory effects on the Sertoli cells.
However, little is known of the nature of receptors for POMC-derived
peptides on Sertoli cells. Whether these peptides act directly on the
Sertoli cells or via an intermediate factor(s) awaits identification
and characterization of their receptors on the Sertoli cell.
1.6.2 Sertoli cell-germ cell interactions
The epithelium of the seminiferous tubule is unique in its
organization consisting of a permanent population of Sertoli cells, and
interspersed among these the germ cells in a continuously evolving
state. The differentiation of the developing germ cells takes place in
a highly organized manner at precise, unvarying time intervals. Each
particular stage of the spermatogenic cycle appears to have different
functional requirements. The Sertoli cell provides the specific milieu
which is required by the germ cells in their different stages of
development.
(i) Functional cycle of the Sertoli cell
Several observations suggest the existence of a functional cycle of
the Sertoli cell, such that neighbouring Sertoli cells may be performing
different functions depending on their germ cell association, despite
being exposed to the same gonadotrophic stimulation. Sertoli cells
undergo morphological and histochemical changes during the cycle of the
seminiferous epithelium. Variations in cell volume (Cavicchia & Dym,
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1977), nuclear morphology (Le Blond & Clermont, 1952), lipid morphology
and position (Kerr & de Kretser, 1975) and some enzyme activities
(Parvinen & Vanha-Pertulla, 1972; Hilscher et al. 1979) related to the
cycle of the seminiferous epithelium have/been reported.
More recently in vitro studies of stage-specific tubule segments
have also demonstrated cyclical variations in Sertoli cell function
(Parvinen, 1982). The number of Sertoli cell FSH-receptors varies
during the cycle with preferential binding of FSH occurring between
stages XII and V in the rat (Parvinen et al. 1980). The ability of FSH
to stimulate cAMP production in the presence of a phosphodiesterase
inhibitor, also varies in a cyclical manner with cAMP production being
lowest during stages VII - VIII reflecting maximal activity of the
phosphodiesterase inhibitor (Parvinen et al. 1980). This pattern of FSH
induced cAMP production is thought to relate to the stage of spermatid
development, indicated by the activity of the spermatid-specific enzymes
protein carboxyl-methylase and manganese-dependent adenylyl cyclase
(Cusan et al. 1981; Gordeladze et al. 1982). These enzymes are
involved in the maturation of step 12 to 17 spermatids during stages XII
to V in the rat (Cusan et al. 1981). Their activity is closely related
to the rise in FSH-induced cAMP production which is thought to be
important for spermatid maturation (Parvinen, 1982). These spermatid
specific enzyme activities fall off in parallel with decreased
production of cAMP prior to spermiation (Gravis, 1978). These data
suggest that the action of FSH on the Sertoli cell is dictated locally
by the stage of the cycle.
In addition, preferential action of testosterone occurs in the rat
during stages VII to VIII (Parvinen, 1982). Decreased availability of
testosterone leads to the degeneration of stage VIII spermatocytes and
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spermatids. Androgen dependent germ cells at stages VII and VIII of the
cycle are thought to communicate with adjacent Leydig cells to maximize
the availability of testosterone (see 1.6.1).
The complex series of changes by which spermatogonia are
transformed into spermatozoa can be divided into three phases,
spermatocytosis, meiosis and spermiogenesis. During the first phase,
spermatocytosis, the spermatogonia proliferate by mitotic division to
replace themselves and to produce primary spermatocytes. These mitotic
divisions occur at specific stages of the spermatogenic cycle,
indicating the presence of a mitotic control mechanism. Likewise in the
second phase, meiosis, the two successive reduction divisions which
produce the secondary spermatocytes and the spermatids, are strictly
limited to particular stages. The Sertoli cell products, seminiferous
growth factor (SGF), meiosis-inducing substance (MIS) and
meiosis-preventing substance (MPS) are thought to control germ cell
mitotic and meiotic divisions (see 1.3.3 (i)). Other Sertoli cell
products, somatomedin-C/lGFl-like factor, testicular interleukin-1 and
possibly inhibin are also potential regulators of germ cell growth (see
1.3.3).
The culmination of the third phase of spermiogenesis, spermiation,
results in the release of the mature spermatozoa into the tubular lumen.
This event occurs concomitantly with the translocation of the
preleptotene spermatocytes from the basal to the adluminal aspects of
the seminiferous tubules. Both spermiation and translocation coincide
with increased secretion of plasminogen activator from the Sertoli cell
as described above (see 1.3.2 (iv)).
(ii) Germ cell effects
As spermatogenesis is dependent on an ordered sequence of changes
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in Sertoli cell function, cell-to-cell contacts between the Sertoli
cells and the germ cells could modulate the responsiveness of the
Sertoli cell to FSH. In other words, do germ cells exert paracrine
effects on the Sertoli cell? Germ cell removal from Sertoli c,ell
enriched cultures induces a reduction of FSH-dependent ABP secretion,
while replacing the removed germ cells promotes ABP secretion (Galdieri
et al. 1984). Furthermore, only germ cells at certain stages of
differentiation have this effect. Pachytene spermatocytes co-cultured
with Sertoli cells show surface junctional structures which are thought
to allow metabolic communication between the two cell types (Ziparo et
al. 1980, 1982). Round and elongate spermatids, which do not form these
junctional structures in vitro, have no effect on ABP production when
co-cultured with Sertoli cells (Galdieri et al. 1984) . Following
sequential depletion of spermatogonia, spermatocytes and spermatids in
rats by in vivo chronic gamma irradiation, there is a high degree of
correlation between elongate spermatids and Sertoli cell activity as
determined by ABP production (Pinon-Lataillade et al. 1986). The
responsiveness of the Sertoli cell to FSH appears therefore to be
modulated, at least in part, by their surface interactions with germ
cells.
Depletion of pachytene spermatocytes by X-irradiation results in a
reduction of plasminogen activator secretion during stages VII to VIII
(Vihko et al. 1984; Parvinen et al. 1986). Moreover, plasminogen
activator secretion by the Sertoli cell is stimulated by retinoic acid
during stage VII (Vihko et al. 1987), but the receptor for retinoic acid
is localized in the germ cells (Porter et al. 1985). The effects of
retinoic acid therefore seem to be indirect and mediated by the germ
cells.
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Isolated Sertoli cells in culture respond to stimulation by FSH by
exhibiting changes in cell shape which are thought to indicate inherent
cyclicity of Sertoli cell function (Spruill et al. 1981). However the
evidence presented here seems to suggest that the differentiation of
germ cells is not entirely influenced by the metabolic responses of the
Sertoli cells, but that it is a two-way process with Sertoli cell
function being modulated by the germ cells.
1.6.3 Sertoli-peritubular-Leydig interactions
External to the basement membrane of each seminiferous tubule lies
the peritubular tissue (Ross & Long, 1966; Bustos-Obregon & Holstein,
1973). This consists of approximately 3-5 alternating layers of
collagen fibres and myoid cells separated by thin layers of microfibrils
and basement membrane-like material, and is devoid of any blood vessels
or nerves (de Kretser et al. 1975). Located between the seminiferous
epithelium and the interstitium , the peritubular tissue is
strategically placed so as to exert an influence on Sertoli cell and
Leydig cell function.
The development of the highly organised peritubular tissue has been
attributed to stimulation by the gonadotrophins. Patients with
hypogonadotrophic hypogonadism show poorly organized peritubular tissue
which subsequent to gonadotrophin therapy takes on a mature appearance
(de Kretser & Burger, 1972). However neither LH nor FSH bind to
isolated peritubular cells (Steinberger et al. 1975; Fritz et al.
1975), and it is likely that the effect of the gonadotrophins is exerted
via androgen production by the Leydig cells (Sar et al. 1975; Skinner &
Fritz, 1985a,b). This androgen mediated effect is supported by studies
both in vivo and in vitro. Bressler & Ross (1972) observed myoid cell
differentiation in testosterone treated hypophysectomized adult rats
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given intratesticular implants of immature testicular tissue. In vitro,
the anti-androgen cyproterone acetate prevents the development of rat
myoid cells (Hovatta, 1972b).
Contractions of the peritubular myoid cells are responsible for the
passage of mature spermatozoa along the lumen of the seminiferous
tubules towards the epididymis (Ross & Long, 1966). Testicular oxytocin
from the Leydig cells is thought to play a role in the regulation of
seminiferous tubule contractions, although this remains to be
substantiated (Nicholson et al. 1984; Guldenaar & Pickering, 1985).
In vivo the Sertoli cells are surrounded by the peritubular cells
separated only by the basal lamina. Co-culture of peritubular and
Sertoli cells results in the synthesis of laminin by the Sertoli cells,
and fibronectin and type I collagen by the peritubular cells (Tung et
al. 1984) which together lead to the formation of a basal lamina-like
structure (Tung & Fritz, 1980). Monoculture of peritubular cells and
Sertoli cells fail to synthesize their respective components of the
basal lamina (Tung & Fritz, 1984). The role of the basal lamina is not
clear but it is thought to promote histotypic expression of the Sertoli
cells in vitro. Sertoli cells plated out on polystyrene culture dishes
form monolayer cultures. If however they are plated on top of
peritubular cells, the basal lamina thus formed influences the
orientation and polarity of the Sertoli cells such that they remain
columnar with abundant cytoplasmic processes and junctional complexes
between adjacent cells (Tung & Fritz, 1984).
An additional cellular interaction which may have a regulatory role
between the peritubular and Sertoli cells is that mediated by the
secretion of paracrine factors. Co-culture with peritubular cells
promotes the secretion of ABP and transferrin from rat Sertoli cells
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both in the presence and absence of FSH (Tung & Fritz, 1980; Hutson &
Stocco, 1981; Skinner & Fritz, 1985 a,b, 1986). In the early studies
the effects of peritubular cells could not be mimicked by peritubular
cell-conditioned medium. Rat peritubular and Sertoli cells cultured in
y/
parabiotic chambers demonstrated that peritubular cell secretions were
unable to influence ABP production (Hutson, 1983). This would suggest
that the action of the peritubular cells requires a specific cell-cell
interaction. More recent studies demonstrate that peritubular cells
produce a protein (P-Mod-S) which is capable of stimulating Sertoli cell
production of ABP and transferrin in a dose-dependent manner (Skinner &
Fritz, 1985a,b,1986). The discrepancy between these studies can be
explained by the presence of contaminating peritubular cells in the
Sertoli cell-enriched preparations of the earlier studies which may have
obliterated the effects of the non-concentrated peritubular
cell-conditioned medium (Skinner & Fritz, 1985b).
The availability of pure Sertoli cell-enriched preparations,
contaminated by approximately 0.3% peritubular cells (Tung et al.
1984), made possible experiments which established that the maintenance
of ABP production by the Sertoli cells is androgen-independent but
dependent on the presence of peritubular cells. Androgen actions on the
seminiferous tubule are therefore in part mediated via their actions on
peritubular cells. Thus androgens produced by the Leydig cells
stimulate the peritubular cells to produce the paracrine factor P-Mod-S
which in turn modulates the functions of the Sertoli cells. Similar
mechanisms are thought to exist in the human as co-culture of human
peritubular and Sertoli cells results in increased production of
transferrin by the latter (Holmes et al. 1984).
The difficulty in obtaining pure myoid cell preparations has
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hindered the purification of myoid cell secretory products. Myoid cells
are known to secrete a number of proteins (Kissinger et al. 1982), many
of which are also secreted by the TR-M cell line, which is thought to be
of myoid cell origin (Mather et al. 1982). It has been suggested that
/
this cell line could be useful in the study of myoid cell function and
the role they play in the regulation of testicular function (Mather et
al. 1983).
1.6.4 Leydig cell - macrophage interactions
Testicular macrophages are situated in the interstitial tissue
where they are closely associated with the Leydig cells
(Fawcett et al. 1973; Miller et al. 1983). The regulatory effect of
FSH on Leydig cell steroidogenesis is thought to result from
interactions between the Sertoli and Leydig cells but recent
observations suggest that testicular macrophages may also be involved.
Studies by Yee and Hutson have demonstrated high affinity binding
sites for FSH on testicular macrophages (1985a), and that these cells
respond specifically to FSH in vitro by increased lactate production
(1983), and in vivo by increased incorporation of labelled amino acids
into secreted products and an accumulation of cAMP (1985b).
Furthermore, culture medium from testicular macrophages enhances rat
Leydig cell steroidogenesis (Yee & Kutson, 1985c). Macrophages are
active in the secretion of many products including prostaglandins and
leukotrienes, in particular leukotriene B4 (LTB4) (Takemura & Werb,
1984). LTB4 has been implicated in the LH-dependent stimulation of
Leydig cell testosterone production (Papadopoulos et al. 1986). These
studies suggest that FSH-regulated secreted products from testicular
macrophages may be involved in the paracrine control of Leydig cell
function similar to the situation which exists in the ovary, in which
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secretion of progesterone by the luteal cells is stimulated by secretory
products from ovarian macrophages (Kirsch et al. 1981).
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1.7 SCOPE OF THIS THESIS
From the time of the early microscopists, who demonstrated that the
testis was divided into seminiferous tubule and interstitial
compartments, the function and control of these compartments have been
considered completely independently. The isolation of two gonadotrophic
hormones from the anterior pituitary, LH which acts on the interstitial
Leydig cells and FSH which acts on the Sertoli cells in the seminiferous
tubule compartment, reinforced this concept of independent control.
Over the past five years there has been increasing experimental
evidence, largely in the rat, to suggest that quantitatively normal
spermatogenesis requires not only stimulation by the gonadotrophic
hormones, but also the complex interactions between the various cellular
components within the seminiferous tubules and interstitial compartments
of the testis - the so-called paracrine control. Thus, in order to
further our understanding of the paracrine control of testicular
function in man, the studies described herein were directed towards
establishing techniques whereby individual components of the testis
could be studied in isolation and in combination and related to the
overall functional state of the testis as defined by systemic hormone
levels and histological assessment of spermatogenesis. These studies
provide a basis for future investigation of seminiferous tubule and





2.1 HUMAN TESTICULAR TISSUE, PLASMA AND INTERSTITIAL FLUID
Testicular tissue for all of the studies described was obtained
from men undergoing either total or subcapsular orchidectomy for
prostatic carcinoma. All samples were collected from the operating
theatre as soon as possible following orchidectomy and placed on ice.
Patients ranged in age from 50 to 94 years (median 73 years) and were
sub-divided into groups according to treatment regimen as follows:-
2.1.1 No treatment
Orchidectomy was the primary treatment for prostatic carcinoma in
this group, other forms of treatment being contraindicated because of
the risk of thromboembolism and cardiovascular complications or because
of the advanced state of the disease.
2.1.2 Radiation treated
All patients who had received radiotherapy at some stage prior to
orchidectomy were included in this group. In all cases radiotherapy was
completed at least 2 years prior to orchidectomy.
2.1.3 Oestrogen treated
This group comprised patients who were receiving diethyl
stilboestrol (DES; 3 mg daily) up to the time of orchidectomy.
2.1.4 Post mortem
Testes from one 17 year old man, killed in a road traffic accident,
were obtained 12 h after death.
2.1.5 Plasma
Peripheral blood was obtained from the patients prior to
anaesthesia. After centrifugation at 1000 x g for 10 min at 4°C, plasma
samples were pipetted off and stored at -20°C prior to measurement of
testosterone, LH, FSH and oestradiol.
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2.1.6 Interstitial fluid
Interstitial fluid (IF) was collected from testes after total
orchidectomy by the method described by Sharpe & Cooper (1983). A small
incision was made in the caudal pole and the testis placed in a glass
funnel. The IF was allowed to drain from the testis into a glass
centrifuge tube for approximately 16 h, after which time it was
centrifuged at 4°C for 10 min to remove any contaminating red blood
cells. The interstitial fluid was then aspirated and incubated at room
temperature for 30 min with charcoal (Norit A; 20 mg charcoal/ml IF),
centrifuged for 10 min at 1000 x g and the supernatant extracted a
second time using the same procedure. Following this double charcoal
extraction, testicular IF levels of testosterone were undetectable. IF
was stored at -40°C.
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2.2 MORPHOMETRY AND STEREOLOGY
2.2.1 Histology
Testicular tissue of approximately 1 mm cubed was sampled at random
from cranial, equatorial and caudal regions of the testis and fixed in
3% glutaraldehyde buffered with 0.2 M sodium cacodylate. Tissue blocks
were post-fixed in 2% cacodylate-buffered osmium tetroxide for 2 h,
stained with 1% uranyl acetate in 0.05 M maleate buffer, dehydrated in
alcohols and embedded in Epon-araldite. Semithin 1 ^im sections were cut
with a Reichert 0mU3 ultramictrotome, stained with toluidine blue and
examined with a Zeiss photomicroscope.
2.2.2 Photography
Photomicrographs were prepared using standard techniques and
printed at a final magnification of 1200 x.
2.2.3 Random sampling
Careful attention was taken to ensure a systematic method of random
sampling such that all morphometric analysis was performed on unbiased,
representative samples.
2.2.4 Standardization
All micrographs were taken at the same magnification. In addition,
a micrograph of a stage micrometer was taken with each film to correct
for any minor inconsistencies in the microscope or in the film
processing routine.
2.2.5 Minimal sample size
On average 4000 observations were made for each parameter measured
for each individual patient (20 sections x 10 areas/section x 20
objects/area).
2.2.6 Measurement of testicular volume
The volume of a preweighted block of testicular tissue was
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determined by fluid displacement. A beaker containing water was placed
on a balance and weighed. A preweighed block of testicular tissue was
suspended by a thin thread so that it was completely immersed in the
water but did not touch the bottom of the beaker. This new weight (g)
minus the weight of the beaker plus water was equal to the volume of the
testicular tissue (cm^). The specific gravity of testicular tissue
was also determined by allowing the tissue to drop to the bottom of the
beaker and this new weight measured. This weight, minus the weight of
the beaker plus water, divided by the volume of the testicular tissue
was equal to the specific gravity. The specific gravity of human
testicular tissue approximates unity (1.03 + 0.08, n=20), thus "g" and
"cm^" are interchangeable.
Tissue processing for light microscopy alters testicular volume by
shrinkage (fixation and dehydration) and swelling (embedding). The
extent of these effects were determined by measuring testicular volume
before and after processing. Testicular tissue processed according to
the protocol detailed above (2.2.1) was reduced in volume to 58.7% - 75%
compared to fresh tissue. Measurements of numerical density (see 2.2.8)
from semithin sections were corrected accordingly and expressed in terms
of fresh intact tissue.
2.2.7 Section thickness
20 sections were re-embedded in Epon-araldite, cut on edge and
their thickness determined with an eyepiece graticule. Mean section
thickness did not deviate significantly from 1 ji (1 + 0.3, p^0.05).
2.2.8 Determination of round spermatid and Leydig cell number
The number of round spermatid and Leydig cell nuclei in individual
testes was derived by the measurement of numerical density (Nv) using
the Floderus equation Ny = NA/D+t-2h (Floderus, 1944), where Na is
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the number of nuclei counted in a known area, D is the mean caliper
diameter of the nucleus of interest, t is the section thickness and h is
the height of the smallest visible nuclear cross section.
Quantitation of was carried out using a Zeiss photomicroscope
with a Plan Apo 40 x oil objective. Round spermatid and Leydig cell
nuclei were counted in random areas (i.e. including areas which did not
contain the cell type of interest) using a squared lattice with an area
of 44,100 ^lm^. Approximately 300 reference areas, or 13.2 x 106
yum^, were examined to determine for each individual.
Measurement of average nuclear diameter (D) was carried out on
photomicrographs, taken with a Zeiss photomicroscope with a Plan Apo 40
x oil objective, printed at a final magnification of 1200 x. Nuclear
diameter was measured in mm in approximately 4000 cells (20 sections x
10 areas x 10 cells / area) per individual, converted to ji using a
photomicrograph of a stage graticule taken at the same magnification and
the mean taken as the actual nuclear diameter. Since the nuclei were
often elongated in section, both the longest and shortest diameters were
measured and the average of the two measurements considered as the
actual diameter.
The height of the smallest visible cap section (h) was arbitrarily
estimated to be one-third of the section thickness, or approximately 10%
of the nuclear diameter (Mori & Christensen, 1980).
Ny gave the number of nuclei per^im^. This was converted to
number per cm-^ (1 cm^ = 10^2 ^m3) i.e. number per g of
testis.
2.2.9 Seminiferous tubule length
Total seminiferous tubule length per testis was calculated from the
formula:-
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Length = volume (of seminiferous tubules)
area (of seminiferous tubule cross section)
Counts to determine volume density of seminiferous tubules were
made with a Plan Apo x 10 objective and 10 x eyepieces, one of which
y
contained a squared grid comprising 49 intersecting points. The volume
density of seminiferous tubules was derived by dividing the number of
points landing on seminiferous tubules by the total number of points
observed (49 points/area x 10 areas/slide x 10 slides/individual = 4900
points).
The area of seminiferous tubule cross sections was derived by
tracing the perimeter of approximately 100 transverse sections (5
transverse sections/slide x 20 slides) for each individual with an image
analyser.
Seminiferous tubule length was expressed as m/testis.
2.2.10 Daily sperm production
Spermatogenesis was quantitated as daily sperm production (DSP)
using a technique described by Johnson and co-workers (1981).
Testicular tissue, of approximately 30-50 mg, was immersion fixed in 2%
glutaraldehyde buffered with 0.2 M sodium cacodylate. Fixed tissue was
stored at 4°C until homogenates were prepared by dicing
glutaraldehyde-fixed tissue in 10 ml homogenizing fluid consisting of
150 mM NaCl, 0.05% (v/v) Triton X-100 and 3.8 mM NaN3. Diced
parenchyma was homogenized at room temperature for 6 min in a VirTis 23
macrohomogenizer (Techmation Ltd., U.K.). All spermatid nuclei were
counted in a haemocytometer under phase contrast microscopy using the
classification system of Clermont (1963) and Heller & Clermont (1964).
DSP/g was calculated by dividing the number of spermatids in the
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homogenate by the product of the weight of tissue homogenized by a time
divisor of 23.9 days. The time divisor is designated to determine the
number of days sperm production represented by the spermatids counted in
the homogenate. This was assumed to be the sum of the duration of the
y
stages of the-spermatogenic cycle in which spermatids are present.
For each patient six blocks of tissue were selected at random from
both left and right testes. DSP for each testis was expressed as X +
SD.
The precision of this technique was estimated by the coefficient of
variation which was 8.1 + 4.5% between spermatid counts within the same
homogenate, and 14.8 + 5.5% between different homogenates from the same
testis.
2.2.11 Morphometric analysis of DSP
DSP was calculated in 7 individuals on lji semithin sections by
dividing numerical density of round spermatid nuclei (see 2.2.8) by a
time divisor of 8.9 days (Johnson et al. 1981). The correlation
coefficient between DSP/g obtained using both homogenization and
morphometric techniques was tested for significance.
2.2.12 Quantitation of spermatogenesis by enumeration of mature
spermatids
Mature spermatids (Scl, Sc2, Sdl, Sd2 in stages I, II, V & VI) were
counted in approximately 100 transverse seminiferous tubule cross
sections (20 slides x 5 cross sections/slide) per man. Seminiferous
tubules cut obliquely were not enumerated. Mature spermatid nuclei were
counted and the total number divided by the number of tubules in which
they were observed.
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2.3 DISTRIBUTION OF TESTOSTERONE IN THE HUMAN TESTIS
2.3.1 Whole testis testosterone
Testes were decapsulated and parenchymal weight determined. Six
blocks of tissue (approximately 0.5 g) were sampled at random to
determine whole testis testosterone. Each preweighed block of tissue
was stored at -20°C prior to extraction of testosterone.
2.3.2 Isolation of human seminiferous tubules
Seminiferous tubules from representative cranial, equatorial and
caudal regions were isolated from both right and left testes.
Seminiferous tubule dissections were carried out on a trans-illuminated
cooled stage through which ice-cold water was pumped continuously.
Attached to the stage was a transparent 1 mm squared grid. Small blocks
of testicular tissue, of approximately 1 g, were in turn placed in 5 cm
plastic Petri dishes containing ice-cold medium 199 containing Hank's
salts and 20 mM Hepes buffer (= ml99H, Flow Laboratories, UK).
Seminiferous tubules were teased apart with watchmakers forceps, and
isolated tubules of varying lengths, with no adherent connective tissue
or interstitial cells, were transferred to another Petri dish, again
containing ml99H. This medium was aspirated to leave only a covering on
the surface of the Petri dish. Individual seminiferous tubules were
aligned above the transparent grid and cut into segments of 0.5 cm. 20
x 0.5 cm aliquots of isolated seminiferous tubules were transferred to
glass tubes containing 300 yl distilled water to cause lysis of the
tissue, and stored at -20°C prior to extraction of tubule testosterone.
2.3.3 Extraction of whole testis and seminiferous tubule testosterone,
dihydrotestosterone and oestradiol on celite columns
(i) Whole testis
Tritiated testosterone (1,2,6,7-^H, 80-105 Ci/mmol, Amersham
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International PLC), dihydrotestosterone (1,2-^H (N), 55.5 Ci/mmol, New
England Nuclear) and oestradiol (2,4,6,7-^H, 100 Ci/mmol, Amersham
International PLC), each at approximately 4000 counts per minute (cpm)
in a volume of 100 js 1 were added to each preweighed testis block to
determine percentage recovery. Each testis block was homogenized and
centrifuged at 1500 x g for 10 min at 4°C. The resulting organic phase
was pipetted off and the residue extracted a second time with 2 ml
methanol. Both organic phases were pooled and dried down under
nitrogen. The residue was reconstituted in 0.5 ml iso-octane
(2,2,4-trimethylpentane).
(ii) Seminiferous tubules
After the addition of ^H-testosteorne , ^H-dihydrotestosterone
and ^H-oestradiol (each at 2000 cpm in 100jil) to monitor for
recovery, each aliquot of seminiferous tubules was sonicated for 30 sec
using an MSE Soniprep 150 (MSE Instruments Ltd., UK). The resulting
preparation was extracted with 3 ml diethyl ether and vortex mixed for
10 min. The aqueous phase was frozen in a solid C02~ethanol bath and
the organic phase dried down under nitrogen and reconstituted in 0.5 ml
iso-octane.
(iii) Preparation of celite columns
Celite 545 (Johns Manville Co., USA) was acid washed overnight with
concentrated hydrochloric acid, rinsed with tap water until it reached
neutral pH, and dried. Each time columns were prepared, celite was
activated at 300°C for 12 h. Activated celite was mixed with ethylene
glycol (1 g : 0.5 ml) and packed into glass columns. Each column was
flushed through twice with iso-octane prior to addition of the samples.
(iv) Elution of steroids on celite columns
Whole testis and seminiferous tubule extracts in 0.5 ml iso-octane
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were loaded onto individual celite columns and allowed to flow through
completely. Each column was then washed with 2.5 ml iso-octane and the
eluate discarded. The dihydrotestosterone fraction was eluted with 5 ml
iso-octane. Next the testosterone fraction was eluted with 5 ml 20%
benzene in iso-octane. Finally the oestradiol fraction was eluted with
/
6.5 ml 40% ethyl acetate iso-octane. Each fraction was dried down under
nitrogen and reconstituted in phosphate gelatin buffered saline (PGBS,
0.1 M). Extracts of whole testis and seminiferous tubule
dihydrotestosterone and oestradiol have as yet not been assayed, and
will not be discussed further. Each testosterone fraction was assayed
using an ■'-^I-testosterone assay.
2.3.4 Iodination of tracer for ^-25j_^-estoster0ne assay
2 ^ig testosterone-3 carboxymethyl oxime-histamine were iodinated
with 2 mCi Na-I-125 (Amersham International Ltd. , UK) using chloramine-T
(1 mg/ml). This reaction was stopped after 2 min by the addition of 10
jil sodium bisulphite (1 mg/ml) in 0.05 M phosphate buffered saline. The
products of this reaction were extracted twice with ethyl acetate and
separated by thin layer chromatography using a solvent mixture of
chloroform:methanol:glacial acid (90:10:1 by volume). Two bands of
iodinated material were obtained and the most active (lower) band was
eluted in ethanol and stored at 4°C for up to 2 months.
2.3.5 Testosterone standards
Standards were prepared from a solution containing 1 yg
testosterone in 1 ml ethanol. 640 ji 1 of this solution were evaporated
to dryness and the residue reconstituted in 100 ml PGBS to give a
concentration of 640 pg/100 jil. Dilutions of this stock solution were
made to produce standards ranging from 640-5 pg/100 yl. Results were




Testosterone was assayed by a double-antibody radioimmunoassay
using 125i-labelled testosterone-3-carboxymethyl oxime-histamine as
tracer and an antiserum raised in the sheep against the same
testosterone conjugate (Sharpe & Bartlett, 1985). Testosterone samples,
standards and quality controls (100 yl in duplicate) were added to 500
jil PGBS, approximately 15,000 cpm 125x-labelled testosterone tracer
and 100 y.1 of a 1:350,000 dilution of the testosterone antiserum and
incubated at room temperature for 4 h. Following incubation, 100 jil of
a 1:1,000 dilution of normal sheep serum (Scottish Antibody Production
Unit) and 100 jil of a 1:25 dilution of goat anti-sheep precipitating
serum (Scottish Antibody Production Unit) were added and incubated for a
further 16 h at 4°C. Each tube was then centrifuged at 1500 x g for 30
min at 4°C, the supernatant decanted, and the precipitate counted in a
gamma counter (NE 1600, Nuclear Enterprises Ltd., U.K.). The results
were computed by a Commodore 4032 micro-computer (CBM Computers Ltd.,
U.K.) linked to the NE 1600. The inter- and intra-assay coefficients of
variation, calculated from quality controls run with each assay, were
12.3 + 3.1% and 8.2 + 3.0% respectively. The limits of detection of the
assay were 0.2 and 3.2 ng/ml.
2.3.7 Measurement of circulating hormones
(i) Testosterone
Tritiated testosterone, approximately 1000 cpm in a volume of 20
^il, was added to 100 jil plasma in duplicate. This was extracted with
1.5 ml redistilled hexane-diethyl ether (4:1). After vortex mixing for
5 min the aqueous phase was frozen in a solid C02-ethanol bath. The
organic phase was decanted, dried down under nitrogen and reconstituted
in 200 jil PGBS. 100 ul was assayed using the l^x-testosterone
radioimmunoassay (2.3.6) and 50 ul was used to determine percentage
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recovery of individual samples. Quality control plasma samples were
extracted and assayed in exactly the same manner.
(ii) LH and FSH
Human plasma LH and FSH were measured using a double antibody
radioimmunoassay (Hunter & Bennie, 1979), and the results expressed in
terms of WHO standards 68/40 and 78/549 respectively. Briefly, 100 jsl
sample, 150 jil 1% BSA/PBS and 50 ^il antiserum (LH: F87-2, 1:200,000,
from the Chelsea Hospital for Women; FSH: M93/2, 1:250,000 from Dr. S.
Lynch, Birmingham) were incubated for 24 h at 4°C. Following the
addition of 50 jil tracer (both from the Chelsea Hospital for Women, LH:
18,000 cpm/tube; FSH 15,000 cpm/tube) the asssay was incubated for a
further 24 h at 4°C before the addition of 100 jil donkey anti-rabbit
serum (Scottish Antibody Production Unit, 1:32) and 100 ^il normal immune
rabbit serum (Scottish Antibody Production Unit, 1:200). Following
incubation overnight at 4°C, 1 ml 0.9% saline was added to each tube and
centrifuged for 30 min at 1500 x g at 4°C. The supernatant was tipped
off and the remaining precipitate counted in an NE 1600 gamma counter.
The results were computed by a Commodore 4032 micro-computer linked to
the NE 1600.
(iii) Oestradiol
Oestradiol was extracted from 100 jil plasma with 1 ml diethyl
ether. After mixing for 30 sec the aqueous phase was frozen in a solid
C02~ethanol bath. The organic phase was decanted and dried down on a
heating block. To each extract 200 ^il antiserum (BW 26/9/80, Tenovus
Institute for Cancer Research, 1:4,500,000) and 200 jil tracer
(oestradiol-3-carboxymethyl ether-[-*-^^1]-iodo-histamine, 15,000
cpm/200 ^il) were added and incubated at room temperature for 2 h.
Following incubation, 500 ul 1.25% dextran-coated charcoal
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(Norit A charcoal, Sigma Ltd., UK; dextran T70, Pharmacia, UK) was
added and each tube allowed to incubate for 15 min on ice. Each tube
was then centrifuged for 10 min at 1500 x g at 4°C and the supernatant
decanted and counted in an NE 1600 and the results calculated using a
log spline curve fit. The intraassay coefficient of variation was^5%.
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2.4 LEYDIG CELL STUDIES IN VITRO
2.4.1 Patients
Testicular tissue was obtained from men aged between 57 and 85
years who were undergoing orchidectomy for prostatic carcinoma. No
patient had received any previous treatment, or had any known endocrine
disease or any chronic systemic illness known to affect Leydig cell
function.
2.4.2 Animals
Adult male Sprague Dawley rats (80-100 days), obtained from Charles
River Ltd., UK were housed under conventional conditions and killed by
dry ice-generated CO2.
2.4.3 Percoll gradients
Stock Percoll (Pharmacia, UK) was mixed with lOx medium 199 with
Hanks' salts (Flow Laboratories, UK) (9:1 v/v) to produce a solution of
90% Percoll with a density of 1.12 g/ml. This solution was diluted with
appropriate quantities of medium 199 containing Hanks' salts and 20 mM
Hepes buffer (= ml99H, Flow Laboratories, UK) to produce solutions of
Percoll with densities of 1.09, 1.07, 1.05 and 1.03 g/ml. Discontinuous
gradients of Percoll consisting of successive 10 ml layers of each of
the Percoll solutions, beginning with 1.09 g/ml and topped with 10 ml
ml99H alone were prepared and stored overnight at 4°C prior to use.
2.4.4 Preparation of human Leydig cells
Testes were weighed, decapsulated and cut into small pieces of
about 5 mm cubed. Approximately 5-8 g of tissue was then placed into 50
ml conical glass flasks and washed briefly with 25 ml medium 199
containing Hanks's salts and 20 mM Hepes buffer (= ml99H, Flow
Laboratories, UK). This medium was then decanted and replaced by 8 ml
ml99H containing 0.5 mg/ml collagenase (Type I; Sigma UK) and 2.5 mg/ml
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bovine serum albumin (BSA, Fraction V; Sigma, UK). The tissue was then
incubated in a shaking water bath (180 cycles/min) for 10 min at 32°C.
The contents of each flask were then transferred to measuring cylinders,
diluted with 40 ml ml99H and inverted 2 or 3 times. Undispersed tissue
and tubule fragments were then allowed to settle and the supernatant was
filtered through a double layer of gauze. The filtrate, containing
isolated cells was then centrifuged at 200 x g for 5 min at 4°C and the
precipitated cells resuspended in medium 199H containing 0.5 mg/ml BSA.
The cell suspension obtained from the paired testes of each subject was
then filtered once through gauze to remove cell aggregates before being
loaded onto a discontinuous gradient of Percoll (Pharmacia, UK). The
gradient was then centrifuged at 1800 x g for 20 min at 4°C. Three cell
bands were formed at the interface between the successive layers of
Percoll and these were termed band 1 (at the interface between 1.03 and
1.05), band 2 (between 1.05 and 1.07) and band 3 (between 1.07 and
1.09). The bands were aspirated, washed in ml99H containing 0.5 mg/ml
BSA and centrifuged at 250 x g for 5 min at 4°C. The precipitated cells
were then resuspended in equal volumes of ml99H containing 0.5 mg/ml BSA
and medium 199 containing Earles' salts, 0.5 mg/ml BSA, L-glutamine (2
mM: Flow Laboratories, UK), penicillin (100 IU/ml; Flow Laboratories,
UK) and streptomycin (100 jug/ml; Flow Laboratories, UK) (= ml99E).
Nucleated cells were then counted in a haemocytometer. In some
experiments all 3 cell bands were studied but, in the majority of
experiments, cells from bands 2 and 3 were combined prior to the final
washing step described above.
2.4.5 Preparation of rat Leydig cells
Rat Leydig cells were isolated using a technique essentially
identical to that described above for the preparation of human Leydig
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cells, but with the following modifications:-
1. 10 testes were used for each Leydig cell preparation.
2. Groups of 5 decapsulated testes were placed in 50 ml conical flasks
together with 8 ml ml99H containing 0.25 mg/ml collagenase plus 2.5
mg/ml BSA and incubated for 7 mins in a shaking water bath at 32°C.
3. Leydig cells were obtained from band 3 only.
2.4.6 Identification of Leydig cells
Leydig cells were identified histochemically by staining for
glass slides, air dried and fixed for 10 min in acetone. Fixed cells
were stained for 3^-HSD by incubating for 2 h at 32°C in a solution
consisting of 0.1 M Tris-HCl (13%), N,N-dimethylformamide (5.4%), sodium
cyanide (0.0003%) and anhydrous magnesium chloride (0.0004%) in
distilled water, to which was added nitro-blue tetrazolium (0.82 mg/ml),
dehydroepiandrosterone (0.27 mg/ml) and ^-nicotinamide adenine
dinucleotide (0.91 mg/ml). Following incubation the slides were rinsed
with tap water, dried and mounted in glycerine jelly. The percentage of
stained nucleated cells (Leydig cells) were determined by counting
random fields of at least 250 cells by light microscopy.
2.4.7 Leydig cell incubation
Aliquots of 0.05 x 10^ cells were incubated in a final volume of
0.25 ml ml99E in plastic multiwell dishes (Nunc, Denmark) at 32°C under
a humidified atmosphere of 95% air : 5% C02« Apart from triplicate
wells which contained no hormone additions to determine basal
testosterone production all other wells contained hCG (Chorulon,
Intervet) at various concentrations but always including a dose (20,000
mlU/ml) that represented a 100- to 1000-fold excess above that needed to
maximally stimulate testosterone production. All incubations were done
Cell smears were prepared on
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21°C in 63 x 11 mm polystyrene tubes in the presence of concentrations
of 125I-labelled hCG (NIAMDD hCG-CR121) ranging from 0.01 to 3.3 pM,
to enable construction of saturation curves. Non-specific binding was
determined by parallel incubation in the presence of a 1000-fold excess
of unlabelled hCG. The ^25l-labelled hCG was prepared using
lactoperoxidase and had a specific activity of 12 mCi/mg as determined
by self-displacement. Cell preparations from one human and one group of
five rats were compared in the same binding assay.
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2.5 INHIBIN BIOACTIVITY IN HUMAN TESTICULAR EXTRACTS
2.5.1 Patients
Testes were obtained from 21 men aged between 60-89 years (median
74) who were undergoing orchidectomy for prostatic carcinoma. Fifteen
patients received no previous treatment, while six men had received
radiotherapy 2-3 years before orchidectomy. No patient had any
endocrine disease or chronic illness known to affect testicular
function. Patients receiving endocrine therapy were excluded from the
study.
2.5.2 Preparation of testicular extracts
Testicular aqueous extracts were prepared from human, rat (adult
male Sprague Dawley), ram, boar (from the local abattoir) and marmoset
(adult from our own colony) as described previously by Au et al. (1983).
Briefly, testicular tissue of known weight was homogenized on ice in 1:1
(w/v) sterile Dulbecco's phosphate buffered saline (DPBS, pH 7.4)
containing penicillin (50 IU/ml) and streptomycin (50^ig/ml).
Homogenates were centrifuged at 100,000 x g for 1 h at 4°C and the
aqueous fraction aliquoted, snap frozen and stored at -20°C. Each
sample was passed through C18 Sep-Pak cartridges (Waters Associates,
Milford, MA, USA) to remove the steroids before bioassay.
2.5.3 In vitro inhibin bioassay
Inhibin was measured using a sheep pituitary cell bioassay as
described previously (Tsonis et al. 1986). Heads from ewe lambs aged
between 8-15 months were obtained from the local abattoir. Anterior
pituitary glands were removed, chopped into blocks of approximately 4
mnp and washed 6 to 8 times in DPBS containing 7.5 mM glucose/1 and
0.1% BSA. Pituitary blocks were placed in a 25 ml spinner flask with 10
ml 0.5% trypsin made up in DPBS + 0.1% BSA and stirred gently for 30
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min at 37°C. The trypsin solution was removed and replaced with 10 ml
Dulbecco's Modified Eagles's Medium (DMEM, Flow Laboratories, UK)
supplemented with 10% lamb serum (Flow Laboratories), 2.5% foetal bovine
serum (Flow Laboratories) 10 mM Na HCO3/I, 2 mM glutamine/1 (Sigma,
UK), penicillin (50 IU/ml) and streptomycin (50 ^ig/ml) and stirred
gently for 30 min at 37°C. The supplemented DMEM was removed and
replaced with 10 ml DPBS~ (Ca^+ and Mg2+ free) supplemented
with 2mM EDTA/1 and 0.1% BSA and stirred gently for 10 min at 37°C.
This medium was centrifuged at 500 x g for 10 min at room temperature
while the remaining tissue was washed 3-4 times with 10 ml DPBS and
dispersed using a series of 3 Pasteur pipettes of decreasing bore (5-2
mm) which were sterile, siliconized and flame treated. The dispersed
cells were made up to 20 ml with supplemented DMEM and centrifuged twice
at 500 x g for 10 min at room temperature, the pellet being resuspended
in 3-5 ml supplemented DMEM between spins. The precipitated cells were
added to those isolated during the first spin, diluted to 20 ml with
supplemented DMEM and counted in a haemocytometer. The average cell
yield per pituitary was 30-50 x 10^ cells. Pituitary cells were
diluted to a final concentration of 180,000-200,000/50 jil with
supplemented DMEM. 50 jil aliquots of cells were incubated in a final
volume of 600 jil supplemented DMEM in plastic multiwell dishes (Nunc,
Denmark) and cultured for 48 h in a humidified atmosphere of 95% air :
5% C02.
Following the initial 48 h culture period, the medium was aspirated
and replaced with either test sample, ovine rete testis fluid inhibin
standard (oRTF lU/mg, kindly donated by Dr. J.K. Findlay (see Eddie et
al. 1979), or ovine follicular fluid quality control (oFF; Tsonis et al.
1986) and cultured with anti-oestradiol and anti-progesterone serum
(Tsonis et al. 1986, 1987c) for a further 48 h. Both the oRTF inhibin
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standard and the oFF quality control were assayed in quadruplicate over
a five-fold dose range to establish an FSH-inhibition curve. Testicular
extracts were tested in duplicate at three dilutions using up to 50 jil/
culture well. Ovine FSH in the culture medium was assayed by a specific
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double antibody radioimmunoassay using an NIH-oFSH-S14 standard as
described by McNeilly and colleagues (1976). FSH dose-response curves
were expressed as percent of control (no exposure to inhibin).
Regression analysis was performed to determine the slope, index of
precision (lamda) and significance of regression (Finney's g; Finney,
1964). Testicular extracts were compared to the oRTF standard and
relative potencies calculated for samples which showed no significant
departure from parallelism and linearity. The index of precision of the
bioassay was 0.055 and the sensitivity was 0.05 - 0.1 U/ml relative to
the oRTF standard.
2.5.4 Bioassay of pituitary cell mitogenic activity
Ovine pituitary cells were cultured for 48 h (2.5.3) after which
the culture medium was removed and replaced with medium containing
extracts of human, rat, ram, boar and marmoset testes. After a further
72 h of culture the medium was aspirated and the pituitary cells removed
from the culture plates by the use of trypsin DPBS- containing 0.2%
trypsin and 0.08% EDTA (250 |il) was added to each culture well for 20
min at room temperature. The trypsin was neutralized by the addition of
250 jil DPBS+ containing 0.1% BSA. The cells were lifted from the
culture plate by repeated, gentle aspiration using a Gilson pipette.
Cell number was counted using a haemocytometer.
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2.6 STATISTICS
As normal distribution of values could not be assumed, both
parametric and non-parametric (in parentheses) analyses were applied to
the results. Where appropriate analysis was by Student's t test (Mann-
y
Whitney test), simple regression (Spearman's rank order correlation
coefficient), multiple interactive regresssion and analysis of variance
(Kruskal-Wallis one way analysis of variance). In no case did the
significance of difference change according to which test was applied.
All results are expressed in terms of parametric analyses, significance
being determined by the t- statistic.
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CHAPTER 3
Relationship between Testosterone and Spermatogenesis
In the Senescent Huaan Testis
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3.1 Introduction
The function of the mammalian testis is two-fold. Firstly there is
the production of androgens by the Leydig cells under the influence of
LH. Secondly there is the production of the male gametes, the
spermatozoa, by the process of spermatogenesis. Maintenance of
spermatogenesis requires a specific hormonal milieu, and androgens have
become regarded as the essential hormones of this milieu (Desjardins et
al. 1973; Nieschlag et al. 1973). In the past it has been accepted
that high intratesticular levels of testosterone are an essential
prerequisite of spermatogenesis, and a number of studies have reported
the existence of paracrine factors which act to maintain high
intratesticular levels of testosterone (Sharpe, 1984, 1986). Indeed
declining levels of testosterone, as a result of a reduction in Leydig
cell number, has been proposed as the reason for impaired
spermatogenesis in elderly men (Neaves et al. 1984).
However a small number of observations have challenged this concept
that high intratesticular levels of testosterone are essential for the
production of spermatozoa. In hypophysectomized rats (Boccabella, 1963;
Buhl et al. 1982) and stalk-sectioned monkeys (Marshall et al. 1983),
the administration of exogenous testosterone resulting in
intratesticular levels of testosterone which are 10-20% of normal is
sufficient to maintain spermatogenesis, at least qualitatively. In
intact adult rats, following the peripheral administration of
testosterone proprionate which, by suppressing serum LH to undetectable
levels, reduces intratesticular testosterone levels to 20% of normal,
spermatogenesis is maintained quantitatively (Cunningham & Huckins,
1979). Similarly in rats made hypogonadotrophic by treatment with a
luteinizing hormone-releasing hormone antagonist, subcutaneous implants
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of testosterone maintained spermatogenesis quantitatively in the
presence of intratesticular levels of testosterone which are 15% of
normal (Rea et al. 1986). In this study, as in that by Cunningham &
Huckins, while the administration of exogenous testosterone suppresses
LH to undetectable levels, FSH is reduced only moderately. Thus it has
been suggested that in the presence of FSH, high intratesticular levels
of testosterone are not essential for spermatogenesis to proceed as
normal.
The present study attempted to investigate the relationship between
intratesticular levels of testosterone and spermatogenesis in the
senescent human testis. Testes obtained from a group of men who had
received orchidectomy as primary or secondary treatment for prostatic
carcinoma provided an ideal source of tissue with varying degrees of
hormonal and germ cell disruption.
3.2 (i) Daily sperm production
Daily sperm production (DSP) was quantitated as described
previously (see 2.2.10). Briefly this involved homogenizing
approximately 30-50 mg of fixed testicular tissue in 10 ml homogenizing
fluid. Spermatid nuclei were examined under phase contrast microscopy,
classified according to Figure 3.1 and enumerated.
DSP in 34 normal untreated males with prostatic carcinoma (60-90
years, median 75 years; 2.8 + 1.3 x 10^/g) was lower than that
reported for 28 healthy men aged between 20-48 years (6.0 + 2.1 x
106/g; Johnson, 1986), but similar to that reported for 28 men aged
between 50-90 years (3.8 + 1.6 x 10^/g; Johnson, 1986). No
significance was attached to the difference in DSP observed between the
young (20-48) and older (60-90) age groups as individual values for the
younger men were not available (Fig. 3.2). Despite the apparent
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FIGURE 3.1
Illustration from Johnson et al. (1981) of Leydig
cell, Sertoli cell and germ cell nuclei in human
testicular homogenates viewed by phase contrast
microscopy.
a) A typical Leydig cell nucleus with euchromatic
nucleoplasm and a single nucleolus.
b,c) Ovoid nuclei of Sertoli cells showing typical
folding of the nuclear envelope, abundant euchromatin
and a single nucleolus.
d-h) Spherical nuclei of spermatogonia with fine
nucleoplasm and multiple nucleoli.
i-1) Nuclei of primary spermatocytes with conspicuous
strands of chromatin and prominent single nucleoli,
m) A characteristic secondary spermatocyte nucleus
which is smaller than that of primary spermatocytes,
yet larger than those of round spermatids,
n-s) Spherical nuclei of Sa spermatids with
distinctive nucleoli and visible acrosomal caps,
t-w) Elongating nuclei of Sb spermatids with less
obvious acrosomal caps than Sa spermatids, but with
distinctive flagellar development.
x,y) Elongated nuclei of Sc spermatids with dark
staining nucleoplasm containing vacuoles.
z-d) Nuclei of Sd spermatids with condensed
nucleoplasm which appears highly retractile under
phase contrast.
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Age related change in daily sperm production in 28
healthy men (28 - 48 years, from Johnson et al. 1981)
and in 34 men with prostatic carcinoma (60 - 90 years)
Values are mean ± SD. There was no significant
difference between daily sperm production in men from
60 - 90 years.
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decrease in DSP in the older men, a number of these men had DSP levels
within the range of the younger men. Furthermore, there was no
significant age related decrease in DSP between 60-90 years (Fig. 3.2).
(ii) Morphometric analysis of daily sperm production
In order to validate the homogenization approach to the
quantitation of DSP, morphometric analysis of this parameter was carried
out in 7 men (see 2.2.11). Parameters of round spermatic nuclei and DSP
are shown in Table 3.1. A highly significant correlation was observed
between estimates of DSP determined by enumeration of spermatid nuclei
in fixed testicular homogenates and by morphometric analysis (R = 0.97,
P<0.001, Fig. 3.3).
(iii) Quantitation of spermatogenesis by enumeration of mature
spermatids
Enumeration of mature spermatids (Scl, Sc2, Sdl, Sd2 in stages I,
II, V & VI) in 1 |i histological sections is a means by which testicular
biopsies can be evaluated. This technique was used to evaluate
spermatogenesis in 22 men and compared to DSP determined by counting
spermatid nuclei in testicular homogenates (Fig. 3.4). A high
correlation between the two techniques was found (R = 0.86, P<^0.001)
providing further validation for the homogenization approach to the
quantification of spermatogenesis in the human testis.
(iv) Systemic hormone levels and their relationship to daily sperm
production
In 21 patients who underwent orchidectomy as primary treatment for
prostatic carcinoma, blood samples were obtained prior to anaesthesia
and the endocrine status of these men compared to that of 100 healthy
young men aged 18-50 years (normal data by kind permission of F.C.W.
Wu). Plasma testosterone did not decline significantly as a function
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DSP (homogenization) x 10 6 /g
FIGURE 3.3
Correlation between estimates of daily sperm
production (DSP) in 7 men derived by enumeration
of spermatid nuclei in homogenates of
glutaraldehyde-fixed human testes and by
morphometric analysis (R = 0.97, PC0.001).
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Daily sperm production ( x 10 6 / g )
FIGURE 3.4
Correlation between the number of mature spermatids per
tubule cross section and daily sperm production in 22
patients (R = 0.86, P<0.001).
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of age (Fig. 3.5). Although the mean testosterone level of 6.0 + 1.2 in
the 18-50 age group was greater than that in each of the older age
groups (60-70, 3.1+1.3; 71-80, 3.5+2.2; 81-90, 2.5+1.0), this
was not statistically significant.
/'
LH was significantly elevated in the 60-70 (12.0 + 5.4), 71-80 (9.5
+ 7.5) and 81-90 (12.3 + 3.9) age groups compared to the 18-50 group
(5.6 + 1.8) (P^O.001). LH did not however rise significantly between
60 and 90 years. Similarly, FSH was significantly increased at each of
the older age groups (13.7+ 9.6, 8.9 + 7.1, 6.5 + 3.4) compared to the
18-50 group (3.2 + 1.5) (P<£^0.001), but did not increase as a function
of age between 60-90 years.
The distribution of circulating testosterone, LH and FSH in these
patients, who were divided into those with normal levels of FSH (n=14)
and those with high FSH (n=7), plus a further 7 patients who had
received radiation treatment prior to orchidectomy, was observed (Fig.
3.6). Significant correlations were observed between plasma
testosterone and LH (R = -0.47, P<^0.05) and between LH and FSH (R =
0.73, P<^0.001).
Levels of spermatogenesis were also correlated to circulating
hormone levels in each of the different patient groups (Fig. 3.7). DSP
was reduced in the high FSH and radiation treated groups and this was
reflected in the significant negative correlations observed between DSP
and both FSH (R = -0.74, P<^0.001) and LH (R = -0.57, P<^0.01). A weak
positive correlation which just reached significance (R = 0.40, P<0.05)



















18-50 60-70 71 -80 81 -90
Age (years)
FIGURE 3.5
Age related change in circulating levels of
testosterone, LH and FSH. Data was obtained from
100 healthy men (18 - 50 years), and from 21 men
with prostatic carcinoma (60 - 90 years). While
circulating testosterone was not significantly
different between any of the age groups, both LH
and FSH were significantly increased in the older
men compared to the younger group (ttt, PC0.001).
Values are mean ± SD.
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30
R = 0.73
Distribution of circulating testosterone, LH and FSH.
Patients were grouped according to FSH (untreated with
normal FSH, n = 14 ; untreated with high FSH, n = 7),
and treatment (radiation treated, n = 7).Significant
correlations were observed between plasma
testosterone and LH (R = -0.47, PC0.05) and between
LH and FSH (R = 0.73, P<0.001).
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Testosterone (ng / ml)
FIGURE 3.7
Correlation between daily sperm production (DSP) and
circulating levels of testosterone (R = 0.40, PC0.05),
LH (R = -0.57, P<0.01) and FSH (R = -0.74, P<0.001).
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(v) Intratesticular testosterone levels and their relationship to daily
sperm production
Figure 3.8 shows the distribution of DSP in relation to circulating
and intratesticular hormone levels in four groups of patients. As in
the previous graph, three of these groups comprised of 21 untreated or
radiotherapy treated patients, with an additional group of 9 men who had
been treated with diethylstilboestrol (DES) up to the time of
orchidectomy. Despite the wide variation in DSP, gonadotrophins, and
circulating levels of testosterone in all four groups, excluding the DES
treated men, there was no apparent change in testicular levels of
testosterone, either in the whole testis or in the seminiferous tubules.
Interestingly, despite the very low levels of both circulating and
intratesticular testosterone levels in the DES treated group,
spermatogenesis in these men was not completely arrested with DSP levels
of 0.5 + 0.4 x 106/g.
Surprisingly when DSP was correlated to testicular levels of
testosterone in 39 individuals, high levels of intratesticular
testosterone were associated with low levels of DSP (Fig. 3.9).
(vi) Leydig cell number, intratesticular testosterone and daily sperm
production
Total Leydig cell number was determined in 14 patients in the
untreated group. While there was a wide variation in total Leydig cell
number, no correlation was observed between daily sperm production and
testicular or tubular testosterone (Fig. 3.10).
(vii) Re-evaluation of intratesticular levels of testosterone
In assessing post-isolation changes in intratesticular testosterone
following orchidectomy, some patients showed a significant increase in





































































Normal High FSH RAD DES
FigUHE 3
Distribution of plasma testosterone, LH, FSH, daily sperm
production, testicular and tubular levels of testosterone
in four groups of men with prostatic carcinoma - untreated
normal FSH (n = 14), untreated high FSH (n = 7), radiation
treated (n = 7) and diethylstilboestrol (DES) treated
(n = 9). All parameters were significantly decreased in the
DES treated group compared to normal (ttt, P< 0.001) . LH
(tt, P<0.01) and FSH (ttt, P<0.001) were significantly
elevated in both the high FSH and radiation treated groups
compared to normal, while plasma and intratesticular
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FIGURE 3.9
Correlations between daily sperm production and testicular
testosterone (R = -0.37, P<0.05), tubular testosterone (R =
-0.65, PC0.001) and the ratio between testicular and tubular
testosterone (R = 0.35, P<0.05) in 39 patients. Thus daily
sperm production appears to be higher in situations of low
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FIGURE 3.10
Lack of significant correlation between Leydig
cell number and daily sperm production (DSP),
total testicular and tubular testosterone.
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a significant decline (Fig. 3.11). However no overall significant
difference existed when testosterone levels from 6 patients were
expressed as mean + SD of percentage of initial levels.
3.3 Discussion
With the uncertainty as to the level of testosterone required to
maintain spermatogenesis, this study set out to determine whether
declining levels of spermatogenesis in elderly men were associated with
reduced intratesticular levels of testosterone. Methods first described
to quantitate intratesticular distribution of testosterone in the rat
(Sharpe & Bartlett, 1985) (see 2.3), and a new approach to quantitate
spermatogenesis in the human testis (Johnson et al. 1981) were adopted
in these studies. This novel approach to the quantitation of
spermatogenesis involves homogenizing small (approximately 10-50 mg)
pieces of fixed testicular tissue and then enumerating spermatid number
under phase contrast microscopy (see 2.2.10). Spermatogenesis
quantitated by this method is expressed as daily sperm production (DSP).
This technique was validated by a classical morphometric technique (see
2.2.11), and a high degree of correlation was observed between DSP
determined by each of the two methods.
Testicular biopsy has for over 40 years been used to differentiate
between obstructive and non-obstructive azoospermia, and also as a tool
to assess spermatogenic disruption in cases of oligospermia. While
microscopic observation of the histologic features provides much
information, the need for quantitative analysis of testicular biopsies
has long been realized. In 1981 Silber & Rodriguez-Rigau described a
simple method for quantitating testicular biopsies by counting easily
recognizable darkly staining mature spermatids in stages I, II, V and VI.
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1 2 3 4 5 6
Time interval
FIGURE 3.11
Changes in intratesticular testosterone following
orchidectomy. Time intervals 1-7 represent tissue
obtained during orchidectomy (1), and at 5 min (2),
lh (3), 2h (4), 3h (5), 4h (6) and 12h (7) after
orchidectomy. Some patients showed a significant
increase in intratesticular levels of testosterone
(top) at each of the intervals following orchidectomy,
while others showed a significant decline (middle). Each
value is the mean ± SD of three testicular samples
obtained at the same time from different areas of the
same testis. No overall significant difference existed
when testosterone levels from 6 patients were expressed
as mean ± SD of percentage of initial levels (bottom).
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Except in cases of obstruction, the results obtained by this method have
been shown to correlate well with sperm in the ejaculate. In the
absence of proper validation of this technique, in the present study DSP
was correlated to mature sperm number in histological sections in 22
men, and a high degree of concordance was observed between the two.
Comparing both techniques for the quantification of spermatogenesis, the
homogenization approach is much more simple and the results are
available much faster. While the homogenization technique requires the
use of a specific homogenizer (VirTis 23 macrohomogenizer) and also a
phase contrast microscope, it is possible that the adoption of this
approach in the clinical situation would provide a convenient method to
quantitatively assess testicular biopsies without laborious histological
preparation.
While circulating levels of testosterone were on the whole reduced
in this group of men, this was not a significant function of age.
Indeed as has been reported previously (Harman & Tsitouras) a number of
these men into their 7th, 8th and 9th decades had circulating levels of
testosterone which were in the range of normal young men. Plasma levels
of both LH and FSH were significantly increased in these men compared to
younger men, although neither LH nor FSH appeared to increase as a
function of age between 60-90 years. The highest serum levels of LH
and, in particular, FSH have been shown to occur in men with the lowest
levels of DSP.
Declining levels of spermatogenesis in elderly men have been
attributed to reduced numbers of Leydig cells resulting in inadequate
levels of intratesticular testosterone (Neaves et al. 1984). Contrary
to this, the results of the present study indicate high intratesticular
levels of testosterone in men with low levels of DSP. Interestingly,
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high intratesticular levels of testosterone are not reflected in the
peripheral circulation in these men, in whom circulating testosterone
was low to normal. Therefore despite the capacity of the Leydig cells
to produce testosterone, this did not appear to gain entry to the
circulation. Testosterone from the interstitial tissue must pass
through the walls of the testicular capillaries in order to enter the
peripheral circulation. Unlike capillaries in other endocrine tissues,
testicular capillaries are unfenestrated, yet despite this, transport
though the capillary wall is thought to be passive (Setchell et al.
1978b). A frequent observation in the testes of old men is the
thickened peritubular tissue surrounding the seminiferous tubules, and
indeed of fibrosis of the testicular tissue to a greater or lesser
extent. While there are no reports of this in the literature,
thickening of the vasculature may provide a barrier to the passive
diffusion of testosterone from the interstitial tissue to the
circulation.
Increased testicular levels of testosterone in these men may be as
a result of Leydig cell stimulation by elevated levels of LH. In rats
the administration of hCG results in Leydig cell hypertrophy and
hyperplasia (Christensen & Peacock, 1980). The physiological
implications of this for the present study are such that chronically
elevated LH may induce an increase in Leydig cell number and/or volume
which would enable the Leydig cell population to produce excessive
amounts of testosterone. However evidence of Leydig cell hyperplasia
was not observed in this study, pointing against a compensatory
mechanism of elevated LH.
In order that increased intratesticular levels of testosterone
associated with suppressed spermatogenesis were not merely a reflection
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of decreased testicular volume, and hence elevated Leydig cell number
per gram of tissue, Leydig cell number was determined in 14 patients who
had not received any treatment prior to orchidectomy. While there was a
wide spread in Leydig cell number, no direct relationship was found
between Leydig cell number and DSP or intratesticular measures of
testosterone, confirming the results of Neaves and colleagues (1987).
High intratesticular levels of testosterone could therefore be the
result of a block in the steroidogenic pathway in these men. Under
normal circumstances, intratesticular testosterone is convered to
dihydrotestosterone by 5bCrreductase, and to oestradiol by aromatase.
A block in this pathway could result in accumulating levels of
biologically inactive testosterone.
These studies therefore appear to support increasing evidence in
the rat that high intratesticular levels of testosterone may not be
essential in the maintenance of spermatogenesis (Cunningham & Huckins,
1979; Rea et al. 1986). Such studies are however completely dependent
on the accurate measurement of intratesticular levels of testosterone,
and doubts about the accuracy of current techniques have emerged
recently. In a study by Maddocks and colleagues (1986), in which
push-pull canulae were used to collect interstitial fluid from
anaesthetized rats, the levels of testosterone measured in this fluid
were much lower than those reported previously. These results have
raised the possibility that conventional techniques to isolate the
testes prior to testosterone measurement may yield spuriously high
testosterone levels due to post-isolation synthesis of this steroid
(Sharpe, 1987). Indeed by comparing testosterone levels in right and
left testes from the same rat isolated in different ways, post-isolation
synthesis of testosterone was significant, and on average resulted in a
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75% overestimate of testosterone levels (Sharpe et al. 1987).
Attempts were made to determine post-isolation synthesis of
testosterone in human testes. Biopsies were obtained during operation
prior to orchidectomy and placed immediately in liquid nitrogen.
Following orchidectomy testes were placed on ice and samples obtained at
various time intervals afterwards were also snap frozen in liquid
nitrogen. While post-isolation synthesis of testosterone was
significant in some cases, in others testosterone levels fell following
orchidectomy. This difference could possibly reflect differing
functional capacity of the Leydig cells in different men, such that
those with healthy Leydig cells would continue to produce testosterone
following isolation, while less healthy Leydig cells would not. Overall
there was no significant effect of post-isolation synthesis of
testosterone. Therefore the effect of this on the results of the
present study are unclear.
In conclusion, the response of the human testis to ageing is highly
variable. While age is a significant correlate of DSP, Leydig cell
number, testosterone and gonadotrophin levels, its predictive value for
individuals is weak. The lack of any significant relationship between
Leydig cell number and testosterone in the decline of DSP suggests that
more significant overriding relationships must exist. Indeed the
importance of high intratesticular levels of testosterone in the
maintenance of spermatogenesis in both rat and man is now being
questioned (Rommerts, 1987), and it must be considered that in both
species the Leydig cells may produce testosterone in excess of that
required to maintain spermatogenesis.
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CHAPTER 4
Isolation of Hunan Leydig Cells and Analysis
of their Function In vitro
111
4.1 Introduction
The effects of LH and human chorionic gonadotrophin (hCG) on rat
Leydig cell LH/hCG receptor number and steroidogenesis in vitro have
been widely investigated (Catt et al. 1980). The limited information
available from in vitro studies in the human has suggested that human
Leydig cells may be inherently less responsive to hCG than are rat
Leydig cells (Huhtaniemi et al. 1982). Furthermore, the response of the
human testis to hCG in vivo is characterized by a rapid but modest
(20-60%) increase in serum levels of testosterone within 6 h of
intramuscular injection (Saez & Forest, 1979; Martikainen et al. 1980;
Padron et al. 1980). In contrast, in the rat, serum testosterone levels
are increased by 10- to 20-fold over the same time period after hCG
injection (Hsueh et al. 1976; Chasalow et al. 1979). This difference,
which has not yet been explained satisfactorily, has led to the belief
that the function of human Leydig cells may be very different from that
in the rat.
The different approaches employed to study Leydig cell function in
vitro, in both the rat and man, has made it difficult to compare results
between the two species. The introduction of density centrifugation
techniques has permitted the isolation of rat Leydig cell populations
which are highly responsive to hCG (Sharpe & Fraser, 1983). In the
present study, such techniques were used to develop a procedure for the
isolation of human Leydig cells. Testicular tissue was obtained from
ten men aged between 57-85 years who were undergoing orchidectomy for
prostatic carcinoma. Leydig cells were isolated as described in Section
2.4, and compared to rat Leydig cells in terms of fractionation
characteristics, cell yield and responsiveness to hCG in vitro.
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4.2 (i) Pattern of Leydig cell fractionation on gradients of Percoll
When loaded onto discontinuous Percoll gradients, both rat and
human testicular cells fractionated into three bands, corresponding to
the interfaces between successive layers of Percoll of different
densities (Fig. 4.1). In the human, band 1 occurred at the interface
between 1.03 and 1.05 and was the most intense cell band as 95-97% of
the added cells migrated to this band. Band 2 occurred at the interface
between 1.05 and 1.07 and 2-4% of cells migrated to this band. Band 3
occurred at the interface between 1.07 and 1.09 and only 0.7-1.5% of
cells migrated to this band. In the rat, although cell bands 1-3 formed
in exactly the same positions as in the human, a different fractionation
pattern of the added testicular cells was observed with 58-65% migrating
to band 1, 29-33% to band 2 and 6-9% to band 3.
In both the human and the rat band 1 contained 12-28% Leydig cells
as determined by 3J3-HSD staining, and 77-95% (human) and 38-46% (rat) of
all Leydig cells were retained in this band. In the human, band 2 cells
showed the highest percentage of 3J5-HSD positive cells (48-70%) with
4-18% of all Leydig cells being retained in this band. In the rat only
30-45% of band 2 cells stained positively for 3J3-HSD and 37-40% of all
Leydig cells were retained in this band. Band 3 was particularly
enriched in Leydig cells (75-90%) in the rat with 15-22% of all Leydig
cells migrating to this band while in the human 30-56% of band 3 cells
stained positively for 3J3-HSD and only 1-6% of all Leydig cells migrated
to this band.
After 20 h incubation, band 1 cells from both the rat and man
showed only a 1.5- to 2.5-fold response to hCG and made very low amounts
of testostrone (Fig. 4.1). In the rat, Leydig cells from band 3 always



























































Left hand panel - Schematic representation of the pattern of
fractionation of rat and human testicular cells on discontinuous
gradients of Percoll using successive layers of Percoll of density
1.09, 1.07, 1.05, 1.03 and 1.0 g/ml. Right hand panel - Basal and
maximal hCG (20 IU / ml) - stimulated testosterone production (ng/10®
3J5-HSD positive cells per 20h) for representative rat and human
testicular cells obtained from cell bands 1-3. Values are mean ± SD
of triplicate incubations.
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stimulation) than were cells from band 2 but in the human, cells from
bands 2 and 3 were generally comparable, both in terms of the amounts of
testosterone secreted and the magnitude of their response (4.5- to
13-fold) to hCG (Fig. 4.1 and Table 4.1). In view of this finding
coupled with the high yield of Leydig cells in band 2, for most
subsequent studies human Leydig cells from bands 2 and 3 were combined,
(ii) Leydig cell yield
For the six subjects from whom Leydig cells were prepared the total
yield of 3J5-HSD positive cells for bands 1, 2 and 3 were 10.6-16.6,
0.7-5.7 and 0.3-1.9 x 10^, respectively, while the total Leydig cell
yield (i.e. bands 1,2 & 3) ranged from 11.6 - 24.2 x 10^. From
morphometric studies (Neaves et al. 1984) aged human testes contain
approximately 200 x 10^ Leydig cells which means that in the current
studies approximately 6-12% of the total number of Leydig cells were
isolated, while the number of highly responsive Leydig cells (i.e. bands
2 & 3) constituted only 0.5-4% of the total number present in the
testes. These values differ somewhat from those obtained for the rat in
that 10.6-22.1, 11.2-19.0 and 6.3-7.2 x 10^ Leydig cells were isolated
in bands 1, 2 and 3 respectively, from a total of 10 testes in several
experiments. As adult rat testes contain approximately 45 x 10^
Leydig cells (Mori & Christensen, 1980) this means that 6.2-10.7% of all
Leydig cells are recovered on the Percoll gradient with the highly
responsive cells (i.e. those in band 3) constituting 1.4-1.6% of the
total present in the testes.
In two experiments an attempt was made to increase Leydig cell
yield further by re-digesting testicular tissue with collagenase after
the initial isolation procedure. Cells from this second dispersion
fractionated identically to those from the first dispersion although the
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Table4.1BasalndhCG(20IU/ml)-stimulatedtesto teroneprod ction byPercoll-purifiedhumanLeydigellsbtainefr mllan2and3. Incubationaddi nsTestoster esecretion( g/10^3^-HSDposi vc lls/20h) Band23P Basal234+6412N.S. hCG1342+9806610N.S. Basal136+4827P<0.02 hCG642+5287546P<0.02 Basal81+3101+38N.S. hCG1052+70839N.S. Valuesrthmean+S.D.ofriplic teincubations,si gcellr pared from3differentm . Pvaluesrefertocomparisonfespectivefoband2and3.
total number of Leydig cells obtained in bands 2 and 3 was only 40-50%
of that obtained in the first dispersion. Somewhat surprisingly, both
band 2 and 3 Leydig cells from the second dispersion produced
significantly more testosterone than did cells from the first
dispersion, and this was equally evident under both basal and
hCG-stimulated conditions (Table 4.2).
(iii) Variation in Leydig cell responsiveness between men and its
relationship to hormone levels and testicular morphology
Basal testosterone production and the maximal response to hCG was
determined for Percoll-purified Leydig cells from a total of 10 men.
The percentage of 3p-HSD positive cells was determined for only 6 of
these men and the results are shown in Table 4.3; for the remaining 4
men the magnitude of the Leydig cell response to hCG was similar to that
shown in Table 4.3 except that in 3 of the 4 men the amounts of
testosterone produced per 10^ nucleated cells was low as shown for
patient 1.
At 5 h basal testosterone values ranged from 6-63 ng/10^ 3^-HSD
positive cells, and by 20 h this parameter was increased to reach 44-234
ng/10^ 3JB-HSD positive cells, values which were comparable to those
obtained for Leydig cells from young adult rats (Table 4.3).
At 5 h human Leydig cells responded to hCG by increasing
testosterone production between 4- and 12-fold. The response to hCG at
20 h varied from 5- to 17-fold (Table 4.3). This range and the absolute
amounts of testosterone produced (up to 1342 ng/10^ 3^-HSD positive
cells) were in general very similar to the values found for rats (up to
1463 ng/10^ 3j3-HSD positive cells), although patient 1 (basal value =
44 ng, hCG stimulated = 171 ng) had clearly lower testosterone responses
in vitro. As mentioned above, low testosterone values (basal = 4-12
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ng/lO^ nucleated cells; hCG = 24-42 ng/10^ nucleated cells) were
also found at 20 h in 3 other men for whom the percentage of Leydig
cells was not determined. Men with poorly responsive Leydig cells in
vitro could not be distinguished from those whose Leydig cells made
large amounts of testosterone on the basis of age, testicular weight or
the plasma levels of LH, FSH or testosterone (Table 4.3).
Testicular morphology was examined in all patients in order to
ascertain whether the differences between men in the capacity of their
Leydig cells to make testosterone in vitro could be related in any way
to morphological criteria. In all patients testicular morphology showed
the Leydig cell population to be heterogenous with small and large
Leydig cell clusters consisting of either pale or darkly staining cells
or a mixture of both. Although it is emphasised that no quantitative
measurements were made on these sections, it appeared that highly
responsive Leydig cell preparations were isolated from testes which
showed clusters of light and darkly staining Leydig cells (Fig. 4.2).
In contrast to this, unresponsive preparations were isolated from testes
which appeared to have low numbers of darkly staining cells which
contained large accumulations of lipid (Fig. 4.2).
(iv) Dose response to hCG and Leydig cell hCG-receptors
The sensitivity of human Leydig cells to hCG was assessed from
detailed dose response curves (Fig. 4.3). That shown for rat Leydig
cells is typical of that found routinely in our laboratory and showed
that the dose response curve covered doses of hCG ranging from 0.03 to
0.5 mU/ml; addition of higher concentrations of hCG did not alter the
maximum response. In contrast, for three representative does response
curves from human Leydig cells there was a large shift to the right.
Thus, the dose-response to hCG covered the range 0.4 to 100 mU/ml,
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FIGURE 4.2
Representative light micrographs of Leydig cells which were highly
responsive (top) and less responsive (middle and bottom) to hCG.
Highly responsive Leydig cells were isolated from testes which
contained a mixture of dark and pale staining Leydig cells. Less
responsive Leydig cells were isolated from testes which contained a
higher proportion of pale staining cells and any dark staining cells,
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FIGURE 4.3
Comparison of the dose response curves to hCG for Percoll -
purified rat and human Leydig cells. Values were obtained from a
representative rat Leydig cell preparation (Q) and from three human
Leydig cell preparations which showed 17-fold (■ ), 13-fold (0) or
6-fold (□) responses to maximally stimulating levels of hCG. As the
maximal testosterone responses for these cell preparations differed,
each dose response to hCG has been expressed as a percentage of the
maximal response i.e. to 20 IU hCG/ml. The latter values, expressed as
ng/10® 3B-HSD positive cells, are shown in parentheses. Inset shows
the full dose response curve for the most responsive human Leydig cell
preparation. Each point is the mean ± SD of triplicate incubations.
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indicating a 10- to 100-fold reduction in sensitivity compared to rat
Leydig cells (Fig. 4.3).
In view of this difference in sensitivity, the number and affinity
of Leydig cell LH (hCG)-receptors was assessed from Scatchard analysis y
of 125-hCQ binding. From this study, purified human Leydig cells
contained approximately 5-fold fewer LH (HCG)-receptors than did
purified rat Leydig cells, while the affinity of receptors (Kd~"
1CT10M) was comparable for both cell preparations (Fig. 4.4).
4.3 Discussion
In this study a method for the isolation of highly responsive human
Leydig cells was established. In terms of testosterone output and
responsiveness to hCG, human Leydig cells were in general comparable to
those of the rat, suggesting that the function of human Leydig cells may
be more similar to those of the rat than has been thought previously.
Leydig cells from both the human and the rat separated into three
bands when run on discontinuous Percoll gradients. In both species,
band 1 contained 12-28% Leydig cells as identified by 3p-HSD staining,
but whilst band 3 was the most Leydig cell-enriched fraction in rat cell
preparations (75-90% Leydig cells), in the human band 2 (48-70% Leydig
cells) was consistently more Leydig cell-enriched than was band 3
(30-56% Leydig cells). However, in contrast to the rat, human Leydig
cells from bands 2 and 3 were very similar in terms of their response to
hCG and the amount of testosterone secreted per 10^ Leydig cells. The
reason for the difference in separation characteristics of rat and human
Leydig cells is not known, but may be due to differences in cytoplasmic
content of lipid or organelles. Human Leydig cells usually contain
large numbers of lipid droplets (Christensen, 1975), whereas normal
adult rat Leydig cells rarely contain such inclusions (Clegg, 1961).
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Left hand panel - Specific binding of ^^I-hCG to human and rat
Leydig cells with increasing concentrations of l^I-hCG. Right hand
panel - Scatchard plot of the same data.
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The presence of lipid droplets would be expected to decrease the buoyant
density of Leydig cells with the result that they would fractionate
higher up the gradient during separation on Percoll. Repeated attempts
to examine the morphology of the 3 bands obtained following Percoll
separation of human testicular cells were however unsuccessful.
With the exception of their somewhat different pattern of
fractionation on Percoll, human Leydig cells were in most instances very
similar to those from the rat, both in terms of the amount of
testosterone produced per 10^ cells and in terms of the magnitude of
their response to hCG. This finding contrasts with what has been
generally accepted until now, namely that human Leydig cells are poorly
responsive in vitro and in vivo when compared to the rat (Saez & Forest,
1979; Smals et al. 1979; Martikainen et al. 1980; Nankin et al. 1980;
Padron et al. 1980; Huhtaniemi et al. 1982). Previous studies in vitro
have generally used either testis pieces (Nieschlag et al. 1979) or
crude cell preparations, the latter being prepared using higher
concentrations of collagenase and longer dispersion periods, both of
which will severely reduce the responsiveness of rat Leydig cells (R.M.
Sharpe, personal communication). It is therefore likely that the
combination of gentler preparative conditions coupled with Leydig cell
purification account for the differences between the present and
previous findings. There remains the possibility that human Leydig
cells from bands 2 and 3 after Percoll separation represent a selected
sub-population of highly responsive cells, and indeed the same may be
true for rat Leydig cells isolated on Percoll. The obvious
heterogeneity of Leydig cells in fixed tissue from human testes (see
Fig. 4.2 and below) could be taken as evidence in favour of this
possibility, although this would fail to explain why some of the
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purified Leydig cell preparations from patients in our study made small
amounts of testosterone despite fractionating identically to highly
responsive cell preparations. This variation could not be linked to any
of the systemic endocrine parameters or to testicular weight, confirming
the findings of Huhtaniemi et al. (1982) and Nieschlag et al. (1979).
However, qualitative morphological assessment of fixed tissue suggested
that there may have been inherent differences in the Leydig cells, such
that poorly responsive cell preparations derived from testes in which
the ratio of darkly staining to lightly staining Leydig cells was low in
comparison to testes generating highly responsive Leydig cells (see Fig.
4.2). These 'dark' and 'pale' Leydig cells are a well-recognized
phenomenon in the human testis, and Christensen and Gillim (1969) have
suggested that the different staining intensities represent artifacts
resulting from immersion fixation. A more recent study (Schulze, 1984)
suggests that this is not the case, since dark and pale Leydig cells
were observed also in perfusion-fixed human testes. Detailed morphology
of the cells in bands 2 and 3 will be required to determine whether the
dark and pale cells predominate in particular bands, and whether there
is any difference in steroidogenic capacity between the two cell types.
In fixed tissue, morphometric studies will be necessary to confirm the
impression that there may be a relationship between the relative number
of dark or pale Leydig cells and the subsequent steroidogenic capacity
of purified Leydig cells in vitro.
Although the magnitude of response to hCG of most human Leydig cell
preparations was comparable to that for the rat, human Leydig cells were
10- to 100-fold less sensitive to hCG stimulation. This difference in
sensitivity may have been due to the 80% fewer LH-receptors on human, as
opposed to rat Leydig cells. These results are comparable to findings
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of previous studies using testicular homogenates (Huhtaniemi et al.
1982), or isolated human Leydig cells (Davies et al. 1979), and lessens
the possibility that this difference results from the artifactual
removal of LH-receptors during collagenase digestion, an event known to
occur during the isolation of human luteal cells (Bramley et al. 1985).
In this respect Huhtaniemi et al. (1982) reported that prolonged (30
min) collagenase dispersion of human testicular tissue had no
significant effect on LH-receptor number.
The testes used in this, and most previous studies, were obtained
from ageing men who generally have raised serum levels of LH (Harman &
Tsitouras, 1980; Takahashi et al. 1983). This might account for the
decreased LH-receptor number, as it is well established that in both
rats (Catt et al. 1980) and men (Sharpe et al. 1980), systemic
administration of LH or hCG will lead to the down-regulation of Leydig
cell LH-receptors. The latter change is not usually associated with any
diminution of the testosterone response to excess LH or hCG in vitro but
does result in a clear shift to the right of the dose response curve to
hCG (Catt et al., 1980; Sharpe & McNeilly, 1980), a change also evident
in the present studies. Contrary to this reasoning, in a study by
Leinonen et al. (1982) no correlation was found between serum LH levels
and the number of LH binding sites in testes obtained from men with
prostatic carcinoma. In addition, our limited number of dose response
curves to hCG would not support such a relationship, as the least
sensitive human Leydig cell preparation (Patient 1, Fig. 4.3) derived
from a patient with normal serum levels of LH (Table 4.3).
The response of both the human and rat testis to hCG in vivo is
characterized by a biphasic increase in testosterone production (Hsueh
et al. 1976; Chasalow et al. 1979; Saez & Forest, 1979; Smals et al.
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1979; Martikainen et al. 1980; Padron et al. 1980). Testosterone
levels reach a peak within a few hours of intramuscular injection of hCG
after which they return to normal prior to the delayed response 2-3 days
later. The delayed response is of the same magnitude in both man and
the rat (2- to 3-fold increase), and is thought to be due to hCG-induced
hypertrophy and hyperplasia of the Leydig cells. The acute response
however, seen within 6 h of hCG administration, differs greatly between
man and the rat. Martikainen et al. (1982) showed by measuring
spermatic vein and systemic steroid concentrations, that the human
testis was able to respond to hCG within 30 min although the magnitude
of testosterone rise at this time interval was under 2-fold. In
contrast, in the rat, serum testosterone levels are increased by 10- to
20-fold within 6 h of hCG injection (Hsueh et al. 1976; Sharpe, 1976).
This difference in the acute response in vivo contrasts with the
similarity in response of purified Leydig cells from the rat and man in
vitro. This discrepancy between in vitro and in vivo findings is not
fully understood but may be related to differences between man and rat
in terms of the relative number of Leydig cells to blood volume.
From the morphometric analysis of Mori and Christensen (1980) it
can be calculated that in a normal rat there are approximately 3 x 10^
Leydig cells per ml of blood, while in aged men there are only
approximately 0.056 x 10^ Leydig cells per ml blood (using the
morphometric data of Neaves et al. 1984). Therefore since the rat has
approximately 50-fold more Leydig cells per ml of blood than does the
human, it is not surprising that the in vivo response to hCG, as
measured by peripheral testosterone concentration, in the rat is much
greater than in man despite the fact that in vitro the respone to hCG is
similar in both species on a per-cell basis. For the human male to
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maintain testosterone in serum at a level comparable to that in the rat,
this would necessitate either increasing Leydig cell mass 50-fold or
retarding clearance of testosterone. This may perhaps explain why man,
but not the rat, has a serum testosterone-binding globulin (TeBG). TeBG
has been found in the blood of several species (Corvol & Bardin, 1973;
Bardin et al. 1981) and while its role has never been fully understood
it is clear that it retards the metabolic clearance of testosterone.
This suggestion is speculative, but it is of interest that animals such
as the ram do have a serum testosterone-binding globulin (Corvol &
Bardin, 1973; Bardin et al. 1971), but of lower affinity than in man
(i.e. less effective in prolonging the half life of testosterone) and,
from morphometric data (Hochereau-de Reviers et al. 1985), these
animals have an estimated Leydig cell to blood volume ratio of
0.4 x 10^ cells/ml, a figure which is intermediate between that of the
rat and man.
These results suggest that the in vitro testosterone response to
hCG of human Leydig cells may be more similar to that of the rat than
has been thought previously, which could mean that the extensive
findings from in vitro studies of rat Leydig cells may have direct
relevance to the human. The establishment of this technique for the
isolation of human Leydig cells has enabled the study of putative
paracrine control mechanisms in the human testis (Chapter 5), and more
importantly, raises several exciting possibilities for future research.
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CHAPTER 5
Paracrine Control of the Human Leydig Cell
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5.1 Introduction
In the rat there is now a substantial body of evidence to suggest
that Leydig cell function is under the dual control of both the
system, by a number of factors produced locally within the testis. In
vitro studies have shown the effects of putative paracrine factors such
as testicular LHRH, oxytocin, vasopressin, opiates and a factor(s)
present in Sertoli cell/seminiferous tubule conditioned medium and
testicular interstitial fluid on Leydig cell testosterone production.
However the techniques applied to these studies, such as the stage
dissection of seminiferous tubules and the isolation of both Sertoli and
Leydig cells, have been limited to experimental animals, and similar
studies on the human testis are lacking.
The opportunity to study the effect of putative paracrine factors
on human Leydig cell function has now arisen with the development of a
reliable method for the isolation of human Leydig cells. In this study
the effects of LHRH-A, vasopressin, human transforming growth factor B
and interstitial fluid factor on human Leydig cell function were
investigated by the measurement of testosterone production.
5.2 (i) Effects of putative paracrine hormones on Leydig cell function
The effects of luteinizing hormone releasing hormone-agonist
and hCG (20 IU/ml)-stimulated testosterone production by
Percoll-purified human Leydig cells were studied at 5,20 and 48 h of
incubation.
LHRH-A ( [D-SerCBu11)6] des Gly NH210 LHRH-ethylamide;
Hoechst A.G. , Frankfurt, F.R.G.; 10""%) had no significant effect on
basal or hCG-stimulated testosterone production at 5,20 or 48 h in
endocrine system, by LH from the anterior pituitary, and the paracrine
(LHRH-A), vasopressin and transforming growth
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Leydig cell preparations from 9 individual men (Fig. 5.1). In 2 of
these preparations the addition of LHRH-A ( [D-Ala^ MeLeu^
Pro^ NEt] LHRH, Dr. R. Milton, Dept. of Chemical Pathology, University
of Cape Town, South Africa; 10~^M) produced identical results (Fig.
5.2).
The addition of vasopressin (Sigma, UK; 10~^M) to each of 7
Leydig cell preparations failed to alter basal or hCG-stimulated
testosterone production at 5,20 or 48 h (Fig. 5.3). Similar results
were obtained following the addition of TGFj? (Dr. A. Roberts, NIH;
10~®M) to each of 4 Leydig cell preparations (Fig. 5.4).
(ii) Effects of testicular interstitial fluid and serum on Leydig cell
testosterone secretion in vitro
The effect of charcoal-extracted testicular interstitial fluid (IF)
and serum from both the rat and man on rat and human Leydig cell
steroidogenesis during 20 h of incubation was tested in the presence of
hCG (20 IU/ml) at a dose in excess of that required to maximally
stimulate testosterone production.
Using Percoll-purifed preparations of rat Leydig cells, the
addition of rat IF consistently enhanced Leydig cell testosterone
production in response to maximally stimulating levels of hCG (P*C
0.001), whereas human IF was without effect (Fig. 5.5). When added to
one preparation of human Leydig cells, rat IF was shown to stimulate
testosterone production in a dose-dependent manner (Fig. 5.6), but this
result was not consistent. Fig. 5.7 shows the reverse effect of rat IF
on human Leydig cell testosterone production. In this case the highest
dose of rat IF (50 ^il) did not significantly increase testosterone
levels above those obtained with hCG alone, but did at a dose of 25 jil
































































Basal hCG LHRH -A hCG +
(20 III/ml) (10"6M) LHRH-A
FIGURE 5.1
Effect of LHRH-A ([ D-Ser(But )6 ] des Gly NH2 LHRH-ethylamide
on human Leydig cells in vitro. Each value is the mean ± SD of
9 Leydig cell preparations, and is expressed as percentage of
basal production. hCG - stimulated testosterone production was
significantly increased compared to basal levels, PC0.001,
PC0.05. LHRH-A did not stimulate testosterone production above
basal or hCG - stimulated levels.
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I I Basal
hCG (20 IU / ml)
LHRH-A1 ( [D-Ser(But )6]desGlyNH21° LHRH-ethylamide ) (10 ~6M)
LHRH-A 2 [D-Ala6 Na Me Leu7 Pro9 NEtLHRH] (10 '5M)
hCG + LHRH-A 1
hCG + LHRH-A 2
FIGURE 5.2
Comparison between the effects of two LHRH - agonists
on the production of testosterone by human Leydig cells
in vitro. Each value is the mean ± SD of 2 Leydig cell
preparations, and is expressed as percentage of basal
production. hCG - stimulated testosterone production was
significantly increased compared to basal levels, P<0.001.
Neither of the two LHRH - agonists stimulated


























































Effect of vasopressin on human Leydig cells in vitro. Each
value is the mean ± SD of 7 Leydig cell preparations, and
is expressed as percentage of basal production. hCG -
stimulated testosterone production was significantly
increased compared to basal levels, PC0.05, PC0.01.
Vasopressin did not stimulate testosterone production above

























Basal hCG TGF6 hCG + TGFB
(20 III / ml) (10"8M)
FIGURE 5.4
Effect of TGFli on human Leydig cells in vitro. Each value
is the mean ± SD of 4 Leydig cell preparations, and is
expressed as percentage of basal production. hCG -
stimulated testosterone production was significantly
increased compared to basal levels, PC0.01. TGFIi did not
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hlF + hCG rIF + hCG
FIGURE 5.5
Effect of human and rat testicular interstitial fluid
(IF) on rat Leydig cell testosterone production in vitro.
hCG (20 IU / ml ) - stimulated testosterone production
was significantly increased compared to basal levels
** PC0.01. Rat IF significantly increased Leydig cell
testosterone production above the level obtained with a
maximally stimulating dose of hCG ttt P<0.001. Human IF
did not significantly enhance hCG - stimulated





































Basal hCG 100^1 50jal 25jal
20IU/ml rat IF+ 20 IU hCG/ml
FIGURE 5.6
Stimulatory effect of rat interstitial fluid (IF) on
human Leydig cell testosterone production in vitro.
hCG - stimulated testosterone production was significantly
increased compared to basal levels,*** P<0.001. Testosterone
production was increased significantly in the presence of IF
compared to hCG - stimulated testosterone production alone,




r IF + hCG r serum + hCG
FIGURE 5.7
Effect of rat interstitial fluid (IF) and rat serum on
human Leydig cell testosterone production in vitro. hCG
(20 IU / ml)-stimulated testosterone production was
significantly increased compared to basal levels,***
P<0.001. Testosterone production was increased
significantly with decreasing amounts of interstitial
fluid, t P<0.05, ttt P<0.001, but was not changed
significantly with the addition of rat serum (NS).
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effect of human IF on testosterone production by human Leydig cells was
observed only once (Fig. 5.8). On this occasion, the IF used was
obtained from a man who had been receiving the anti-androgen cyproterone
acetate'as treatment for prostatic carcinoma.
In another human Leydig cell preparation (Fig. 5.9) 50 yl of human
IF significantly decreased testosterone production compared to
hCG-stimulated testosterone production alone (P<(^0.01), while 25 jil and
12.5 ^il were without effect (NS). Rat IF added to the same Leydig cell
preparation was without effect at 50 |il and 25 jil (NS), but at 12.5 ji 1
testosterone production was significantly increased (P<^0.05). Controls
in the form of human and rat serum were mainly without effect (NS),
although at 12.5 jil rat serum did significantly enhance testosterone
production.
In an identical experiment with another human Leydig cell
preparation (Fig. 5.10) both human and rat IF did not significantly
increase testosterone production above levels obtained with a maximally
stimulating dose of hCG. Likewise rat serum controls were without
effect, however human serum significantly enhanced testosterone
production (P<^0.05, P<^0.01).
Figure 5.11 shows data pooled from seven individual human Leydig
cell preparations indicating that there is no consistent effect of human
or rat IF on testosterone production. Likewise, serum controls did not
significantly enhance testosterone production. The large errors
associated with human IF derive from one preparation (Fig. 5.8) where
the addition of human IF increased testosterone production from 19.3- to
28.3-fold that of basal production.
5.3 Discussion










Basal hCG 50jil 25^1 12.5^1
human IF + 20 III hCG / ml
FIGURE 5.8
Stimulatory effect of human testicular interstitial fluid
(IF) on human Leydig cell testosterone production in vitro.
hCG (20 IU / ml) - stimulated testosterone production was
significantly increased compared to basal levels,*** P<0.001.
Testosterone production was increased significantly in the
presence of IF compared to hCG-stimulated testosterone
production alone, tt PC0.01, t P<0.05. Values are the
mean ± SD of triplicate incubations.
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Basal hCG 50p.l 25nl12.5jJ 50jal 25m.I12.5hI
r IF + hCG r serum + hCG
FIGURE 5.9
Effect of human and rat interstitial fluid (IF) and serum
on human Leydig cell testosterone production in vitro. hCG
(20 IU / ml)-stimulated testosterone production was
significantly increased compared to basal levels, *** PC0.001
The addition of 50|J.l human IF significantly decreased
testosterone production, ft P<0.01. Rat IF stimulated
testosterone production at a concentration of 12.5|ll,
t PC0.05, but was without effect at higher concentrations
(NS). Rat serum significantly increased testosterone
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Basal hCG 50jxl 25|il 12.5^1 50(_lI 25|il 1 2.5|_lI
rlF + hCG r serum + hCG
FIGURE 5.10
Effect of human and rat interstitial fluid (IF) and
serum on human Leydig cell testosterone production
in vitro. hCG (20 IU / ml)-stimulated testosterone
production was significantly increased compared to
basal levels, *** PCO.001. Human serum significantly
increased testosterone production at 20 h of
incubation, t P<0.05, tt P<0.01, whereas human and
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h IF + hCG h serum + hCG
y
Basal hCG 50^1 25^112.5|il 50|il 25p.l 12.5jal
rIF + hCG r serum + hCG
FIGURE 5.11
Effect of human and rat interstitial fluid (IF) and
serum on human Leydig cell testosterone production
in vitro. Each value is the mean ± SD of 7 Leydig
cell preparations, and is expressed as percentage of
basal production. hCG (20 IU / ml)-stimulated
testosterone production was significantly increased
compared to basal levels, P<0.001.Increasing
concentrations of IF and serum from both species had
no significant effect on testosterone production (NS).
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peptide (Bourne et al. 1980; Sharpe & Fraser, 1980; Clayton & Catt,
1981; Huhtaniemi et al. 1985) of Sertoli cell origin (de Jong et al.
1979; Sharpe et al. 1981, 1982a; Nagendranath et al. 1983) has led to
the idea that the regulatory effect between the Sertoli cell and the
Leydig cell is mediated, at least in part, by this peptide. This idea
is backed up by experimental evidence using analogues of hypothalamic
LHRH. Short-term (20 h) incubations with LHRH-agonist stimulates
testosterone production. This effect has been demonstrated in vivo, in
both normal (Sharpe & Rommerts, 1983; Sharpe et al. 1983), and
hypophysectomized rats (Sharpe et al. 1982; Sharpe & Harmar, 1983), and
in vitro (Hunter et al. 1982; Sharpe & Cooper, 1982a, 1982b).
In the present study, LHRH-agonist ([D-Ser(But)^] des Gly
NH2IO LHRH-ethylamide) had no effect on basal or hCG-stimulated
testosterone production by human Leydig cells at a dose known to
stimulate testosterone production in the rat (Fig. 5.1). In order that
this negative effect was not merely a reflection of enzymatic
degradation of the agonist, a second LHRH-agonist (D-Ala^ N^MeLeu?
Pro^ N ethylamide), substituted in the 6, 7 and 10 positions resulting
in greater resistance to enzyme degradation and increased binding
affinity (Karten & Rivier, 1986) was tested, and it too was without
effect (Fig. 5.2). This lack of a direct gonadal effect of LHRH-agonist
may reflect the uncertainty about the presence of receptors for this
peptide in the human testis. The absence of receptors for LHRH was
reported by Clayton & Huhtaniemi (1982) in the testes of both the human
and the monkey, yet despite this Popkin et al. (1985) observed that
testicular receptors for LHRH did exist in the human, but that they were
of much lower affinity (100-1000 fold lower) than those found in the
rat. Similarly mice do not possess specific binding sites for LHRH and
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subsequently LHRH-agonist has no effect on hCG binding, testosterone or
cAMP production (Hunter et al. 1982). If LHRH-like peptide does indeed
exist in the human testis it may be quite different structurally from
the LHRH-agonists used, whereas in the rat testicular-LHRH and the
LHRH-agonist [D-SerCBu11)^] des Gly NH2^® ethylamide do not
differ in size or structure (Sharpe & Fraser, 1980).
Chronic administration of LHRH-agonist in man (Linde et al. 1981;
Schurmeyer et al. 1984) as well as in the rat (Bambino et al. 1980;
Hsueh et al. 1981; Hsueh & Jones, 1981) results in a direct inhibitory
effect on steroidogenesis both in vivo and in vitro. While it is clear
that by binding to specific Leydig cell receptors, LHRH-agonist directly
inhibits steroidogenesis in the rat, pituitary desensitization appears
to be the mode of action in man. Thus in response to hCG, serum levels
of testosterone in man are unchanged before and after the administration
of LHRH-agonist (Evans et al. 1984; Heber et al. 1984; Schaison et al.
1984; Rajfer et al. 1987).
Significant species differences therefore appear to exist between
the rat, man, monkey and mouse in their response to LHRH-agonist. While
in the rat a direct gonadal effect appears to predominate, the
hypothalamic-pituitary axis is the primary, if not the only, site of
action of LHRH-agonist in man.
Vasopressin is another peptide which is present in the rat testis
(Kasson et al. 1985) and is reported to act through specific high
affinity receptors on the Leydig cells (Meidan et al. 1985; Kasson &
Hsueh, 1986). In long-term cultures (3 days) of mixed testicular cells
(Meidan et al. 1985; Kasson & Hsueh, 1986) and purified Leydig cell
preparations (Sharpe & Cooper, 1987), vasopressin inhibits Leydig cell
testosterone production. However, during short-term culture (5 h)
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vasopressin stimulates basal testosterone production but has no
significant effect on hCG-stimulated testosterone production (Sharpe &
Cooper, 1987). This stimulatory effect is dose-dependent and of small
magnitude (3-fold). y
In the present study, vasopressin (10~^M) did not significantly
alter basal or hCG-stimulated testosterone production by human Leydig
cells at 5, 20 or 48 h (Fig. 5.3). This may be due to the lack of
vasopressin-like peptide or receptors for such a peptide in the human
testis. If such a peptide does exist, structural differences between
the native peptide and the vasopressin used in the present study may be
the reason for the observed lack of effect. Indeed the physiological
significance of the effects of vasopressin in the rat testis are
questionable since the levels of interstitial fluid testosterone remain
unchanged following intratesticular injection of vasopressin in vivo
(Sharpe & Cooper, 1987).
Dimers of the ^-subunit of inhibin, which have been shown to be
potent stimulators of pituitary FSH synthesis and secretion in vitro
(Ying et al. 1986), show significant structural homology with TGFjB
(Derynck et al. 1985; Mason et al. 1985). This structural homology
raises the possibility that dimers of the JS-subunit of inhibin may play
a role as autocrine and/or paracrine modulators of gonadal function,
analogous to the effects of TGF^B reported in other tissues (Brown &
Blakeley, 1984).
When added to short- and long-term cultures of human Leydig cells
(Fig. 5.4), TGFyB (lCT^M) had no significant effect on testosterone
production. Likewise in the rat, TGFJ? has no consistent effect on
Leydig cell testosterone production (R.M. Sharpe, personal
communication). These results indicate that ^5-dimer forms of inhibin
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are unlikely to have any effect on the Leydig cell. Studies in the rat
have shown that TGF^ can enhance FSH-stimulated LH receptor induction
and secretion of oestradiol and progesterone by granulosa cells in a
dose-dependent manner (Ying et al. 1986; Dodson & Schomberg, 1987). If
^5-dimer subunits of inhibin do exist as independent entities, they may
exert paracrine effects on the Sertoli cell. Moreover, in vivo, these
peptides may be released into the peripheral circulation to increase
pituitary FSH synthesis and secretion.
Any factor produced within the seminiferous tubules which has an
effect on Leydig cell steroidogeneisis must pass into the testicular
interstitial fluid (IF). A factor present in rat IF has been shown to
enhance Leydig cell testosterone production in the presence of maximally
stimulating levels of hCG (Sharpe & Cooper, 1984). This factor, which
is not LHRH (see 1.6.1 (vii)), appears to be similar to a Sertoli cell
factor observed in a number of studies (Grotjan & Heindel, 1982;
Benahmed et al. 1984; Parvinen et al. 1984; Janecki et al. 1985;
Verhoeven & Cailleau, 1985).
Testicular IF contains a number of factors present in serum
(Sharpe, 1979) from which it is formed (Setchell & Sharpe, 1981). The
addition of serum to cell cultures is known to result in changes in
their structure and function, so as a control for these non-specific
serum effects, in the present study where possible, both IF and serum
from the same individual or animal were added to the Leydig cell
preparations.
The addition of both human and rat IF and serum to human Leydig
cells produced inconsistent results (Figs. 5.6 - 5.11). In different
Leydig cell preparations, human and rat IF either stimulated
testosterone production in a dose-dependent manner (Figs. 5.6 & 5.8),
150
or in a reverse dose-dependent manner (Figs. 5.7 & 5.9), or was without
effect compared to maximally stimulating levels of hCG (Fig. 5.10).
Furthermore, the stimulatory effects of both human (Fig. 5.10) and rat
serum (Fig. 5.9) on Leydig cell testosterone production are difficult to
interpret.
Although the variable results obtained with human and rat IF on
Leydig cells of the opposite species may be explained simply by species
differences, the lack of any consistent effect of human IF on human
Leydig cell testosterone production is in direct contradiction to the
results obtained in a recent study by Verhoeven & Cailleau (1987). In
this study spent media from human seminiferous tubule cultures was
reported to contain a Leydig cell stimulatory factor similar to the IF
factor(s) described in the rat. This factor derived from two young
patients (25 and 37 years) with Leydig cell tumours. These tumours
synthesize androgens and oestrogens directly and indirectly by
aromatization of androgens (Bercovici et al. 1987). These patients as a
rule have suppressed gonadotrophin levels, impaired spermatogenesis and
are infertile. Analogous to this is the situation in the present study,
in which IF obtained from a patient who had received the gestagenic
anti-androgen cyproterone acetate, as primary treatment for prostatic
carcinoma, significantly enhanced hCG-stimulated testosterone production
by human Leydig cells (Fig. 5.8). This patient had undetectable levels
of gonadotrophins, and severely disrupted spermatogenesis.
Similarly, in the rat, situations which lead to reduced
intratesticular testosterone levels and subsequently suppressed
spermatogenesis, for example depletion of Leydig cells by EDS (Sharpe et
al. 1986a) or short-term cryptorchidism (Sharpe et al. 1986b), also
results in increased IF-factor activity. Following short-term
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morphological damage to the seminiferous epithelium when testosterone
and LH levels are back to normal, IF factor activity remains elevated,
the activity being highest in animals with the most severe disruption of
spermatogenesis (Sharpe et al. 1986a, 1986b).
In situations of acute severe spermatogenic disruption IF-factor
activity appears therefore to be elevated. This however fails to
explain why IF obtained from normal adult rats is capable of stimulating
Leydig cell testosterone production. Human IF was obtained from men who
underwent orchidectomy as primary treatment for prostatic carcinoma.
These men, as a function of age, have chronically disrupted
spermatogenesis, and elevated gonadotrophin levels. Raised serum levels
of FSH are usually associated with Sertoli cell malfunction (de Kretser
& Kerr, 1983) and secretory functions of the Sertoli cell decline when
there is impairment of spermatogenesis (Au et al. 1983; de Kretser &
Kerr, 1983; Jegou et al. 1984). Furthermore Sertoli cell number is
known to decrease in the human testis with age (Johnson et al. 1984). A
combination of reduced Sertoli cell number, and a reduction in the
function of the remaining Sertoli cells, may be the cause of reduced
production of IF-factor by the human Sertoli cells in this group. At
the present time therefore, we can only speculate as to the role of
IF-factor in the paracrine control of the human testis.
Despite the clear cut effects of a number of putative paracrine
factors on Leydig cell function in the rat, similar effects on human
Leydig cell function were not observed. Essentially, the dose of
LHRH-A, vasopressin and TGFjl used in the present study was the same as
that used in the rat studies. Dose-response experiments would have to
be performed before it could be established that these factors have no
effect on human Leydig cell function. If indeed these putative
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paracrine factors exist in the human testis, they may exert their
effects on other cell types, the peritubular cells or macrophages for
example. Furthermore, apart from LHRH which has been shown consistently
to have effects in vivo, it remains to be established whether the other
factors described above have any physiological significance.
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CHAPTER 6
Inhibln Bioactivity and Immanoactlvlty
in Hunan Testicular Extracts
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6.1 Introduction
Inhibin is a peptide produced by the gonads which acts on the
anterior pituitary to selectively inhibit the synthesis and secretion of
follicle-stimulating hormone (FSH) (de Jong, 1979; Baker et al. 1983).
Within the last 2 years the purification, nucleotide sequencing and gene
cloning of bovine, porcine and human inhibin have been achieved
(Miyamoto et al. 1985; Robertson et al. 1985; Forage et al. 1986;
Fukuda et al. 1986; Mason et al. 1986). However, studies to define a
physiological role for inhibin are still scarce, particularly in the
male.
In the male rat, testicular inhibin is produced by the Sertoli cell
(Steinberger & Steinberger, 1976; Bicsak et al. 1987). Spermatogenic
disruption results in a decrease in inhibin with an accompanying
increase in levels of plasma FSH (Au et al. 1983, 1984, 1987).
Following hypophysectomy, rat testicular inhibin is decreased and can be
restored by exogenous FSH (Au et al. 1985). These data provide
convincing experimental evidence for the role of inhibin within the
pituitary FSH-testicular feedback loop in the male rat.
In infertile men, atrophy of seminiferous tubules is usually
associated with a selective increase in circulating FSH (de Kretser et
al. 1974) and this has been attributed to decreased inhibin feedback.
Human seminal plasma inhibin levels have been correlated with FSH and
sperm count in normal and infertile men (Scott & Burger, 1981a). Human
seminal plasma inhibin is however distinct from testicular inhibin,
being of prostatic rather than gonadal origin (Beksac et al. 1984).
Furthermore, there is conflicting evidence as to whether seminal plasma
inhibin is able to suppress pituitary FSH secretion in vitro (Ramasharma
et al. 1984; Sheth et al. 1984; de Jong & Robertson, 1985; Liu et al.
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1985) .
At present, direct evidence for the existence of testicular inhibin
in the human male is lacking. The aim of this study was to quantify
y
levels of inhibin in human testes by means of a sensitive bioassay and
to relate inhibin bioactivity to circulating FSH and spermatogenesis.
In addition, following the development of a radioimmunoassay for the
detection of inhibin in the human (McLachlan et al. 1986), by kind
permission of Professor D.M. de Kretser, a comparison was made between
testicular inhibin immunoactivity and bioactivity.
6.2 (i) Testicular inhibin bioactivity, gonadotrophins, steroids and
spermatogenesis
Inhibin bioactivity was detectable in testicular extracts from all
21 patients using a sheep pituitary cell bioassay (see 2.5.3). In the
ten men from whom both testes were available, there was no significant
difference in inhibin bioactivity (4.5 + 1.7 U/ml left and 4.5 + 1.9
U/ml right) or daily sperm production (DSP) (1.7 + 0.9 x 10^/g left
and 1.6 + 1.1 x 10^/g right) between left and right testes. In these
cases, results were expressed as the average of the two testes.
The mean values of testicular inhibin, DSP, plasma FSH, LH,
testosterone and oestradiol concentrations in the whole group and in the
untreated and post-radiotherapy sub-groups are shown in Table 6.1 The
group as a whole had low DSP, low normal testosterone and minimally
increased FSH and LH with reference to young adults, although the range
of individual values was very widely distributed. Patients who received
radiotherapy previously had significantly lower inhibin bioactivity (P-C.
0.05) and DSP (P<0.01) but higher circulating FSH (P<Q).001) and LH (P<^
0.01) compared with the untreated group while testosterone and
oestradiol remained unchanged (Fig. 6.1).
156
































































*P<0.05 Forreferencepu poses,correspondingvaluef n male tilma eund r50y rsar : DSP,5.9+0 8x106/g;F H5-0mU ml;LH,U/mlTestosterone3-10ng l Oestradiol200pM/1
FIGURE 6.1
Comparison between the levels of inhibin, FSH, daily sperm production
(DSP), LH, testosterone and oestradiol in both the untreated and
radiation treated groups. Inhibin and DSP were significantly reduced
(P<0,05, P<0.01 respectively), FSH and LH significantly increased
(P<0.001, P<0.01 respectively), and testosterone and oestradiol
unchanged (NS) in the radiation treated as compared to the untreated
group. Values are mean ± SD from 15 patients in the untreated group
and 6 patients in the radiation treated group.
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The distribution of these variables against inhibin in individual
patients are shown in Figure 6.2. As expected, there was a highly
significant inverse relationship between DSP and FSH in the overall
group (R = -0.78, P<^0.001). However, the'apparent negative correlation
between inhibin and FSH did not reach statistical significance in this
group (R = -0.36). Single-factor regression analysis also failed to
elicit any significant relationships between inhibin and DSP, LH,
testosterone or oestradiol (Table 6.1). These variables, when analysed
by multiple interactive regression, did become significantly correlated
with inhibin (R = 0.48, P<^_0.05).
(ii) Comparison between testicular inhibin immunoactivity and
bioactivity
In 17 patients, in whom inhibin bioactivity had been measured
previously, testicular inhibin immunoactivity was measured by
radioimmunoassay using an antiserum raised against purified bovine
follicular fluid inhibin as a primary immunogen boosted with 31 kDa
bovine inhibin. Results were expressed in terms of a human IVF plasma
pool assayed against a partially purified human follicular fluid
standard (D.M. de Kretser, personal communication). Testicular inhibin
bioactivity (4.8 + 1.1 U/ml - untreated group; 3.2 + 1.4 U/ml -
radiation treated group) was significantly lower than immunoactivity
(155.6 + 75 U/ml - untreated group; 392.8 + 397.4 U/ml - radiation
treated group). Furthermore, single-factor regression analysis showed
the lack of correlation between inhibin bioactivity and immunoactivity
in this group of men (Fig. 6.3). A positive correlation was observed
between inhibin immunoactivity and FSH (R = 0.62, P<C.0.001) and also
between inhibin immunoactivity and LH (R = 0.74, P<^0.001), in a
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FIGURE 6.2
Single-factor regression analyses showing a highly significant
inverse relationship between daily sperm production and FSH
(R = -0.78, PC0.001), but a lack of significance between inhibin
bioactivity and daily sperm production (DSP), FSH, LH,
testosterone and oestradiol. The closed squares represent 15
patients in the untreated group, and the open squares, 6 patients
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FIGURE 6.3
Regression analysis showing the lack of significant
correlation between inhibin bioactivity and
immunoactivity in testicular extracts from 17 patients
(including values for both left and right testes in
eight patients).
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0.001) (Fig. 6.4). No significant relationship existed between inhibin
immunoactivity and either DSP, testosterone or oestradiol (Fig. 6.4).
(iii) Relationship between inhibin immunoactivity and FSH in the
peripheral circulation
Previous studies have failed to detect inhibin bioactivity in
spermatic vein blood in men undergoing embolization treatment for
variocoeles or in the peripheral circulation of two normal males who
received FSH infusion (Metrodin, Serono; 25 IU 3 hourly for 5 days)
(F.C.W. Wu & C.G. Tsonis, unpublished observations). With the
availability of a radioimmunoassay capable of detecting plasma levels of
inhibin immunoactivity in males, the relationship between FSH and plasma
levels of inhibin can now be investigated.
Plasma from the two males who received infusion of FSH for 5 days
was assayed for inhibin immunoactivity, FSH, LH and testosterone. While
FSH levels rose significantly during FSH infusion, plasma levels of
inhibin immunoactivity, and also LH and testosterone, were not altered
significantly (Fig. 6.5).
6.3 Discussion
The presence of FSH-suppressing bioactivity in pooled human
testicular extracts has been reported previously (Krishnan et al. 1982),
but this is the first attempt to quantify levels of inhibin in the human
testis and to relate this to direct and indirect measures of
spermatogenesis. Despite the high average age of the patients (60 - 89
years, median 74) and the low DSP in some cases, inhibin bioactivity was
detectable in all samples. The mean level of inhibin in the human
testis of 4.38 U/ml (^ 90 U/testis) is, on a per testis basis,
approximately half that reported by Au et al. (1984) in testicular






















Single-factor regression analyses showing highly significant
correlations between inhibin immunoactivity and FSH (R = 0.62,
P<0.001) and LH ( R = 0.74, PC0.001), and also between LH and
FSH (R = 0.81, P<0.001). Inhibin immunoactivity was not
significantly correlated to DSP, testosterone or oestradiol.
The closed squares represent 12 patients in the untreated group,
















































Effect of FSH infusion (Metrodin, 25 IU 3 hourly) in two normal
males on plasma levels of inhibin, FSH, LH and testosterone.
While FSH rose significantly during Metrodin infusion,
plasma levels of inhibin were not significantly altered.
Likewise, LH and testosterone remained unchanged.
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rat pituitary cell bioassay but the same inhibin reference standard
(ovine rete testis fluid, lU/mg) as in the present study. This may be
due to differences in the sheep and rat inhibin bioassays or may reflect
the decreased number of Sertoli cells seen in the ageing human testis
(Johnson et al. 1984). Furthermore, inhibin bioactivity observed in the
human female during both spontaneous and gonadotrophin-stimulated cycles
seem to be considerably higher than that observed in human testicular
extracts. Thus the concentrations of inhibin bioactivity in follicular
fluid at mid-cycle in women receiving human menopausal gonadotrophin
and/or clomiphene were 200-300 U/ml (Baird et al. 1987) and in
peripheral plasma, in both spontaneous and stimulated cycles, 1-8 U/ml
(Tsonis et al. 1987b, Tsonis et al. 1987c). In contrast, inhibin was
undectable in the spermatic vein of normal adult rats (Au et al. 1984).
Similarly, we were unable to detect inhibin bioactivity in spermatic
vein blood in 12 men undergoing embolization treatment for varicocoeles
or in the peripheral plasma of two normal males who received FSH
infusion for 5 days (F.C.W. Wu & C.G. Tsonis, unpublished observations).
Taken together, these results suggest that inhibin production in the
human male may be substantially lower than in the female.
In patients who received radiotherapy, testicular inhibin
bioactivity was significantly lower than in those not previously treated
(Table 6.1), although in no instance was inhibin undetectable. In the
former group, DSP was profoundly reduced and FSH, though grossly
elevated, was still below the castrate range, while testosterone and
oestradiol were normal. These findings are compatible with the concept
that inhibin is important in the feedback control of FSH, and implicate
a relative deficiency of inhibin as the underlying mechanism for the
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predominant FSH rise frequently observed in infertile men with
spermatogenic failure. Scott & Burger (1981a) reported the absence of
seminal plasma inhibin in eight azoospermic men with increased FSH, but
their finding that vasectomized men also had inhibin activity in seminal
plasma makes it unlikely that they were detecting a hormone of gonadal
origin as in the present study. Although a role for prostatic inhibin
in the control of FSH secretion has been postulated (Ramasharma et al.
1984; Sheth et al. 1984), a more important point is the possibility
that pituitary FSH-suppressing activity in vitro may not be specific to
inhibin as it is currently defined.
If inhibin does play a physiological role as a modulator of FSH
secretion, one might expect to find a negative correlation between
inhibin and FSH and a positive one between inhibin and DSP in a
situation where a significant inverse relationship between FSH and DSP
exists (Fig. 6.2). In the 21 patients studied, the relationships
between these three variables were in the directions anticipated but
there was no significant correlation between testicular inhibin
bioactivity and circulating FSH or DSP (Fig. 6.2). One possible
explanation for this may be that gonadal inhibin concentrations are not
representative of inhibin in the peripheral circulation. Studies on rat
Sertoli cell cultures show that FSH stimulates both intracellular and
secreted levels of inhibin in a dose-dependent manner, with
approximately 1/2 - 2/3 of the inhibin being secreted (Bicsak et al.
1987). Little is currently known about the mechanism(s) or route(s) by
which inhibin is secreted from the testis into the peripheral
circulation although, in sheep, the high concentration of inhibin in the
ovarian vein (Tsonis et al. 1986) and ovarian lymph (Findlay et al.
1986) indicate that both vascular and lymphatic routes may be
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important. However as yet, it has not been possible in the male to
determine the exact relationship between circulating inhibin and FSH.
An interesting analogy is our finding that testicular testosterone
concentrations from a similar group of men bore no significant
correlation to either circulating testosterone or LH (Simpson & Wu,
1986). One interpretation of these findings for both testosterone and
inhibin is the compensatory response of the Leydig and Sertoli cells to
germ cell loss or degeneration, so that the gonadal production of these
hormones is stimulated by the elevated levels of LH and FSH
respectively. However, these changes in gonadal inhibin and
testosterone are not reflected by levels of these hormones in the
peripheral circulation. This type of chronic adaptation in the
pituitary-testicular axis of the ageing human male is in distinct
contrast to that observed during acute experimental disruption of
spermatogenesis in young adult rats (Au et al. 1983, 1984, 1987), where
an inverse relationship between testicular inhibin bioactivity and
circulating FSH was consistently observed.
Following spermatogenic disruption in rats, the decline in
testicular inhibin does not occur immediately, but is delayed to
coincide with a reduction in testicular weight, an event known to
reflect germ cell loss. Restoration of normal spermatogenesis following
heat damage (Au et al. 1987) results in a return to normal FSH levels
associated with a return to normal levels of testicular inhibin. The
possibility of an interaction between different Sertoli cell/germ cell
associations to regulate the production of inhibin has been suggested
previously. The involvement of the spermatids in the regulation of
inhibin production has been suggested by a number of authors
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(Franchimont et al. 1975; Davies et al. 1978; Dandekar et al. 1984).
In the present study however no significant relationship between
testicular inhibin bioactivity and spermatid number (expressed as DSP)
was observed (Fig. 6.2). Other studies have suggested the interaction
between spermatocytes and Sertoli cells in the regulation of inhibin
production, as FSH levels remain within the normal range despite the
depletion of more advanced germ cells by vitamin A deficiency (Krueger
et al. 1974) or hydroxyurea treatment (Mecklenburg et al. 1975). More
recent studies have shown that "crude" germ cells co-cultured with
Sertoli cells have no signficant effect on inhibin production
(Steinberger, 1980). It would appear therefore that, as in the control
of ABP secretion by the Sertoli cell (see 1.6.2 (ii)), particular
Sertoli cell-germ cell associations may be required to regulate inhibin
production.
Our finding that DSP and FSH were the two parameters with the
highest correlation to inhibin is compatible with the notion that the
latter is an index of Sertoli cell function. However, the fact that the
correlations did not reach significance until testosterone was included
implies that the interaction between FSH, germ cells, Leydig cells and
Sertoli cells in the production of inhibin is more complicated than we
had previously envisaged. In keeping with this are the findings that
androgens stimulate inhibin production by rat testes in vivo and in
vitro (Steinberger, 1981; Verhoeven & Franchimont, 1983), and also by
human granulosa-lutein cells in vitro (Tsonis et al. 1987a).
In 1985 the full sequence of 32 kDa forms of inhibin in bovine and
porcine follicular fluid were published (Ling et al. 1985; Mason et al.
1985; Robertson et al. 1985). This smallest active form of inhibin was
shown to comprise of an 4X^(18 kDa) and a B chain (13 kDa) interlinked by
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a disulphide bridge. This 32 kDa form of inhibin is derived from a 58
kDa form by proteolytic processing of the<X^subunit (Robertson et al.
1985; Forage et al. 1986; Leversha et al. 1987), a process which has
y
been shown to occur in plasma (McLachlan et al. 1986). However, there
is little information on the molecular form or heterogeneity of the
inhibin molecule within the testis or in the circulation. Our reliance
on in vitro bioassays for the detection of testicular inhibin has the
disadvantage that other intragonadal factors may interfere with the end
point of FSH suppression in cultured pituitary cells. Recent work has
demonstrated the existence of a homodimer of the inhibin J3-subunit in
porcine follicular fluid which is capable of stimulating FSH release in
vitro (Ling et al. 1986; Vale et al. 1986). A significant structural
homology has also been described between the j?-subunit of inhibin and
human transforming growth factor-^ which can stimulate and inhibit cell
growth (Mason et al. 1985), suggesting that the inhibin subunit may
possess paracrine activities. The mitogenic activity of sheep pituitary
cells in culture has been shown to be stimulated by conditioned media
from cultured chicken ovarian thecal cells (Tsonis et al. 1987d) and by
a factor from human testicular extracts (Chapter 7), both of which also
possess FSH-suppressing activity. These findings highlight the
non-specificity and potential pitfalls of in vitro bioassays, and
therefore, with the development of specific radioimmunoassays for
inhibin, testicular inhibin immunoactivity was measured in 17 patients
in whom inhibin bioactivity had been measured previously.
Although testicular inhibin immuno- and bioactivity were expressed
in terms of different standard preparations, and as such cannot be
compared directly, nevertheless, the two were not significantly
correlated (Fig. 6.3). Contrary to the accepted dogma that inhibin
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selectively inhibits the synthesis and secretion of FSH from the
anterior pituitary, a highly significant positive correlation was
observed between inhibin immunoactivity and circulating levels of FSH
(Fig. 6.4). The differences observed in the relationships between
inhibin immuno- and bioactivity and FSH may be explained, at least in
part, by the demonstration of inhibin-related factors which are capable
of stimulating pituitary cell release of FSH in vitro (Ling et al. 1986;
Vale et al. 1986). By increasing the release of pituitary FSH, these
factors would result in inhibin activity measured by bioassay being
underestimated. The radioimmunoassay used in the present study did not
however cross-react with these FSH-releasing peptides, or indeed, TGFJ5,
MIS or any other potentially cross-reacting peptide (D.M. de Kretser,
personal communication). In addition, the presence of a potent
mitogenic factor in human testicular extracts, which stimulated the
division of ovine pituitary cells in vitro, thus inhibiting the
production of FSH from these cells, may also confound the inhibin
bioactivity measurements (see Chapter 7). In view of the difficulties
inherent to the inhibin bioassay, the significance of the positive
correlation between inhibin immunoactivity and FSH must be further
considered.
While at present there is no information as to the relationship
between testicular levels of inhibin and those in the peripheral
circulation, if, in the light of the present results, testicular inhibin
is representative of levels in plasma, a positive correlation between
FSH and plasma inhibin might be expected to exist. While bioassay
techniques proved too insensitive to measure inhibin in the peripheral
circulation of two males who received FSH infusion for five days,
inhibin immunoactivity was measureable in these samples. Despite the
5-fold increase in circulating levels of FSH in these men,
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no consistent rise in plasma inhibin was observed (Fig. 6.5). Studies
in vitro have shown conclusively that FSH causes a dose-dependent
increase in immature rat Sertoli cell inhibin production, while
comparison between secreted and intracellular levels of inhibin reveal
that approximately 1/2 - 2/3 of the inhibin is secreted (Bicsak et al.
1987). The discrepancy between testicular and plasma levels of inhibin
in relation to FSH may indicate that in man also, Sertoli cell inhibin
is stored prior to release into the circulation. This is in contrast to
the situation in the female where, following FSH-stimulation, granulosa
cells do not contain measurable intracellular levels of inhibin (Bicsak
et al. 1986). The fact that Sertoli cell inhibin is stored while
granulosa cell inhibin is not, suggests that there may be differences in
inhibin processing between the two cell types.
The indication of the present results that inhibin alone is not the
negative feedback regulator of FSH production is in keeping with studies
in vitro, and also with recent data in the human female and other
species. In the sheep it has been shown that during the follicular
phase of the oestrous cycle, the secretion of inhibin from the ovary
declines concomitantly with a fall in levels of FSH as oestradiol
increases (Tsonis et al. 1986). Similarly, during the menstrual cycle
in women, inhibin production by the granulosa cell is stimulated by FSH,
while inhibition of FSH is mainly by the interaction of both inhibin and
oestradiol (Tsonis et al. 1987b). Testosterone has also been shown to
stimulate the production of inhibin by both the granulosa cells prior to
luteinization and by the corpus luteum (Tsonis et al. 1987a). Therefore
the role of LH and steroid hormones in the negative feedback control of
FSH secretion in the female must be considered, and the function of
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inhibin in this process re-investigated.
In the male, investigation of the extent to which steroids are
involved in the control of FSH release is made difficult in view of the
non-cyclical nature of steroid secretion. Conflicting evidence exists
as to whether androgens are effective in stimulating Sertoli cell
inhibin production in vitro (Verhoeven & Franchimont, 1983; Bicsak et
al. 1987). In the present study no significant relationship existed
between testicular inhibin immunoactivity and peripheral levels of
testosterone or oestradiol (Fig. 6.4) or intratesticular levels of
testosterone.
In conclusion, this is the first report of the presence of inhibin
immunoactivity in the human testis. Comparison between inhibin
bioactivity and immunoactivity revealed the non-specificity and
potential pitfalls of in vitro inhibin bioassay. The highly significant
positive correlation between testicular inhibin immunoactivity and
circulating levels of FSH suggest that in the male, as in the female,
the concept of FSH-stimulated inhibin production in the negative
feedback control of FSH must be re-examined. The development of
radioimmunoassay techniques, capable of detecting inhibin levels in the
peripheral circulation, will assist greatly in this task. Recent
findings have however led to the speculation that the production of
inhibin may be under complex paracrine/autocrine control, and that
inhibin might also subserve a paracrine function(s) within the testis in
addition to its better recognized systemic role of FSH regulation.
While the importance of inhibin in the negative feedback control of FSH
should not be underestimated, the mechanism of this control appears to
be much more complex than thought previously. Future studies must take
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into account the interaction between inhibin and the steroid hormones in
this process, in particular the modulatory effects of steroids on the





Mltogenlc Activity In Testicular Extracts
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7.1 Introduction
During the course of a routine bioassay to determine whether
inhibin was present in the pre-ovulatory follicle of the domestic hen,
Tsonis and colleagues (1987d) observed that conditioned medium from
chicken thecal/stromal cells, but not granulosa cells, stimulated the
proliferation of ovine pituitary cells in culture (Tsonis et al. 1987d).
While the identity, cellular origin and physiological significance of
the thecal/stromal factor remains to be established, it has been
suggested that this factor may be involved in the division of thecal
layer fibroblasts or in the stimulation of granulosa cells during
folliculogenesis (Tsonis et al. 1987d). This increasing awareness that
cell metabolism and cell division may be regulated by growth factor has
also stimulated much interest in their possible role in
spermatogenesis.
When measuring inhibin bioactivity in human testicular extracts
during the present study, it was observed that these extracts also
stimulated the proliferation of ovine pituitary cells in culture. A
number of Sertoli cell-derived growth factors are thought to be involved
in autocrine and/or paracrine regulation of testicular function (see
1.3.3). The mitogenic activity in human testicular extracts was
therefore further investigated in relation to a number of aspects of
testicular function. Preliminary findings are reported in this
chapter.
7.2 (i) Presence of mitogenic activity in human testicular extracts
Mitogenic activity was determined in testicular extracts in a group
of 17 men (61-86 years, median 74) who had underwent orchidectomy for
prostatic carcinoma. This group consisted of 9 previously untreated, 5
radiation treated, 2 diethylstilboestrol (DES) treated men and 1 man
treated with cyproterone acetate. A human testicular extract pool was
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also prepared from 21 men in whom testicular inhibin had been measured
previously (Chapter 6). Mitogenic activity of human testicular extracts
was determined using the same conditions as for the ovine pituitary cell
inhibin bioassay (see 2.5.3), and the same time-course as employed
previously to detect mitogenic activity in chicken thecal/stromal cells
(Tsonis et al. 1987d). Following pre-incubation for 48 h, ovine
pituitary cells were incubated with testicular extract, or culture
medium alone (control), for a further 48-72 h, before being lifted from
the culture plates by the addition of trypsin (see 2.5.4). Pituitary
cell number was then counted in a haemocytometer.
Following the initial observation that human testicular extracts
had potent mitogenic effects on ovine pituitary cells in culture, the
effect of a human testicular extract pool (HTE) on ovine pituitary cell
number was observed. The addition of HTE from 6.25 jil to a maximum of
25 jil (P<Q.001), produced a dose-dependent increase in pituitary cell
number while the addition of higher doses reduced the viability of these
cells in culture (Fig. 7.1). In spite of the increased number of
pituitary cells, however, no accompanying increase in FSH, LH or
prolactin was observed (Fig. 7.2). Indeed the total release of FSH was
suppressed in a dose-dependent manner, while LH and prolactin were not
significantly changed. In contrast, when expressed as release per final
pituitary cell number (percentage of control), both LH and prolactin
were also suppressed in a dose-dependent manner, although FSH was
suppressed to an even greater extent (Fig. 7.2).
When mitogenic activity in individual testicular extracts from 16
patients was correlated to FSH release in the same ovine pituitary cell
culture, a significant negative correlation (R = -0.51, P<^0.05) was
observed (Fig. 7.3). Thus if the presence of mitogenic activity is
associated with a reduction in the release of FSH from pituitary cell,
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FIGURE 7.1
Increase in cultured ovine pituitary cell number with
increasing levels of a human testicular extract pool
(HTE) up to a dose of 25 |il compared to control (***,
P<0.001). The addition of higher doses reduced the
viability of these cells in culture {***, P<0.001).
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FIGURE 7.2
Histograms showing the effect of increasing concentrations
of a human testicular extract pool (HTE) on the total
release of FSH, LH and prolactin from cultured ovine
pituitary cells (left panel), and the release expressed
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FIGURE 7.3
The effect of increased mitogenic activity in individual
testicular extracts on the release of FSH from ovine
pituitary cells in culture (R = -0.51, P<0.05) (n = 16),
and on testicular inhibin bioactivity (n = 14) and
immunoactivity (n = 13).
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inhibin bioactivity measured in the same assay system might be expected
to be overestimated. However inhibin bioactivity measured in 14 of
these patients just failed to show the expected positive correlation
with mitogenic activity (Fig. 7.3). Inhibin immunoactivity measured in
13 of these patients failed to show any significant relationship with
mitogenic activity. These observations suggest that the HTE mitogenic
activity is associated with an apparent suppressive effect on FSI1
release independent of inhibin bioactivity.
To assess the individual variability in mitogenic activity,
testicular extracts from 17 men were examined at a maximum dose of 25 jal
and at a 1:4 dilution. The results were divided into four groups
according to treatment regimen, and are shown in Figure 7.4. In all
cases, except for one man who had been treated with cyproterone acetate,
the addition of testicular extracts stimulated the division of pituitary
cells in culture. There was no significant difference in the response
of the pituitary cells to testicular extracts from untreated or
radiation treated patients although the hormonal and germ cell status of
these patients were very different (see Fig. 6.1). Interestingly at a
dose of 25 jil, testicular extracts from two men treated with DES did not
stimulate pituitary cell division to the same extent as did the 1:4
dilution (Fig. 7.4). While the intratesticular hormonal milieu, and
also the state of the seminiferous epithelium was significantly
different between the treatment groups, no correlation was observed
between either daily sperm production, testicular levels of testosterone
or gonadotrophin levels and mitogenic activity (Fig. 7.5) - mitogenic
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FIGURE 7.4
Effect of testicular extracts at two doses from 16
individual men on cultured ovine pituitary cell number.
The results are divided into four groups according to
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FIGURE 7.5
No significant correlation was observed between mitogenic
activity (an arbitrary figure calculated from final
pituitary cell number minus control) and daily sperm
production (DSP), testicular testosterone, tubular
testosterone, FSH or LH.
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7.2 (ii) Presence of testicular mltogenic activity in other species
In addition to HTE, the mitogenic activity of testicular extracts
from a number of species was observed. When added to ovine pituitary
cells in culture, testicular extracts from rat, boar and marmoset did
not stimulate pituitary cell number above control levels, while ram
testicular extract contained a mitogenic factor which appeared to be
even more potent than that present in the HTE pool (Fig. 7.6).
7.2 (iii) Effect of human testicular extract on rat Leydig cell
function
In order to look at a more physiological situation, the effect of
HTE and rat testicular extracts were observed in cultures of rat Leydig
cells (Fig. 7.7). All additions of both rat and human testicular
extracts significantly depressed Leydig cell number compared to control
levels (P^O.OOl).
7.3 Discussion
While determining the presence of inhibin bioactivity in human
testicular extracts it was observed that these steroid free extracts
contain a factor which has potent mitogenic effects on ovine pituitary
cells in culture. The addition of a human testicular extract pool to
the pituitary cells results in a 2- to 3-fold increase in pituitary cell
number above control by 48 - 72 h of incubation. Similarly it has been
shown that chicken thecal/stromal cell conditioned media (ThCM), but not
granulosa cell conditioned media (GCCM), stimulates the proliferation of
ovine pituitary cells during inhibin bioassay (Tsonis et al. 1987d).
The addition of GCCM to ovine pituitary cells causes a dose-dependent
suppression of FSH while not affecting the release of LH or prolactin.
This effect has been attributed to the presence of inhibin from the












Effect of testicular extracts from human, ram, rat, boar and
marmoset on cultured ovine pituitary cell number. Extracts
from human and ram testes significantly increased pituitary
number above control levels, while those from rat, boar and
marmoset were without any significant effect. Values are


























Effect of rat and human testicular extract pools and serum
controls on rat Leydig cell number in vitro. At all doses
studied, both rat and human testicular extracts suppressed
Leydig cell number to values significantly below control
and serum levels (P<0.001).
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development (Tsonis et al. 1987d). While stimulating a 4- to 5-fold
increase in total pituitary cell number during 96 h of incubation, ThCM,
which should not contain inhibin activity, also suppresses FSH release
in a dose-dependent manner while not affecting the release of LH or
prolactin. Tsonis and colleagues suggest that this inhibin-like
activity of the ThCM is due either to contamination of the preparation
by granulosa cells, or to the presence of the mitogenic activity since a
previous study (Yoshimura et al. 1974), which followed the life stage
and secretory cycle of the anterior pituitary gonadotrophs, suggested
that following pituitary cell division the release of FSH is
suppressed.
Considering that bioassay of inhibin depends upon the extent to
which FSH release is suppressed in pituitary cell cultures, then the
presence of any factor which might alter the synthesis or release of FSH
would bias inhibin bioactivity measured in this system. Following the
addition of HTE, ovine pituitary cell proliferation was determined by
counting total cell number, as suitable facilities for distinguishing
between gonadotrophs, lactotrophs, somatotrophs and other pituitary cell
types were not available. Therefore in this study, as in that by
Tsonis et al., there is no way of knowing whether the mitogenic factor
induced the gonadotrophs to divide. Pituitary cell proliferation may
have been the result of division of primitive stem cells, of
non-secretory chromophobe cells, of one particular type of pituitary
cell or of all pituitary cell types. Considering the extent of
pituitary cell proliferation (2- to 3-fold in 48 - 72 h) in view of the
lengthy pituitary cell cycle (A.M. McNichol, personal communication), it
would appear that the mitogenic factor was inducing all pituitary cell
types to proliferate.
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On the assumption that all pituitary cell types were dividing
equally, the total output of FSH, LH and prolactin were expressed in
terms of release per final pituitary cell number. While FSH release was
suppressed due at least in part to the presence of inhibin, the release
of LH and prolactin were also suppressed, although to a lesser extent
than FSH. This indicates that the mitogenic factor may indeed affect
peptide hormone release from a number of pituitary cells, including the
gonadotrophs. Furthermore when mitogenic activity of individual
testicular extracts was correlated to the release of pituitary cell FSH,
a significant negative correlation was observed, indicating that
increased mitogenic activity is associated with reduced output of FSH.
Also the lack of any significant relationship between inhibin
immunoactivty and mitogenic activity illustrates that the release of FSH
is suppressed to a greater extent than by inhibin alone. Despite this,
inhibin bioactivity just failed to show a positive correlation with
mitogenic activity. If therefore the assumption that following the
addition of HTE all pituitary cells divide equally, then it would appear
that the newly formed pituitary cell population has reduced capacity to
secrete its peptide hormones. Reduced production of FSH would result in
overestimation of inhibin bioactivity in human testicular extracts.
Spermatogenesis is the most proliferative cell process in the male,
and as such, has prompted study of specific growth factor contribution
to this process. A number of Sertoli cell-derived growth factors are
thought to be involved in autocrine and/or paracrine regulation of
testicular function. Although the cellular origin of the mitogenic
factor remains unknown, it is likely to derive from the Sertoli cell,
and as such investigation of the physiological role of the mitogenic
factor in germ cell development and function is therefore of great
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interest. At the time of this study however, the techniques for the
isolation and co-culture of Sertoli cells and germ cells were not set up
in our laboratory. Instead however, with the availability of techniques
for in vitro study of Leydig cell function, an attempt was made to study
the effect of HTE on rat Leydig cell steroidogenic capacity in vitro.
At all doses, HTE and also steroid free testicular extracts from rats,
severely reduced the viability of the Leydig cells in vitro compared to
control.
Studies to identify this factor are in the preliminary stages, but
it is unlikely to be fibroblast growth factor, which has been shown
previously to have only minimal mitogenic activity on pituitary cells in
culture (Baird et al. 1986), or either epidermal growth factor or
transforming growth factor p, which show only limited mitogenic activity
in the present system (Tsonis et al. 1987d). Likewise, it appears not
to be interleukin-loc or J> which do not stimulate the division of ovine
pituitary cells in culture (G. Duff & J. Symons, personal
communication). While this rules out a number of possibilities, it is
feasible that this mitogenic factor is one of many other well-
documented growth factors of Sertoli cell origin, for example,
seminiferous growth factor (Feig et al. 1983), meiosis-inducing
substance (Grinsted & Byskov, 1981) or insulin-like growth factor (Tres
et al. 1986).
Since the purification of this mitogenic factor requires a constant
supply of material, and as human testicular tissue is not available on
demand, the presence of this factor was investigated in other species.
Testicular extracts from ram, rat, boar and marmoset were added to the
ovine pituitary cell bioassay and their effects on cell number
investigated. Testicular extracts from rat, boar and marmoset did not
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stimulate cell proliferation above control levels. Ram testicular
extract however contained a mitogenic factor with similar potency to
that present in the human.
In trying to explain these species differences it was noted that
the ram testes were obtained during mid-June, a time of great germ cell
proliferation, and increased gonadotrophin levels in these seasonal
breeding animals. Similarly in the elderly patients in this study,
gonadotrophin levels were also elevated as a result of suppressed
spermatogenesis, while in the rat, boar and marmoset, spermatogenesis
and gonadotrophin levels were normal. It is possible therefore that in
situations of suppressed spermatogenesis, under the appropriate
steroidal and/or gonadotrophic milieu, this factor is produced, possibly
by the Sertoli cell which acts on the germ cells to stimulate their
development and function. In senescence however this putative
mechanism appears not to function efficiently, as despite the presence
of the mitogenic factor, germ cell development is chronically
suppressed. Thus while the intratesticular hormonal and gonadotrophic
environment and germ cell status were very different between individual
patients, no correlation was observed with mitogenic activity. If
indeed this factor is derived from the Sertoli cell, which decline in
number with age (Johnson et al. 1984), a combination of reduced Sertoli
cell number, and a reduction in the function of the remaining Sertoli
cells, may result in insufficient production of this mitogenic factor to
induce germ cell proliferation.
The serendipitous observation that the addition of human testicular
extracts to ovine pituitary cell cultures results in great proliferation
of these cells, throws into doubt the validity of the sheep pituitary
cell bioassay for the detection of inhibin in these extracts. As yet it
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is not possible to say whether the gonadotrophs, and in particular the
synthesis and secretion of FSH are affected by this mitogenic activity.
If as seems likely the gonadotrophs are induced to divide, any
subsequent alteration in FSH synthesis or release would bias inhibin
bioactivit'y measured in this system. From the present results,
increasing mitogenic activity appears to be associated with suppression
of pituitary cell FSH release, resulting in overestimation of inhibin
bioactivity. Indeed this may explain the lack of correlation between
inhibin bioactivity and immunoactivity observed in these testicular
extracts. Until histochemical or monoclonal antibody techniques are
applied to determine the extent of acidophil, basophil and chromophobe
proliferation, then we can only speculate as to the implications of the
mitogenic factor in the in vitro bioassay of testicular inhibin.
The presence of this putative mitogenic factor in testicular
extracts implies a gonadal role, possibly in germ cell proliferation
during episodes of high gonadotrophic stimulation. Studies are now
underway to determine the presence of this factor in human foetal
testes, and future studies might also investigate its presence in the
rat during puberty and also following experimental disruption of the
seminiferous epithelium.
To conclude, a factor of testicular origin has been found to have
potent mitogenic effects on ovine pituitary cells in culture. While
this is unlikely to be of any physiological significance, it has
important implications for detection of testicular inhibin in the human
using pituitary cell bioassay techniques. Studies to identify and to






Fertility in the male has been shown conclusively to be dependent
on the pituitary gonadotrophins, LH and FSH, which regulate testicular
development and maintain its function. In addition to endocrine control
y
by the gonadotrophins, there is increasing evidence of paracrine
involvement in the control of testicular function, paracrine control
being a form of regulation whereby one cell type in a gland or organ
selectively influences the activity of an adjacent cell type through the
synthesis and release of factors which pass through interstitial spaces
to act on neighbouring target cells. In the rat, an increasing number
of paracrine factors are being identified which modulate the testicular
actions of the pituitary gonadotrophins according to local conditions
and requirements.
In a recent World Health Organization (WHO) survey of 6682
infertile males from 25 countries (Diczfalusy, 1986), while testicular
dysfunction, including primary idiopathic testicular dysfunction and
abnormal sperm morphology and motility, accounted for approximately 21%
of all infertility, a further 42.8% appeared to have no demonstrable
cause as investigated by conventional semen analysis and endocrine
tests. This high percentage of apparent idiopathic infertility or
subfertility in man may reflect disturbance of local intratesticular
paracrine regulation.
Studies on the paracrinology of testicular function have almost
exclusively been limited to the rat, and similar in vitro studies in the
human are lacking. However since the process of spermatogenesis through
its testosterone dependent stages of mitosis, meiosis, translocation and
spermiation is basically similar in both the rat and man, it seems
likely that paracrine mechanisms in the human testis would not be
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appreciably different from those in the rat. With this in mind, the
present study was aimed towards establishing techniques whereby
individual components of the human testis could be studied in isolation,
and related to the overall functional state of the testis as defined by
systemic hormone levels and histological assessment of spermatogenesis.
Testes from elderly men with prostatic carcinoma were utilized to
establish a basis for the in vitro study of testicular paracrinology in
the human. The lack of investigation of this nature in the human
previously has undoubtedly arisen from the shortage of available
material. While tissue was obtained from elderly men, who in general
are known to have decreased levels of spermatogenesis and circulating
testosterone, and also decreased Sertoli and Leydig cell number,
concomitant with increased gonadotrophin levels, a number of these men
had quite normal levels of these parameters, despite their age and
prostatic illness. Indeed the ability of Leydig cells from these
patients to produce testosterone in response to hCG was in many cases
similar to that in young adult rats. Furthermore, patients treated with
either radiotherapy, synthetic oestrogens or anti-androgens provided a
suitable model of chronically suppressed testicular function. These
patients therefore provided a suitable model to study paracrine control
in the human testis.
Better known for its systemic endocrine role, testosterone is also
the most important paracrine hormone in the testis. The main thrust of
this study revolved around the importance of testosterone in the
maintenance of spermatogenesis. While spermatogenesis is completely
dependent on an adequate supply of this hormone, the question of how
much testosterone is required locally to maintain spermatogenesis has
been fraught with controversy over the years. Initial studies set out
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to determine the distribution of testosterone within the human testis,
and whether a lack of available intratesticular testosterone was related
to a decline in spermatogenesis. While the decline in peripheral levels
of testosterone commonly seen with advancing age has fuelled the idea
that reduced Leydig cell function in elderly men is the cause of reduced
sperm production, the results of the present study do not confirm this.
On the contrary, men with high levels of daily sperm production, in the
range of normal healthy young men, appeared to have lower levels of
intratesticular testosterone compared to those with low levels of daily
sperm production, who had surprisingly high intratesticular levels of
testosterone. At face value these results would suggest that the
original hypothesis of depressed levels of spermatogenesis associated
with reduced available testosterone is not substantiated. However
towards the end of this study it became apparent from studies in the rat
that the methods employed to measure absolute amounts of testosterone
within the testis may yield spuriously high results. This is due to
continued Leydig cell function following isolation of the testes. In
view of the apparent methodological difficulties, the validity of the
techniques used in the present study were re-evaluated. While the
post-isolation synthesis of testosterone in the human was not
consistently observed, in a number of cases testosterone production did
continue significantly after testicular isolation. This variability may
reflect the functional capacity of the Leydig cells in different
individuals and may also explain why the original validation of the
techniques did not pick up this problem. As such, before any
conclusions can be drawn as to the minimum amount of testosterone
required to maintain quantitatively normal spermatogenesis,
intratesticular concentrations of testosterone in both the rat and man
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must be re-evaluated taking special precautions to minimize the
post-isolation synthesis of testosterone.
The most widely studied paracrine mechanism in the rat is that of
the interaction between the Sertoli and Leydig cells in the maintenance
of high intratesticular concentrations of testosterone. A number of
factors thought to be produced by the Sertoli cell have been shown to
increase Leydig cell production of testosterone in vitro. The ability
to perform this type of study in the rat is due to the ease with which
Leydig cells can be isolated and their function studied in vitro.
Previous in vitro human Leydig cell studies have generally involved the
use of testis pieces or crude cell preparations, both of which are
unsuitable for investigation of the paracrine control of Leydig cell
function. In the present study, density centrifugation techniques were
adopted for the isolation of highly responsive human Leydig cells,
permitting further investigation of their function in vitro.
The effect of a number of putative paracrine factors which have
been shown to have stimulatory effects on rat Leydig cell function in
vitro were studied in 5 - 48 h incubations of human Leydig cells. The
addition of LHRH-agonist, testicular interstitial fluid, vasopressin and
TGF^ at concentrations known to stimulate testosterone production in
the rat, had no significant effect on human Leydig cell testosterone
production. In addition to possible species differences, this lack of
effect may be accounted for in a number of ways. Firstly there is the
possibility that human Leydig cells isolated on Percoll may represent a
sub-population of cells which are highly responsive to hCG, but which
are not representative of the whole Leydig cell population. This seems
unlikely however as poorly responsive Leydig cells in vitro fractionate
on Percoll in exactly the same manner as do highly responsive cells.
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Secondly there is the possibility that reduced responsiveness of the
human Leydig cells to these putative paracrine factors may reflect the
advanced age of the sample population. While this is indeed a
possibility, again it seems an unlikely explanation as at least some of
the men studied had peripheral hormone levels and quantitative measures
of spermatogenesis in the range of healthy young men. From these
studies therefore it would seem that the fine regulation of Leydig cell
steroidogenesis via paracrine mechanisms may not be required for the
maintenance of spermatogenesis in man. Indeed the importance of these
putative paracrine mechanisms in the in vivo situation in the rat have
been questioned recently in view of evidence that in this species
spermatogenesis can be maintained in the presence of testosterone levels
which are approximately 10 - 20% of available intratesticular levels.
In the light of these results it seemed appropriate to move on to
study human Sertoli cell function, utilizing the new techniques
available for Sertoli cell isolation and co-culture with germ cells. At
this point however the policy for the treatment of men with prostatic
carcinoma changed, and the number having primary orchidectomy dropped
considerably. With the increasing use of LHRH-agonists as first line
treatment, orchidectomy will no longer be the choice of treatment for
this condition. As such, the future of in vitro studies involving human
testicular material looks bleak.
While studies in vitro will inevitably further our understanding of
testicular physiology and pathophysiology, the assessment and treatment
of malfunction of testicular paracrine mechanisms in the clinical
situation is a long way off. One way forward in this area appears to be
by non-invasive techniques through the identification of markers which
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can be measured and related to testicular function. This approach has
already been adopted to some extent. For example, transferrin in
seminal plasma is thought to be of Sertoli cell origin, and measurement
of this transferrin has been suggested as a suitable marker of Sertoli
cell function. Unfortunately this has turned out to be of little
clinical value as the range of seminal transferrin levels overlaps
between normal men and those with seminiferous tubule malfunction.
Now that the technology is available to detect circulating inhibin
in man, inhibin too may be a possible marker of Sertoli cell function.
The highly significant positive correlation between testicular inhibin
immunoactivity and circulating levels of FSH, found in the present
study, suggest that the concept of FSH-stimulated inhibin production in
the negative feedback control of FSH must be re-examined. These
findings have led to the speculation that the production of inhibin may
be under complex paracrine/autocrine control, and that inhibin might
also serve a paracrine function within the testis in addition to its
better recognized role of FSH regulation. So before inhibin can be used
as a suitable marker of testicular function, further investigation is
required to clarify its role in man.
So at the present time while there is a lack of potential markers
of paracrine events within the testis, the results of a recent study
provide hope that such a marker will be found. The isoenzyme lactate
dehydrogenase - C4 in semen, when expressed in relation to the number of
ejaculated sperm, is a good indicator of the efficiency of
spermatogenesis in that individual. While this enzyme does not reflect
any testicular paracrine event, it demonstrates that in the near future
markers of testicular paracrine events may be detected in blood or
semen. As such it is this approach, in conjunction with studies in
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vitro, that we must now undoubtedly pursue.
Advances in our knowledge of the paracrine control of the testis
should have major consequences in our understanding of and ability to
treat idiopathic infertility in men. The studies reported herein
provide a basic starting point for future investigations of paracrine
control in the human testis.
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